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ABSTRACT 
 
Bioprocessing groups must keep pace with the many biologics and vaccines entering 
development, while ensuring process robustness, controlling costs, and accelerating 
project timelines.  Microscale techniques provide a means to cope with these 
challenges by enabling high-throughput investigations to identify problems early, 
reduce requirements for costly large-scale experiments, and promote quality-by-
design approaches for process optimisation.  Micro-tip columns (packed sorbent in a 
pipette tip) for chromatography and Adaptive Focused Acoustics (AFA) for cell 
disruption are two such techniques with potential to deliver high-throughput process 
development.  This thesis characterises these platforms and integrates them as 
elements of the development workflow. 
 
Firstly, the key parameters are defined for robust, automated micro-tip 
chromatography.  Finite-bath methods for isotherms and kinetic measurements are 
demonstrated, with sorbent contact time found to be critical for uptake of proteins on 
porous adsorbents, consistent with pore diffusion being rate-determining.  Based 
upon these micro-tip data, two data-driven models are applied to predict dynamic 
binding capacity, one employing a shrinking-core model, and the other, a staged-
reaction model.  Both show satisfactory agreement with experimental laboratory 
column results.  Micro-tip chromatography is then illustrated as an accelerated 
process development strategy for a mixed-mode chromatography step, with the 
results found to be predictive of laboratory column-scale yield, purity and capacity.  
In a second application, micro-tip chromatography is used to evaluate the interaction 
of upstream fermentation changes upon the downstream chromatography.  The 
microscale chromatography is predictive of laboratory-scale yield and purity, despite 
being 1000-times smaller, while increasing productivity by over ten-fold.  The 
miniaturisation of the chromatography, however, necessitates the development of a 
microscale cell disruption method to fully realise the gains in throughput and volume 
reduction.  The AFA technique meets this goal, providing representative feed 
material for chromatographic study.  Together, micro-tip chromatography and AFA 
form the basis for a next-generation bioprocess development platform.   
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Melander et al. (1989) to describe protein retention in 
chromatography.  
ii. Constant associated with axial diffusion in the van Deemter equation. 
 
Bi 
 
Biot number 
C i. Solute (sample, adsorbate) concentration in mobile phase (bulk 
solution) 
ii. Hydrophobic interaction parameter in the three-parameter equation by 
Melander et al. (1989) to describe protein retention in 
chromatography.  
iii. Constant associated with mass transfer kinetics in the van Deemter  
     equation. 
 
C0 Initial solute (sample, adsorbate) concentration 
 
cpb Cycles per burst (in Adaptive Focused Acoustics) 
 
CHT Ceramic hydroxyapatite chromatography 
 
CEX Cation exchange chromatography 
 
CV Coefficient of variation 
 
cyc Number of aspiration-dispense pipetting cycles (up, down) used in a 
micro-tip chromatographic operation 
 
dp Average chromatographic particle size (diameter) 
 
D Molecular diffusivity 
 
De Effective pore diffusivity (may also be referred to as DP) 
 
Ds Effective adsorbed phase diffusivity (in surface diffusion) 
 
DBC Dynamic binding capacity 
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DBC10% Dynamic binding capacity at 10% of breakthrough 
 
dc Duty cycle (in Adaptive Focused Acoustics) 
 
F Fractional uptake to maximum equilibrium adsorbent binding: q/qm 
 
DoE Design of experiment 
 
FTE Full-time equivalent (unit of labour) 
 
h Height; column height 
 
HETP Height equivalent of a theoretical plate 
 
HPV Human papillomavirus 
 
huIgG Human immunoglobulin 
 
i.d. Inner diameter 
 
IgG Immunoglobulin 
 
J Mass transfer flux from the bulk mobile phase to the adsorbent surface 
 
k' Retention (capacity) factor 
 
k1 (or ka) Forward rate constant (adsorption) 
 
k2  (or kd) Reverse rate constant (desorption) 
 
kf Film mass transfer coefficient 
 
kp Pore hindrance parameter 
 
K Constant in Freundlich adsorption isotherm model 
 
KD Dissociation constant in adsorbate-adsorbent binding; constant in the 
Langmuir adsorption isotherm model 
 
Keq Equilibrium binding constant; a constant in the linear and Langmuir 
adsorption isotherm models (may also be referred to as KA) 
 
Kp 
 
Partition coefficient (= q/C) 
KSMA Equilibrium binding constant derived from the steric mass action model 
 
L Column length 
 
m Adsorbate mass 
 
ms Molality of salt 
 
mAb Monoclonal antibody 
 
M  Molecular weight (also referred to as MW) 
 
n Exponential constant in Freundlich adsorption isotherm model 
 
N Number of theoretical plates; number of pore transfer units. 
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q Concentration of the adsorbed species on an adsorbent (mass of 
adsorbate per volume of adsorbent) 
 
qm Maximum equilibrium binding capacity of the adsorbent; can be derived 
from the Langmuir adsorption isotherm model; also referred to as qmax 
 
Q Volumetric flow rate 
 
Re Reynolds number 
 
Rp Adsorbent particle radius 
 
Sc 
 
Schmidt number 
Sh 
 
Sherwood number 
STR Stirred tank reactor 
 
t0 Retention time of the unretained solute; used in the calculation of k' 
 
tr Retention time of adsorbing solute; used in the calculation of k' 
 
TC Total contact time (loading time) that the sorbent is in contact with 
liquid (sample) during a chromatographic loading step 
 
TD Delay time following each micro-tip pipetting step 
 
TR Column residence time; for micro-tip columns = 2×× cyc
Q
VA  
v Column interstitial linear velocity  
 
VA  
 
Adsorbent (matrix particles, column) volume (may also be referred to as 
VM) 
 
VE Elution volume 
 
VS  Sample or mobile phase solution volume (also referred to as V) 
 
VT Total tank volume (mobile phase + adsorbent) in a staged reaction model 
 
VLP Virus-like particle 
 
z Characteristic charge of the solute 
 
α10% Empirical correction factor used to relate micro-tip contact time to 
laboratory-column contact time 
 
δ Thickness of laminar sublayer around the adsorbent particle 
 
ε  Column (extra-particle, interstitial) void fraction 
 
εp  Intra-particle void fraction (pore porosity) 
 
φ Phase ratio, defined as the accessible surface area of the adsorbent per 
unit volume of mobile phase 
 
υ  Kinematic viscosity 
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λ Wavelength 
 
μ Column superficial linear velocity 
 
σ Steric hindrance factor; used in the steric mass action model 
 
τ   Tortuosity factor (also represented as θ in Figure 1.5) 
 
Λ i.  Parameter in the steric mass action model: Total ion exchange   
    capacity of the stationary phase  
ii. Term in the shrinking core model  
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1. INTRODUCTION 
1.1. Motivation for the project 
The pharmaceutical industry is under increasing pressure to deliver safer yet cheaper 
medicines, with novel mechanisms of action.  At the same time, one-size-fits-all 
blockbusters have become difficult to achieve because of safety and efficacy 
concerns in patient subpopulations, prompting a push for more personalised 
therapies.  Biotech drugs, or biologics as they are often called, present new options 
for responding to these pressures.  These biologics include therapeutic proteins, 
recombinant vaccines, peptide conjugates, gene therapy, RNA interference, and 
regenerative medicine.  Increasingly, biologics are accounting for a larger share of 
the total pharmaceutical market.  In 2000, there were only three blockbuster (defined 
as > $1 billion in sales) biotech products, whereas in 2006 there were eight 
(Lawrence, 2007).  Sales of biologics amounted to over $75 billion in 2007, making 
up over 10% of the prescription drug market and defined by sales growth that was 
twice that of pharmaceuticals (Fiercebiotech.com).  Furthermore, seven of the 26 
new drugs approved by the FDA in 2009 were biotech therapies (Fiercebiotech.com).  
While overall progress in gene therapy and nucleic-acid based medicines has been 
slow, the therapeutic protein sector has exploded due to the success of monoclonal 
antibodies (mAbs), growth factors such as erythropoietin, and hormones like insulin.  
There were 29 mAbs approved in the US market in 2008 (Aggarwal, 2009) and more 
than 200 in the pipeline worldwide (Tuft Center for the Study of Drug Development, 
2009), with projected sales growth of 14% per year through 2012 (Reichert, 2008).  
In addition to therapeutic proteins, vaccines, like the ones used to prevent 
pneumococcal and human papillomavirus infections, represent another important 
category of multi-billion dollar sales.   
 
The present paradigm of bioprocess development must evolve to keep pace with the 
growing number of new biopharmaceutical candidates entering preclinical 
development while containing cost and reducing product development cycle time.  
Moreover, regulatory initiatives such as 'quality by design' (QbD) are raising the bar 
for biologics manufacture even higher, demanding a thorough understanding of the 
product and its manufacture design space (Rathore and Winkle, 2009).  One solution 
has been to use platform bioprocesses for biomolecules within a same product class, 
such as mAbs (Shukla et al., 2007A).   However, this is not a solution for the vast 
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number of therapeutic proteins and vaccines having unique structural and 
biochemical properties.  Microscale bioprocessing techniques (Micheletti and Lye, 
2006; Titchener-Hooker et al., 2008) offer a step change for bioprocess development.  
These techniques hold the promise of accelerating process development by enabling 
parallel experimentation and automation while requiring only small quantities of 
material.  With less material required, quantitative bioprocess information can be 
obtained earlier in development so that critical process parameters can be better 
understood.  Although these microscale systems do not need to perfectly emulate 
every aspect of large scale operation, they should be able to mimic the key 
engineering characteristics of that operation so that parameters affecting large-scale 
performance can be better understood and their impact predicted.   
 
Development of a process chromatography step is usually performed empirically 
because of the complexity of the separation, meaning that the parameter space often 
is not fully explored at the laboratory scale due to time and resource constraints. 
However, with microscale methods, fundamental parameters that affect the 
operation, such as equilibrium binding and kinetic constants, can be obtained rapidly 
with small amounts of material and then be used to predict column scale performance 
using appropriate engineering correlations or in silico models.  Alternatively, these 
techniques can be used qualitatively to probe the parameter space in the selection of 
adsorbent type and mobile phase conditions, narrowing the focus for subsequent 
larger-scale column optimisation.  In this way, microscale techniques advance QbD 
initiatives while also accelerating process development.  This thesis examines one 
such microscale technique for chromatography study, that being micro-tip 
chromatography and how it can be used as part of a strategy for accelerated 
bioprocess development.  Micro-tip chromatography employs a packed 
chromatographic bed immobilised at the bottom of a pipette tip, thereby offering a 
number of operational advantages over other microwell methods such as micro-batch 
adsorption, in which adsorbent is statically mixed in a microwell.   
 
With the miniaturisation of chromatography experiments, however, comes the need 
for integration with upstream microscale bioprocessing techniques along with low-
volume, high-throughput analytical methods.  New analytical technologies are 
increasingly becoming available for this purpose, while assay automation is reducing 
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the toll on analytical resources.  For sample feed preparation, microscale disruption 
and/or primary recovery methods are essential for realising the advancements in 
throughput and low-volume processing provided by microscale chromatography.  
Therefore, in this project, the technique of Adaptive Focused Acoustics (AFA) is 
evaluated as a means for microscale cell disruption for the purpose of providing 
representative feed material for the downstream chromatography.   
 
 
1.2. Aims for the Project 
This thesis seeks to demonstrate micro-tip chromatography as a platform for 
microscale chromatography and AFA as a platform for microscale yeast cell 
disruption.  Each technique will be fully characterised, with critical operating 
parameters defined.  The primary focus of this thesis will centre on micro-tip 
chromatography and determining how the format can be used to predict 
chromatography scale-up.  The development of a small-scale cell disruption 
technique, in contrast to the goal of micro-tip chromatography, is not intended for the 
study and development of large-scale cell disruption, but rather to provide 
representative feed material for microscale chromatographic experiments, thereby 
yielding an integrated microscale purification.  The use of these microscale 
techniques in the process development workflow will be examined, with the impact 
on developmental and analytical resources considered. 
 
Specific aims of this project include: 
 
i. Automating the micro-tip column format on a robotic liquid-handling 
workstation (Tecan) and defining all critical operating parameters. 
 
ii. Characterising the flow and mass transport properties of the micro-tip 
format and describing how this approach differs from other microscale 
formats.    
 
iii. Developing and evaluating micro-tip methods for determining static binding 
capacity and uptake kinetics.  Examining modelling approaches for 
predicting dynamic binding capacity from these data. 
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iv. Demonstrating the use of micro-tip chromatography for high throughput 
process development, specifically in the case of a mixed-mode 
chromatography step, and considering strategies for efficient experimental 
design.   
 
v. Addressing the capability of the micro-tip format for studying the interplay 
between process unit operations.  In particular, demonstrating the 
miniaturisation of a multi-step chromatographic purification as a scale-down 
mimic of the laboratory-scale chromatography for informing upstream 
fermentation development.  
 
vi. Developing a microscale disruption technique for yeast cells using Adaptive 
Focused Acoustics to provide a feedstock for chromatography experiments 
that is representative of the laboratory-scale homogenate.  Combining this 
microscale cell disruption step with the multi-step micro-tip 
chromatography to yield an integrated microscale purification.   
 
 
1.3. Production of Recombinant Proteins 
Bioseparations encompass the extraction or purification of natural products, live 
viruses and recombinant biomolecules.  Bioprocesses used in the manufacture of 
biologics are typically divided into upstream and downstream processing, with the 
upstream process constituting the cell culture or fermentation and the downstream 
process dealing with its purification.  However, these two components are not 
mutually exclusive and often strongly influence each other.   
 
A typical protein purification process is comprised of a sequence of unit operations 
which exploit the chemical and physical properties of the molecule such as charge, 
hydrophobicity, size, and solubility.  For a review of unit operations used in 
bioseparations, refer to Belter et al. (1988), Ladisch (2001), Harrison et al. (2003), 
and Lightfoot and Moscariello (2004). The unit operations of a purification can 
generally be divided into four stages based on their function: primary recovery, 
capture of the product, intermediate purification, and polishing.  Primary recovery 
involves the removal of cells or cellular debris by filtration, sedimentation, or 
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centrifugation.  For intracellular proteins, a cell disruption step is required as a first 
step in the primary recovery.  Following the primary recovery, the bioproduct is 
isolated (captured) from impurities having different biophysical and chemical 
properties by ultrafiltration, extraction, fixed-bed chromatography, and/or 
precipitation.  The product stream is then further purified by chromatography, 
affinity methods, crystallization, or fractional precipitation.  Lastly, final product 
polishing is carried out by chromatography and/or membrane filtration.  The purified 
bioproduct is then formulated for drug delivery. 
 
Bioprocess development remains largely an empirical exercise, although process 
simulation and computer-aided design techniques have been developed for the 
evaluation of large numbers of process variables and to probe the interaction between 
unit operations (Jungbauer and Kaltenbrunner, 1996 and 1999; Zhou and Titchener-
Hooker, 1999; Rouf et al., 2001; Vasquez-Alvarez et al., 2001).  To reduce process 
development time and cost, platform bioprocesses have been applied for products 
having the same biophysical properties, such as those for monoclonal antibodies 
(Shukla et al., 2007A) and plasmid DNA (Prather et al., 2003; Murphy et al., 2006).  
However, de novo process development is usually required for completely new 
biologics.  Hence, a spectrum of process development exists (Fig. 1.1), ranging from 
platform processes on one end to new developed processes on the other end. 
 
The goal of any bioseparation from a regulatory perspective is to maximally purify 
the product while maintaining bioactivity and product stability, with the ultimate 
goal being to ensure product safety and efficacy.  However, in practice, the design of 
a manufacturing process is also strongly driven by cost and productivity.  Half of the 
cost of biopharmaceutical purification is typically associated with chromatography 
steps (Ladisch, 2001).  Furthermore, material handling can drive the economics of a 
process, with Lightfoot and Moscariello (2004) contending that the overall 
processing cost is inversely proportional to the feed concentration of the 
bioseparation and independent of final purity.  In the end, both cost and product 
quality must be considered in developing a commercially viable biopurification. 
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      Figure 1.1. The process development spectrum, from platform to de novo processes.     
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1.3.1.Fermentation and Cell Culture 
The choice of which expression system to use is one of the most important decisions 
in the production of a protein therapeutic or vaccine since it strongly influences the 
product quality, safety, and process economics.  Escherichia coli, Saccharomyces 
cerevisiae, and immortalised Chinese hamster ovary (CHO) cell lines are the staple 
for biopharmaceutical production, although several new options have emerged, as 
reviewed by Schmidt (2004), Wurm (2004), and Walsh (2006).  E. coli is the most 
widely used prokaryotic system because of historical experience, low cost, short 
generation times, high productivity, and ease of handling.  However, proteins 
expressed in E. coli often may form insoluble aggregates known as inclusion bodies, 
which require additional processing for re-solubilisation.  Consequently, there has 
been recent focus on designing secretory E. coli systems like those of mammalian 
cell lines (Choi and Lee, 2004), although with mixed results.  Alternatively, E. coli 
and Pseudomonas fluorescens expression systems (Chae et al., 2002; Retallack et al., 
2007) have been developed in which the expressed protein is transported to the 
periplasm, providing a simple way of recovering the protein in its soluble form.  
Disadvantages of prokaryotic systems are that they are not suitable for proteins 
requiring post-translational modification (such as N- and O-glycosylation), and there 
is a burden to clear pyrogenic or pathogenic impurities.  Yeasts, like prokaryotes, can 
be grown cheaply and quickly with high product titres, yet they have little of the 
safety risk associated with prokaryotic systems.  The most commonly used yeast host 
cells are Saccharomyces cerevisiae and Pichia pastoris.  While most yeast systems 
are also not suitable for glycosylated protein expression since they do not naturally 
produce human glycans, Pichia pastoris strains have recently been engineered to do 
so (Li et al., 2006), thereby taking advantage of the fast processing times and high 
titres provided by yeast.   
 
Despite the advances with glyco-engineered yeasts, mammalian cell lines are still the 
preferred system for producing human (or humanised) glycosylated proteins, 
especially for monoclonal antibodies.  CHO cells are the most commonly used of 
these, although mouse myeloma  (NS0), baby hamster kidney (BHK), human embryo 
kidney (HEK-293), and human retinal cells have also been used in the production of 
approved products (Wurm, 2004).  Drawbacks of mammalian cell lines are their cost, 
the fact that their cultivation usually requires days to weeks, and that the resulting 
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product may have a heterogeneous glycan distribution.  As a result, development of 
these cell lines typically centres on increasing productivity while achieving a desired 
glycan distribution for the product.  The productivity of many of these cell lines has 
increased significantly since they were first introduced in the mid-1980s, with 
product titres now often exceeding 4 g/L in the production of monoclonal antibodies 
in CHO cells (Wurm, 2004).   
 
1.3.2. Cell Disruption and Primary Recovery 
The first step in the purification of a recombinant protein is to harvest it from the cell 
suspension used in its production.  For secretory systems, this means gently 
removing the cells and recovering the product in the resulting supernatant.  However, 
for intracellular proteins, the cells must first be disrupted.  An overview of some 
commonly used cell disruption techniques is shown in Table 1.1.  Selection of the 
appropriate method must balance economic and operational considerations with cell 
breakage, product release and stability, and the impact on downstream processing.  
Disruption of prokaryotic and yeast cells at the industrial scale is almost always 
carried out by a one of the mechanical methods, with the most common being solid-
shear (bead-mill) and high pressure homogenisation (Middelberg, 1995; Garcia, 
1999; Hopkins, 2001; Hatti-Kaul and Mattiasson, 2003.)  Non-mechanical methods 
offer a gentler and sometimes more selective alternative that is based on physical, 
chemical, or enzymatic lysis.  However, these methods are typically used only for 
laboratory experiments or to supplement mechanical disruption.  
 
The primary recovery step constitutes a solid-liquid separation in which the cells and 
cellular debris are removed from the liquid phase.  For soluble proteins, the product 
is recovered in the liquid medium; however, for inclusion bodies produced by E. coli, 
the insoluble protein must first be differentially recovered from the other cell solids 
and then the soluble form of the protein renatured from these inclusion bodies.  
Primary recovery is typically carried out by centrifugation, sedimentation, filtration, 
or microfiltration.  Flocculation and filter aids are sometimes used to enhance the 
efficiency of these techniques (Sharma, 1999; Lightfoot and Moscariello, 2004).  The 
choice of the specific technique and its operating conditions depends on the 
expression system, the solubility of the expressed protein, and whether or not whole 
cells or cellular debris are being removed. 
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Table 1.1. Methods for cell disruption in the recovery of intracellular proteins.  
Mechanical Non-Mechanical 
 
 Physical Chemical Enzymatic 
Bead Mill 
 
 
Osmotic shock Detergents Lytic Enzymes 
Rotor-Stator   
  Homogeniser 
 
Thermolysis Chelating Agents Autolysis 
High-Pressure  
  Homogeniser 
 
Freeze-fracturing Chaotropes  
Ultrasonicator 
 
 
 Solvents  
 
 
 Antibiotics  
 
 
In addition to these techniques, expanded-bed adsorption (EBA; also known as 
fluidised bed chromatography) has been developed as a way of combining primary 
recovery with the initial capture chromatography (Chase, 1994).  In EBA, a 
distribution of chromatographic particle diameters with varying densities is operated 
in a fluid field, resulting in an expansion of the bed by a factor of two- to three-fold.  
This expanded bed has a significantly increased void volume, allowing cellular 
debris and whole-cell broth to move through the column more easily as long as the 
feed is diluted to around 10-15% wet cell weight (Bierau et al., 1999).  Although 
EBA has been demonstrated at the pilot scale, its deployment in industrial-scale 
production is still not commonplace due to concerns about fluid distribution, 
cleaning validation, and chromatographic performance.   
 
1.3.3. Preparative Chromatography  
Preparative chromatography forms the backbone of most protein purification 
processes because of its high efficiency and selectivity, with many of these processes 
consisting of two to three chromatography steps (Fig. 1.2).  An initial 
chromatography for product capture is carried out, followed typically by a second  
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Figure 1.2. Typical bioprocess for protein production, consisting of two to three 
chromatographic steps.   
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chromatography for additional purification of the product from residual host-cell  
contaminants and process excipients.  In some cases, a third chromatography may be 
performed as a polishing step to clear hard-to-remove residual impurities not purified 
away in the preceding steps. 
 
1.3.3.1.  Modes of Operation 
Process chromatography is a term encompassing all chromatographic separations in 
the manufacture of defined products.  As opposed to analytical chromatography, 
process chromatography attempts to maximise throughput and capacity while 
achieving a defined purity.  Therefore, the stationary phase is typically overloaded.  
Preparative chromatography may be operated in a packed-bed, stirred-tank, or 
expanded-bed configuration.  In the case of packed-bed chromatography, the 
adsorbent may be packed in either an axial-flow or a radial-flow column, and may be 
operated as a single column or in a simulated-moving-bed format (Cramer and 
Jayaraman, 1993; Lyddiatt, 2002).  Of these, a single axial-flow column is the most 
common.   
 
Process chromatography is typically operated in one of two modes, 'bind-and-elute' 
or 'flow-through'.  In bind-and-elute mode, the protein product is bound to the 
column and then separated across the length of the column under isocratic, linear-
gradient, or step-gradient elution conditions (Harrison et al., 2003; Guiochon et al., 
2006).  A typical bind-and-elute chromatography step includes a column 
equilibration stage, sample loading, one or more wash steps, and product elution.  In 
contrast, in flow-through mode, the feed (sample) is loaded continuously on the 
column with the goal being to bind contaminants to the column while the product 
passes through and is recovered.  The typical stages in this mode include column 
equilibration and sample loading, with a column wash sometimes performed after the 
load.  A slight variation to the typical flow-through mode is 'weak-partitioning 
chromatography', which was developed by Kelley and co-workers (2008A) for the 
purification of monoclonal antibodies.  In weak-partitioning chromatography, the 
mobile phase conditions of the feed are adjusted so that the protein product binds 
weakly to the column, eluting isocratically during the load and in a short wash 
following the load.  By carrying out the chromatography in this fashion, better 
separation can be achieved between the product and more tightly binding impurities.     
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An alternative to single column chromatography is simulated-moving-bed (SMB) 
chromatography, which seeks to improve production rates by providing a format for 
a continuous separation (refer to Guiochon, 2002, for a review of SMB).  Here, the 
column is configured as a column train having four or more successive sections.  A 
counter-current movement of the stationary phase is simulated by column switching 
of two successive columns in the train.  SMB has found renewed interest in the 
industrial separation of enantiomers but is still used infrequently for bioseparations.        
 
A chromatographic separation can also be carried out as a batch adsorption process 
in a continuously stirred tank, where the adsorbent is then recovered by settling, 
filtration or centrifugation (Belter et al., 1988; Lyddiatt, 2002).  Unlike column 
chromatography, batch adsorption can be operated in the presence of cells or cellular 
debris and does not require a geometrically refined adsorbent particle.  However, a 
significant limitation of this approach is that it offers only a single-stage of 
equilibrium adsorption as opposed to the rapid multistage processes achievable by 
packed-bed chromatography.  Therefore, batch adsorption is used less frequently in 
protein purification processes, although it has been used in antibiotic purification, 
blood plasma fractionation, and hepatitis B vaccine processing (Beyzavi, 1999).   
 
1.3.3.2.  Sorbent Properties  
Chromatography sorbents are characterised by their base support and surface 
chemistry.  The sorbents are functionalised by attaching a binding ligand to the base 
matrix, with or without a spacer.  Use of a spacer can affect retention by impacting 
the accessibility of the biomolecule to the ligand, decreasing the effective pore 
volume, and providing a source of non-specific interaction.  While the surface 
chemistry determines the primary separation mechanism, the base matrix can 
strongly influence the mass transport properties of the separation and contribute to 
secondary binding effects (Boschetti, 1994; Muller, 2005).  The base matrix may 
either be porous or non-porous, with the majority of base matrices used in 
preparative protein chromatography being porous.  Both inorganic and organic 
materials are used in the preparation of base matrices (Muller, 2005).  Inorganic base 
matrices include hydroxyapatite, alumina, silica, and controlled pore glass.  Organic 
polymers include cellulose, agarose-based matrices, cross-linked dextran, 
polyacrylates, and polyvinyl polymers (Beyzavi, 1999).  Composite materials have 
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also been developed in order to combine the rigidity of one material with the 
biocompatibility and stability of another (Muller, 2005).   
 
The ligand chemistries commonly used for process-scale protein purification are 
anion exchange (AEX), cation exchange (CEX), hydrophobic interaction (HIC), 
affinity, size-exclusion (SEC), and ceramic hydroxyapatite (CHT) chromatography.  
These are summarised in Table 1.2 along with their separation mechanism.  Reversed 
phase chromatography is used only to a limited basis because of concerns about 
protein denaturation.  In addition to the above chemistries, a new generation of 
ligands have recently emerged offering new modalities for purification.  Specifically, 
these include biomimetic ligands for affinity chromatography (Roque et al., 2005; 
Clonis, 2006) and mixed-mode ligands with dual separation modalities, e.g. 
hydrophobic and ion-exchange properties (Burton and Harding, 1998; Johansson et 
al., 2003A; Johansson et al., 2003B; Chen et al., 2008A).   
  
The properties of the chromatographic base matrix and their potential influence on 
the chromatography are summarised in Table 1.3 (Boschetti, 1994; Muller, 2005).  
Smaller sorbent particle sizes can increase dynamic binding capacity and improve the 
overall resolution of the chromatography; however, they usually lead to higher 
column back-pressures.  Therefore, particles sizes of less than 20 microns are 
generally not used in process chromatography.  In addition, sorbent properties such 
as the pore volume and pore size distribution can affect protein uptake rates (pore 
diffusivity) as well as protein retention (DePhillips and Lenhoff, 2001).  
Consequently, adsorbent design and optimisation must consider not only the ligand 
chemistry but also these physical properties of the base matrix.  
 
Two major limitations of conventional preparative adsorbents are the slow diffusive 
mass transport within the pores and the stability of the packed bed (Cramer and 
Jayaraman, 1993; Guiochon, 2002).  Consequently, new packing materials and 
modes of chromatography have been developed to address these concerns.  Many 
manufacturers now offer resins with greater mechanical stability, such as the Capto 
resins by GE Healthcare (Uppsala, Sweden), thereby enabling more rapid processing 
and higher productivity.  Radial flow chromatography also has been used as a way to 
avoid the instability, large pressure drops, and flow problems of large, axial-flow 
  - 32 -
columns.  The geometry of the radial flow design increases the flow area and 
decreases the flow path; however, it is less effective for multistage separations 
(Cramer and Jayaraman, 1993).  Monolithic columns offer the potential for fast mass 
transfer (Barut et al., 2008), which is of particular importance to large molecular  
 
 
 Table 1.2. Types of ligand chemistries used in preparative protein chromatography. 
 
Type 
 
 
Examples of Ligand Types 
 
 
Mechanism of Separation 
 
 
Cation-exchange 
 
Sulfopropyl (SP) 
Methylsulfonate (S) 
Carboxymethyl (CM) 
 
 
Electrostatic interaction 
Anion-exchange 
 
 
Diethylaminoethylene (DEAE) 
Quaternary aminoethyl (QAE) 
Quaternary ammonium (Q) 
 
Electrostatic interaction 
Hydroxyapatite (Ca5(P04)3OH)2 Cation-exchange and coordination 
bonds (between Ca2+ and 
carboxyl/phosphoryl groups) 
 
Hydrophobic 
Interaction 
Phenyl- 
Butyl- 
Octyl 
 
Hydrophobic complex formation 
Mixed Mode N-benzyl-N-methyl-      
  ethanolamine 
4-mercapto-ethyl-pyridine 
Phenylpropylamine 
MMC 
 
Multi-modal (e.g. hydrophobic 
interaction and ion exchange) 
Reversed phase 4-carbon alkyl (C4) 
18-carbon alkyl (C18) 
 
Hydrophobic complex formation 
Size-exclusion 
chromatography 
 
N/A (porous inert base matrix) 
 
Steric exclusion 
Affinity, Pseudo-
affinity  
Protein A/G 
Glutathione 
Heparin 
Dye 
Antibody 
Recombinant  protein 
Biomimetic 
Lectin 
Immobilised metal affinity  
 
Biospecific interaction, 
coordination complex formation 
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assemblies such as viruses, but only recently has the technology been available at 
process scale.  Therefore, it has yet to find widespread use.  Perfusion 
chromatography attempts to improve mass transfer by using a chromatographic 
support with very large through-pores for convective flow in addition to a network of 
short diffusive pores (Afeyan et al., 1990; Regnier, 1991).  At high linear velocities 
(>1000 cm/h), convective flow through these large pores is thought to dominate over 
diffusive transport.  In addition, a number of chromatography manufacturers now 
produce adsorbents with a hydrogel structure, in which the pore is filled with a three 
dimensional network of ligands (the so-called "gel in a shell"). As a result, these 
resins have significantly higher binding capacities and improved mass transfer.  
Examples of these resins include Ceramic Hyper D and Hyper Q from Pall (Port 
Washington, NY, USA), Toyopearl Super Q from Tosoh Bioscience 
(Montgomeryville, PA, USA), and Capto S and Q from GE Healthcare (Uppsala, 
Sweden).    
 
1.3.3.3.   Operational Parameters  
In addition to the sorbent properties, chromatographic behaviour depends on the 
mobile phase composition and operating conditions of the chromatography (Table 
1.3).  These operational parameters include column geometry, flow rate, and 
temperature.  Once an adsorbent is selected for a particular purification step, the 
mobile phase composition of the load, wash, and elution steps must then be 
optimised to maximise recovery and purity.  This optimisation typically involves 
varying the pH, ionic strength, buffer type, and mobile-phase modifier (i.e. salt or 
solvent) type and concentration.  Column height and flow rate are two other 
important factors that are optimised to increase the separation efficiency and 
dynamic binding capacity of the step.   
 
1.3.4. Membrane Separations 
Membranes are used in protein purification processes for primary recovery (cell 
harvest and clarification), product purification or fractionation, product 
concentration, buffer exchange, sterile filtration, and virus removal. The most 
commonly used membrane processes are microfiltration and ultrafiltration.  
Microfiltration is used to remove solid particulates such as cells and cellular debris 
from the liquid medium.  These membranes usually have pore diameters in the 
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micron range and may be classified as depth filters, surface filters, or screen filters 
(Kalyanpur, 1999).  Depth filters are made of fibrous, granular, or sintered material 
with a random pore structure, whereas surface filters are comprised of layers of glass 
or polymeric microfibers (i.e. 'hollow fibres').  Screen filters are made of a porous 
matrix, often a polymeric material, with a well-defined pore size in the range of 0.1  
to 1 μm (Kalyanpur, 1999).  Particles and solutes larger than the rated pore size are 
retained at the surface of these membranes.  Therefore, membranes of this type are 
also used for sterile filtration, viral removal, and ultrafiltration.  In the case of 
ultrafiltration, the pore sizes are usually rated by the molecular weight of the 
dissolved solute(s) rather than by their diameter. 
 
Table 1.3. Parameters affecting performance in preparative column chromatography. 
Parameter Influence on 
 
   
Mobile Phase Buffer type Retention, selectivity 
 pH Retention, selectivity 
 Ionic Strength Retention, selectivity 
 Modifier (salt, solvent) type Retention, selectivity 
 Modifier (salt, solvent) conc. Retention, selectivity 
   
Operational Flow rate Efficiency 
 Temperature Efficiency, retention, selectivity 
 Column length (geometry) Efficiency 
 Loading amount Efficiency 
 Elution gradient Selectivity 
   
Sorbent Surface chemistry (ligand) Retention, selectivity 
 Ligand arrangement, Spacer arm Efficiency, retention, selectivity 
 Ligand density Retention, selectivity 
 Pore structure (geometry) Efficiency, retention, selectivity 
 Pore volume Efficiency and retention 
 Particle size Efficiency 
 Base matrix material Efficiency, retention, selectivity 
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Adsorptive membrane chromatography (Ghosh, 2002) is a variation on a traditional 
membrane separation in which the membrane is functionalised with a charged group 
or affinity ligand.  This offers an alternative to the slow diffusive mass transfer in 
porous resin since the flow through the membrane pores is convective, thereby 
allowing for fast on-off separations.  This approach can be easily scaled up, and 
because membranes are cheaper to manufacture, they are potentially disposable.  In 
addition, adsorptive membranes allows for the possibility of combining the lysate 
clarification with an initial purification.  Disadvantages, however, are that these 
membranes have lower capacities than most chromatographic adsorbents and can be 
variable in their thickness, pore size distribution, and inlet flow distribution.    
 
 
1.4. Theoretical Considerations in Preparative Liquid Chromatography 
Chromatography was first developed by the Russian botanist Tswett at the turn of the 
20th century in the separation of plant pigments (Tswett, 1906).  It is defined as a 
separation process in which a solute interacts with a chromatographic stationary 
phase and is separated according to its distribution between the mobile phase and the 
stationary phase.  Hence, the separation of a mixture depends on the differing 
migration velocities of each component, which in turn is defined by the unique 
structural properties and surface chemistry of these components.   
 
Although the development of a bioprocess chromatographic step is often done 
empirically, development is aided by a fundamental understanding of the 
thermodynamics and kinetics (mass transfer) of the chromatographic process.  Each 
of these concepts in turn requires the mode of contact to be considered, i.e. flow 
through a fixed bed or batch adsorption in a stirred vessel.  Adsorption equilibrium 
between the solute and stationary phase are typically characterised by adsorption 
isotherms, which may be linear or nonlinear and which may model single-component 
or multi-component (competitive) systems (Belter et al., 1988; Ladisch, 2001; 
Harrison et al., 2003; Guiochon et al., 2006).  However, column chromatography is 
not typically operated at equilibrium and is subjected to dispersive effects and mass 
transfer resistances.  In porous resins, mass transport is affected not only by factors 
such as flow rate, bed packing quality, and sorbent particle size but also by the pore 
size distribution and the pore tortuosity.  A variety of models of varying complexity 
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have been developed to describe mass transport, considering such components as 
axial dispersion, external film mass transfer, pore diffusion, surface diffusion, and 
surface reaction kinetics (Guiochon and Lin, 2003; Carta et al., 2005).   
 
1.4.1. Adsorption 
The adsorbent capacity, binding affinity, resolution, and selectivity of a 
chromatographic separation are affected strongly by the ligand chemistry, its density 
and distribution, and the accessible surface area of the stationary phase.  Binding of a 
biomolecule to an adsorbent may involve electrostatic interactions (e.g. van der 
Waals or dipole-dipole forces), hydrophobic interactions, and hydrogen bonding.  
Consequently, the three dimensional structure of the protein (shape and size), its 
surface chemistry (e.g. charge), and the specific distribution of amino acids all 
contribute to binding.  In addition, the physical properties of the base matrix can 
strongly influence retention.  DePhillips and Lenhoff (2001 and 2004) in their work 
with cation-exchange adsorbents found that the anion type on the ligand, the 
adsorbent pore-size distribution, and local patches on the surface protein (instead of 
its overall net charge) were key determinants of protein retention.  Interestingly, with 
respect to the pore size distribution, retention was enhanced for those adsorbents 
having pore dimensions similar to the size of the protein solute, presumably because 
the protein was surrounded by the charged ligand.  Cramer and co-workers have used 
protein crystal structures and primary amino acid sequence information in 
combination with quantitative structure-property relationship (QSPR) models to 
predict chromatographic behaviour in ion-exchange (Tugcu et al. 2003; Yang et al., 
2007A) and hydrophobic interaction chromatography (Chen et al., 2008B), as well as 
in the a priori design of mixed-mode ligands (Yang et al., 2007B).  All of these 
studies attempt to gain a more comprehensive understanding of the underlying 
mechanisms of adsorption at the molecular level.   
 
1.4.1.1.  Single-Component Adsorption Isotherms  
The thermodynamics of phase equilibria in liquid chromatography is described by 
adsorption isotherms.  Knowledge of isotherms is important in understanding 
adsorption and integrating the differential mass balance equations used in 
chromatography models (Guiochon, 2002).  Adsorption isotherm studies are carried 
out by having excess amounts of the binding species in the mobile phase close to the 
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surface of the stationary phase, with adsorption influenced by the chemical potential 
of each species.  Isotherms are used in preparative chromatography for determining 
static binding capacity, revealing separation characteristics and the extent of 
purification, comparing the potential of different separation schemes, and modelling 
chromatographic separations.  An incomplete understanding of isotherm curvature 
can often explain problems in scale-up of preparative chromatography (Guiochon, 
2002).  While bioseparations almost always involve multiple components, single-
component isotherms still provide the simplest and most convenient means for 
understanding the thermodynamics of product binding and optimising the 
chromatographic step.   
 
The simplest procedure for determining adsorption isotherms is by static batch 
adsorption, in which either the adsorbate (protein) or adsorbent concentration is 
varied across a concentration range and then mixed together in a vessel until 
equilibrium is reached (usually a few hours to a few days).  The concentration of the 
adsorbate (binding species) in the liquid phase is measured following the incubation, 
with the concentration on the stationary phase (mass loaded per unit volume of 
adsorbate) calculated by material balance and graphed as a function of the 
equilibrium concentration in the mobile phase (Fig. 1.3).  This approach can be time-
consuming and laborious, unless automated, and does not guarantee an accurate 
reflection of dynamic column conditions.  Alternatively, dynamic methods using a 
column configuration have been developed for faster and more accurate 
determination of adsorption isotherms.  These methods attempt to solve the general 
inverse problem of chromatography, i.e. determining isotherm and rate constants by 
knowing the solution of the system of mass balance equations from band profiles and 
controlling boundary conditions (Guiochon et al., 2006).  Commonly used dynamic 
methods include frontal analysis (FA), elution by characteristic point (ECP), frontal 
analysis by characteristic point (FACP), and pulse methods (as reviewed by 
Guiochon et al., 2006).  Of these, only the pulse method is typically used for 
competitive adsorption isotherms.   
 
A number of adsorption isotherm models exist to describe liquid-solid equilibria for 
single- and multi-component systems.  A review of these is provided by Guiochon et 
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Figure 1.3. Graphical example of three equilibrium adsorption isotherm models used 
to describe protein adsorption: the Linear, Freundlich, and Langmuir models.   
 
 
 
 
 
 
 
 
 
 
 
 
 
  - 39 -
al. (2003 and 2006).   While some of the models have a theoretical basis, others are 
simply empirical.  Three commonly applied single-component isotherm models for 
protein adsorption are the Linear, Freundlich, and Langmuir models, as shown in 
Figure 1.3.  In the ideal case, adsorption is assumed to be completely reversible, 
there is no non-specific binding, and the binding sites are homogeneous.  When the 
concentration of adsorbent binding sites significantly exceeds the adsorbate 
concentration (i.e. adsorbent is vastly underloaded with adsorbate relative to its 
saturation concentration), the chromatography is linear and is given by:  
q = qmKeqC ,       Equation 1.1 
where q is the concentration of adsorbed species on the resin, qm is the maximum 
binding capacity, C is the concentration of the species in solution, and Keq is the 
equilibrium constant for the adsorption reaction.  This is typically the case in 
analytical chromatography, where baseline resolution and reproducible elution times 
are important.  In contrast, preparative chromatography is rarely operated in the 
linear limits because the capacity of the adsorbent must be maximised for highest 
productivity.      
 
Two classical adsorption isotherm models used to describe nonlinear 
chromatographic bioseparations are the Freundlich and Langmuir isotherms.  The 
Freundlich isotherm describes the energetic heterogeneity on the surface of the resin 
(Harrison et al., 2003) and corresponds approximately to an exponential distribution 
of heats of adsorption (LeVan et al., 2008).  It is used most often for antibiotic, 
steroid, and hormone adsorption (Belter et al., 1988; Harrison et al., 2003).  It is 
given by: 
 q = K Cn ,         Equation 1.2 
where K and n are constants that are determined experimentally, typically from a log-
log plot of q versus C.  When the adsorption is favourable, n is less than 1, while 
when it is unfavourable, n is greater than 1.      
 
The Langmuir isotherm was originally developed for the adsorption of gases to glass 
and mica surfaces but now is one of the most widely used models for protein 
adsorption in single-component systems on homogeneous surfaces.  It postulates that 
a reversible binding reaction occurs between the adsorbate and the vacant sites of the 
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adsorbent, with these sites being equivalent, distinguishable, and independent (Belter 
et al., 1988; Zhu et al., 1991).  It also assumes that only one solute molecule can bind 
per binding site and that this binding is localised and does not influence adsorption of 
another molecule at another site (Gritti et al, 2003).  The Langmuir isotherm is 
described by:    
q = 
CK
CKq
eq
eqm
+1
,       Equation 1.3 
where qm is the maximum binding capacity (monolayer) of the adsorbent.  It can also 
be expressed as a function of KD, the dissociation constant in adsorbate-adsorbent 
binding: 
 q = 
CK
Cq
D
m
+
.       Equation 1.4 
The consequence of the Langmuir isotherm in preparative chromatography is that 
adsorption depends not only on the equilibrium constant of the adsorbate but also on 
the binding capacity of the adsorbent.  Typically, a process column is overloaded and 
is therefore operated in the nonlinear region of the isotherm, where baseline 
resolution may be difficult to achieve.   
 
The assumptions of the Langmuir isotherm do not always hold, however.  This can 
be the case if the adsorbent surface is not homogeneous, there are two or more 
different types of ligand functional groups, there is extensive non-specific interaction 
with the base matrix, or the binding is not localised (Guiochon et al., 2006).  
Therefore, other single-component isotherm models have been developed to 
addresses these situations, such as the bi-Langmuir, Fowler, Quadratic, Jovanovic, 
Jovanovic-Freundlich, Martire, Moreau, and Toth isotherms.  Each of these models 
attempts to account for surface heterogeneity on the adsorbent and/or adsorbate-
adsorbate interactions, although many of these are not relevant to the binding of large 
biomolecules onto preparative adsorbents.  As a result, despite its limitations, the 
Langmuir isotherm remains the most commonly used isotherm model for describing 
single-component protein adsorption in preparative chromatography. 
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1.4.1.2.  Multi-Component Adsorption Isotherms  
Competitive isotherm models have been developed for binary and multi-component 
systems, but these models are generally less rigorous than their single-component 
counterparts since a full understanding of multi-component interactions is incomplete 
(Guiochon et al., 2006).   The Langmuir isotherm can be modified to deal with multi-
component systems, in which the rate of desorption is considered along with the rate 
of adsorption.  While the rate of adsorption of each component is proportional to its 
concentration and the free surface area, the rate of desorption is proportional to the 
surface area occupied by each component.  Therefore, a system of linear equations 
can be written and solved.  For the ith component of a multi-component system, the 
competitive isotherm is described by (Guiochon et al., 2006): 
qi = 
jj
n
j
ii
Cb
Ca
11 =∑+
,      Equation 1.5 
where n is the number of components in the system and a (= qm* Keq) and b (= Keq) 
are the coefficients of the single-component Langmuir isotherm for component i, and 
their ratio (a/b) is the column saturation capacity for component i.   
 
The competitive Langmuir isotherm has a number of limitations.  Although it 
provides a very useful first-order approximation of the experimental data, it lacks 
thermodynamic rigor and does not sufficiently predict overloaded elution profiles.  
Specifically, it cannot quantitatively predict competitive isotherm behaviour when 
the difference between the column saturation capacities for each component exceeds 
5 to 10% (Felinger and Guiochon, 1996).   
 
Other competitive adsorption isotherm models have been developed for multi-
component systems where the competitive Langmuir falls short (reviewed by Zhu et 
al., 1991; Guiochon et al., 2006).  These include the competitive bi-Langmuir model 
to deal with a surface covered with two different binding sites, the Ideal Adsorbed 
Solution model to account for differences in column capacities between two 
components in a binary mixture where the single-component adsorption is 
Langmuirian, and Statistical Isotherm models in which equilibrium binding is 
described by the ratio of two second-degree polynomial equations.  In addition, the 
Fowler model has been modified to deal with binary mixtures, and the hybrid 
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Freundlich-Langmuir isotherm has been extended to address the situation of strong 
adsorption at low concentration in multi-component separations.    
 
1.4.1.3.  Adsorption Isotherm Models for Ion-Exchange Chromatography  
Several adsorption isotherm models have been developed for the special case of ion-
exchange chromatography, in which the exchange between the solvent and the 
adsorbed molecules is considered to be stoichiometric rather than statistical.  
Classical stoichiometric theory of the salt elution of biomolecules in ion-exchange 
chromatography was developed by Boardman and Partridge (1955) and then 
expanded upon by Rounds and Regnier (1984) to correlate protein retention with 
mobile phase composition and protein charge in linear chromatography.  Regnier and 
Mazsaroff (1987) later applied the theory to the competitive adsorption of proteins.   
These stoichiometric displacement models (SDM) assume binding by coulombic 
interaction at fixed sites but fail to consider other stationary phase interactions such 
as hydrophobic interaction.  
 
Melander et al. (1989) considered hydrophobic effects in their mathematical 
treatment of the stoichiometric model, which is described by Langmuirian kinetics 
with a mobile phase modulator and is based on an adaptation of solvophobic theory. 
Solvophobic theory predicts that the contribution of hydrophobic interaction to the 
free energy of binding is proportional to the hydrophobic contact area and surface 
tension of the salt solution.  Here, the salt is considered to be inert and the 
biomolecule is assumed to be retained by the electrostatic field at the surface of the 
stationary phase but retains some freedom of movement in the layer above it.  The 
interplay of hydrophobic and electrostatic interactions is then described by a three-
parameter equation: 
Log k’ = A – B log ms + C ms ,    Equation 1.6  
where k’ is the retention factor (capacity factor), ms is the molality of the salt in the 
eluent, and A is a constant encompassing all characteristic system parameters.  
Parameter B is the electrostatic interaction parameter and depends on the charge of 
the protein and counter-ion.  Parameter C is the hydrophobic interaction parameter 
and depends on the contact area of the protein with the stationary phase and on the 
properties of the salt.   
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Whitley et al. (1989) and Velayudhan (1990) observed that a macromolecule such as 
a protein shields a large number of charged binding sites due to its sizeable surface 
area, thereby reducing the capacity of the resin below its stoichiometric capacity.  
Accordingly, if an empirical shielding factor is incorporated into a mass action 
model, it provides a much better representation of ion-exchange isotherms for a 
number of model proteins.  Brooks and Cramer (1992) extended this work to 
competitive systems, and then later Gallant et al. (1995) expanded the theory to the 
non-linear elution of proteins.  In this steric mass action adsorption (SMA) model, 
the salt competes with the protein for available binding sites.  The shielding factor 
used in the model depends not only on the ionic strength and composition of the 
solution but also on the adsorbent composition and on the properties and 
concentration of the protein.  The SMA isotherm model for a single component 
(protein) i is given by: 
    Ci =
iz
iii
salt
SMA
i
qz
C
K
q
⎥⎥⎦
⎤
⎢⎢⎣
⎡
+−Λ
×
)(σ
,    Equation 1.7 
where Ci is the protein concentration, KSMA is the equilibrium constant, Csalt is the 
mobile phase salt concentration, zi is the characteristic charge of the protein, σi is a 
steric hindrance factor, qi is the adsorbed protein concentration, and Λ is the total 
ionic capacity of the stationary phase.   
 
1.4.1.4.  Retention Factor 
The retention of a protein across a chromatographic column can be characterised by 
its retention factor, k', thereby providing an alternative method to adsorption 
isotherms for studying chromatographic adsorption.  The retention (or capacity) 
factor is defined as the ratio of the time spent by the solute of interest in the 
stationary and mobile phases under linear conditions (Guiochon et al., 2006): 
0
0'
t
tt
k r
−
= ,       Equation 1.8 
in which the retention factor k' is a dimensionless value, tr is the retention time of the 
solute of interest, and t0 is the time that it takes the unretained solute to pass through 
the column.  The retention factor is related to the equilibrium constant, Keq, by: 
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φeqKk =' ,       Equation 1.9 
where φ  is the phase ratio defined as the accessible surface area of the adsorbent per 
unit volume of mobile phase.  The retention factor is useful in that it reflects both the 
molecular interaction of binding and the physical characteristic of the stationary 
phase.  Furthermore, the separation of two binding species, A and B, can then be 
described by comparing their retention factors.  The separation between A and B is 
defined by the selectivity factor, a: 
  
A
B
k
ka
'
'
= ,       Equation 1.10 
where k'B and k'A are the retention factors for species B and A, respectively, with A 
being the faster eluting species.   
 
1.4.2. Mass Transport 
The separation efficiency (i.e. peak resolution) and dynamic binding capacity (DBC) 
of column chromatography is impacted by the mass transport within the 
chromatographic bed.  Mass transport factors include axial diffusion, eddy diffusion 
(resulting from variability in the flow path through the column), bed heterogeneity, 
and mass transfer kinetics (Guiochon et al., 2006).  In porous adsorbents, the mass 
transfer kinetics depend on the external (extraparticle) mass transfer, pore 
(intraparticle) diffusion, pore surface (solid) diffusion, and surface reaction kinetics 
(adsorption/desorption kinetics).  Consequently, the column packing efficiency, 
adsorbent particle size, pore size, and pore network all can impact mass transport and 
hence chromatographic performance.   
 
1.4.2.1.  Plate Models and Rate Theory 
Plate models (Martin and Synge, 1941; Craig, 1944) have been used to describe the 
band broadening and retention of a solute migrating through a column. In these 
models, a column is divided into a set of identical theoretical plates, representing 
stages of equilibrium.  The height equivalent of a theoretical plate (HETP) for a 
column (L) with N theoretical plates is defined by: 
 
N
LHETP = .       Equation 1.11 
The number of theoretical plates, N, is determined by: 
  - 45 -
 2
2/1
255.5
w
tN r= ,       Equation 1.12 
where w1/2 is the peak width of the eluting chromatographic peak at half-height.  
Plate models are empirical, with the number of theoretical plates correlated to the 
variance observed in the chromatographic profile.   
 
Van Deemter et al. (1956) related plate height to the mobile phase linear velocity by 
considering the effects of axial diffusion, eddy diffusion, and mass transfer kinetics: 
 μ
μ
CBAHETP ++=  ,      Equation 1.13 
where μ is the linear velocity, A is a constant associated with eddy diffusion, B is a 
coefficient associated with axial diffusion, and C reflects the mass transfer kinetics. 
(Note that although the same symbols are used, these do not refer to the same 
constants as those in Equation 1.6).  Figure 1.4 shows the relationship between 
reduced plate height (HETP divided by the adsorbent particle diameter) and reduced 
velocity (product of the velocity and the adsorbent particle diameter divided by the 
solute diffusion coefficient).  For the chromatography of proteins on preparative 
adsorbents, Carta et al. (2005) calculate that the reduced velocity is between 140-
8000, implying that the efficiency of the separation is determined mostly by the mass 
transfer kinetics. 
 
1.4.2.2. Mass Transfer in Porous Adsorbents 
The mass transfer of a solute onto a porous stationary phase is illustrated in Figure 
1.5 (from Horvath and Lin, 1978).  The chromatographic process proceeds by the 
following steps: (1) external transport of the solute from the bulk mobile phase to the 
surface of the particle; (2) diffusion within the pore; (3) adsorption to the ligand; (4) 
desorption; and (5) diffusion out of the pore (Guiochon et al., 2006).   The external 
film mass transfer resistance in step (1) is due to the fact that each particle of the 
stationary phase is surrounded by a laminar sublayer having a stagnant film across 
which the solute must diffuse.  Therefore, it is dependent on convection and affected 
by mobile phase velocity.  Specifically, the mass transport flux (J) at the particle 
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Figure 1.4. Generalised van Deemter plot showing the relationship between reduced 
plate height (h) and reduced velocity (v'), obtained from Carta et al. (2005).  In this 
figure, v is the linear velocity (defined also as μ in this thesis), dp is the adsorbent 
particle diameter, and D0 is the solute diffusion coefficient.  Based on calculations by 
Carta et al. (2005): v' = 140 – 8000 for proteins separated on preparative stationary 
phases if D0 is ~ (1-10) x 10-7 cm2/s, dp is ~ 50-100 μm, and v is ~ 100-500 cm/h. 
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Figure 1.5. Schematic of the mass transport of solute in porous adsorbents, from 
Horvath and Lin (1978).   In this figure, ka and kd are the rate constants for 
adsorption and desorption, respectively; ke is the film mass transfer coefficient 
(referred to as kf in equation 1.14), Cm,e and Cm,s are the concentrations of the solute 
in the bulk mobile phase and stationary phase, respectively (referred to as C and CS 
in equation 1.14); εi is the internal porosity; θ is the tortuosity factor; and Dm is the 
intraparticle diffusion constant.  (Note that these terms may differ from those used 
elsewhere in the text).  
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surface correlates to the effective film mass transfer coefficient, kf, and the linear 
driving force (LeVan et al., 2008): 
 J = kf (C-Cs) ,       Equation 1.14   
where J is the mass transfer flux at the particle surface, C is the solute concentration 
in the bulk mobile phase and Cs is the solute concentration at the chromatographic 
particle surface.  Generally speaking, kf will increase with fluid velocity and solute 
diffusivity, and decrease with particle size.  Differences in the film mass transfer 
resistance can also result between fixed bed and stirred tanks systems, with kf 
increasing with the Reynolds number (Re).  kf can be determined from the 
dimensionless Sherwood (Sh) number (LeVan et al., 2008): 
 
D
dk
Sh pf= ,       Equation 1.15 
where D is the molecular diffusivity and dp is the adsorbent particle diameter.  In 
packed beds where 0.0015<Re<55, the Sherwood number can be estimated from the 
Re and the Schmidt (Sc) numbers using the following expression (Wilson and 
Geankoplis, 1996): 
33.033.0Re09.1 ScSh
ε
=  ,     Equation 1.16 
where ε is the interstitial column voidage.  The Reynolds number in a packed bed is 
defined by (LeVan et al., 2008): 
υ
εvd p
=Re  ,       Equation 1.17 
where v is the interstitial linear velocity in cm/s and υ  is the kinematic viscosity of 
the mobile phase (cm2/s).  Sc is described by (LeVan et al., 2008):  
   
D
Sc υ= .       Equation 1.18 
 
1.4.2.3. Intraparticle (Pore) Mass Transport  
The intraparticle transport of proteins in preparative ion-exchange adsorbents has 
been extensively studied.  Within the adsorbent pores, transport has been shown to 
occur primarily by two different mechanisms: molecular diffusion in the pore liquid 
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(referred to as pore diffusion) and surface diffusion (also referred to as homogenous 
or solid diffusion) on the adsorbed phase (Carta et al., 2005).  There is typically no 
convective flow within the pores because of their small diameter.  One exception, 
however, is in the case of the very large through-pores (600-800 nm) of perfusive 
resins (Afeyan et al., 1990).  Pore diffusion requires that the pore be large enough 
that the biomolecule can diffuse freely from the surface and is driven by the 
concentration gradient in the pore liquid.  Surface diffusion occurs along surfaces 
and in pores filled with a hydrogel structure (Hunter and Carta, 2002) and is driven 
by the solute concentration gradient on the adsorbed phase.  General diffusional  
transport models for spherical particles exist for describing pore diffusion (Carta et 
al., 2005).  A simplification of the general pore diffusion model, known as the 
shrinking core model, is frequently used when the adsorption isotherm is highly 
favourable (Weaver and Carta, 1996; Dziennik et al., 2005).  In this case, protein 
uptake occurs as a sharp front moving inward with increasing load amounts.  Semi-
empirical models have also been used, such as the linear driving force model, which 
lumps the sources of mass transfer resistance into one equation (Fernandez and 
Carta, 1996; Guiochon et al., 2006).   
 
In practice, intraparticle diffusion is difficult to describe because it depends on the 
pore structure (its size distribution and tortuosity) and network connectivity, which 
are difficult to characterise.  Therefore, the diffusivity (D) in pores is often expressed 
as the effective pore diffusivity (De or Dp) and effective adsorbed phase diffusivity 
(Ds).  The pore diffusivity can be described by (Carta, 2006; Guiochon et al., 2006): 
 
τ
ε D
kD ppe = ,      Equation 1.19  
where kp is a pore hindrance parameter (<1), εp is the intra-particle void fraction, and 
τ is a tortuosity factor (>1).  Tortuosity has to do with the fact that the pores are 
rarely perfect cylinders but instead are convoluted, resulting in slower solute 
diffusion.  The intraparticle void volume and tortuosity factor can be determined 
experimentally by methods such mercury porosimetry, nitrogen adsorption, or 
inverse size-exclusion chromatography (Hagel et al., 1996; DePhillips and Lenhoff, 
2000).  The hindrance parameter depends on the ratio of the solute size and pore size, 
and is inversely related to size exclusion effects (steric exclusion of the solute from 
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the immediate vicinity of the pore walls) and viscous drag.  Therefore, kp should 
generally decrease as protein size increases.  De/D is always less than one, and often 
ranges from 0.1 to 0.2 when the pore size is at least 5 times larger than the protein 
size (Carta, 2006).   
 
Intraparticle diffusivities for proteins can be determined by macroscopic methods, in 
which the mass transfer rate is measured, or by microscopic methods, in which the 
intraparticle concentration profile is followed (Carta et al., 2005).  Macroscopic 
methods include dynamic column approaches such as frontal analysis, isocratic pulse 
response, and gradient elution response as well as batch adsorption in stirred tanks or 
shallow beds.  Determination of the effective diffusivity from the resulting data then 
requires a pre-established model.  The isocratic pulse response method determines 
the intraparticle diffusivity by carrying out an injection and measuring the moment of 
the response peak in an isocratic elution.  In the gradient method, the diffusivity is 
determined from the retention factor in a set of experiments in which the gradient 
slope and flow rate are varied.  Batch methods are carried out with either well-mixed 
suspensions of the stationary phase or in very small packed (shallow) beds through 
which the sample is re-circulated at high flow rates.  Protein uptake is determined by 
measuring the concentration of the solute in the mobile phase or on the adsorbed 
phase (following elution). 
 
Microscopic techniques offer an advantage over macroscopic methods in that the 
effective diffusivity can be determined directly without requiring a pre-established 
model (Carta et al., 2005).  Moreover, qualitative observations can be made that are 
reflective of the transfer mechanism, i.e. sharp concentration profiles associated with 
the shrinking core model and diffuse profiles associated with homogeneous transport.  
A commonly used microscopic technique is confocal laser scanning microscopy 
(CLSM), in which optically transparent, whole sorbent particles can be observed.  
Protein transport is then followed over time in optical sections using a fluorescently-
labelled protein.  To avoid quenching effects, the labelled protein is first diluted with 
unlabelled protein.  However, since the observed protein is labelled, care must be 
given to ensure that the binding properties of the protein have not been altered by the 
fluorescent dye.  A number of research groups have reported over the last decade on 
the use of CLSM for the determination of protein mass transport kinetics and the 
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elucidation of transport mechanisms in ion-exchange chromatography (Linden et al., 
1999; Dziennik et al., 2003 and 2005; Hubbuch et al., 2003A and 2003B; Yang et al., 
2006; Zhou et al., 2006).  These researchers have observed pore and/or surface 
diffusion mechanisms, and in some cases the mechanism appeared to change with the 
mobile phase conditions.  In addition, some of these researchers postulate that a non-
diffusive mechanism such electrokinetic-based transport might be at play (Dziennik 
et al., 2003), although this remains controversial (Carta et al., 2005).    
 
1.4.3. Scale Considerations 
Ideal column chromatography assumes a homogeneous bed, yet columns are never 
perfectly homogeneous, with the extent of their heterogeneity influenced by the 
packing conditions and the mechanical stress on the bed (Guiochon, 2002).  In the 
axial direction, the top part of the column is usually less densely packed than the 
bottom part, although this usually has only a minimal effect on band variance 
(Guiochon et al., 1997).  This being said, for a compressible gel with a broad particle 
size distribution, the packing quality can be more of a concern since the particles 
have a tendency to separate according to Stoke’s law (Jungbauer, 1993).  Distortions 
in the radial distribution, in contrast to variance in the axial distribution, can lead to a 
significant decrease in column performance, with column efficiency lowest in the 
region closest to the wall (Knox et al., 1976; Guiochon et al., 1997; Shalliker et al., 
2000 and 2003).  This results in a perturbation of the flow profile and an increase in 
band broadening.    
   
Radial heterogeneity in the local packing density are generally attributed to wall 
effects, which are proposed to extend a distance of about 30 particle diameters into 
the column (Knox et al., 1976).  Using optical on-column visualisation of the 
migration of sample bands, Shalliker and co-workers (2000) found physical evidence 
of two wall effects.  The first has to do with the geometry of the particles.  Because 
the wall is flat and smooth, the particles cannot penetrate it, so the void volume 
increases along the wall. As a result, the mobile phase velocity is higher there than 
the bulk flow velocity, leading to band dispersion.  While the effect of this wall 
effect is usually negligible in large-diameter preparative columns, it can be 
significant in micro-bore columns like those used for analytical HPLC, where the 
column diameter may only be about 10 to 15 times greater than the particle radii 
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(Knox, 1999).   The second wall effect identified by Shalliker et al. (2000) arises 
from the friction between the bed and the column wall.  This strong friction results in 
a heterogeneous stress distribution during column packing, leading to a packing 
density that is higher along the walls and lower at the column core.  Consequently, 
this causes differential migration.   
 
Approaches for scaling up chromatographic production include carrying out repeated 
chromatographic cycles, overloading the column, changing the adsorbent particle 
size, and increasing the column size (Jungbauer, 1993).  With respect to increasing 
the column size, the conventional way of doing so is to increase the column diameter 
while maintaining a fixed bed length, adsorbent particle size, and residence time.  
This approach generally avoids distortions in resolution and a significant rise in 
column back pressure.  However, the flow distribution and packing efficiency can 
deteriorate as the column diameter becomes larger, leading to band broadening and a 
decrease in performance.  The column size can also be increased by a keeping its 
aspect ratio constant, but this approach can lead to unexpected changes in 
performance and is usually avoided.    
 
Many of the same scale effects associated with the scale-up of a chromatographic 
separation must also be considered when scaling down the chromatography.  For 
batch adsorption, the scaled down system must ensure that the resin is uniformly 
mixed and efficiently recovered.  Incubation times for adsorption and desorption 
have to be optimised accordingly.  For separations carried out across a fixed bed, 
wall effects and packing efficiency must be carefully considered, especially in small-
bore or capillary columns (Knox et al., 1976; Shalliker et al., 2000).  Furthermore, it 
may not always be possible to keep either the column length or the aspect ratio fixed 
in scale down.  All of these factors can impact chromatographic performance and 
should be considered accordingly.     
 
1.4.4. Models of Nonlinear Chromatography 
Models to describe chromatography have been around at least since the 1940s, 
although they still are not routinely used for bioprocess development.  Three broad 
categories of models have emerged to describe linear chromatography, as reviewed 
by Guiochon (2002): (1) plate models, (2) rate models (i.e. solutions to the 
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differential equations that describe the mass balance and mass transfer kinetics), and 
(3) statistical models.  Preparative chromatography, however, is rarely performed 
under linear conditions since the column is typically overloaded to maximise 
productivity.  Therefore, versions of the linear models have been adapted for 
nonlinear chromatography, in which the equilibrium isotherms no longer behave 
linearly and become competitive with other components in the mixture.  This 
situation makes the mathematical description of the chromatography considerably 
more complex.   
 
While the thermodynamics of phase equilibria and the kinetics of mass transport will 
vary with experimental conditions, the mass of each component should remain 
constant throughout a chromatographic separation since it is assumed that no 
chemical reaction occurs (Guiochon et al., 2006).   Consequently, a series of partial 
differential equations can be derived to describe the mass balance of the solute in the 
mobile phase and adsorbed on the stationary phase.  An assumption is then made as 
to the relationship between the concentration of the stationary and mobile phases 
since the system is rarely at equilibrium.  Different forms of these equations were 
derived by Wicke (1939), Wilson (1940), and DeVault (1943).  In addition, a set of 
heat balance equations may be required if the process is not isothermal, although this 
is rarely the case in process chromatography.  Upon setting initial and boundary 
conditions, several models can then be derived from the solution of these differential 
equations, with the thermodynamics of the separation described by the equilibrium 
adsorption isotherm.   
 
Since column chromatography is subjected to dispersive effects and mass transfer 
resistances, different modelling approaches of varying complexity have been 
developed to account for one or more of these mass transport components, ranging 
from simple equilibrium models to multi-component general rate models which 
attempt to account for multiple sources of mass transfer resistance.  Most of these 
models assume that the column is homogeneous in the radial direction, the mobile 
phase is incompressible, the column is run under isothermal conditions, and the 
phase ratio remains constant (Jungbauer and Kaltenbrunner, 1999).  Reviews of 
models for nonlinear chromatography are provided by Guiochon et al. (2002, 2003, 
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and 2006) and by Jungbauer and Kaltenbrunner (1999).  Some of the more 
commonly used models are summarised in Table 1.4.     
  
 
1.5. Microscale Bioprocess Development 
Conventional bioprocess development involves performing early development and 
optimisation experiments at the laboratory scale with milligram-to-gram quantities 
and millilitre-to-litre volumes.  This is followed by increasing the scale to pilot and 
production scales.  Traditionally, this process has been slow and resource intensive.  
Furthermore, it does not always lead to the most robust process since the parameter 
space cannot be fully explored.  Microscale and ultra scale-down techniques 
(Titchener-Hooker et al., 2008) enable a platform for next-generation bioprocess 
development that decreases cycle times while increasing process understanding. 
 
1.5.1. Terminology 
Microscale bioprocess methods are defined here as techniques for bioprocess study 
carried out with microlitre-to-low-millilitre volumes (i.e. <10 mL).  The term 
microscale is often associated in the literature with microfluidic separations.  In this 
thesis, the term has been broadened to also include microwell formats since they too 
are carried out with microlitre volumes.  Another term that is sometimes used 
interchangeably with microscale when referring to bioprocess techniques is ultra 
scale-down.  However, this is a slightly different term that refers to the significant 
scale-down of a bioprocess unit operation or some feature of that operation, often 
with the goal being to directly simulate a critical parameter of the operation (e.g. 
shear during centrifugation).  These techniques may use volumes that range from 
microscale volumes to 100s of millilitres.  Finally, the term high-throughput process 
development is sometimes used synonymously with microscale or ultra scale-down 
methods, although this is not always the case.  This term refers specifically to 
methods that can be carried out with a high degree of experimental parallelisation 
and usually with automation, such as experiments carried out in 96-well microtitre 
plates.  Many microscale bioprocess techniques are indeed high throughput, but this 
need not necessarily be the case. 
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   Table 1.4. Models of non-linear chromatography (as reviewed by Guiochon et al., 2002).   
 
Model 
 
Description 
  
Assumptions / Considerations 
 
 
Ideal 
(Equilibrium) 
 
Band profile depends only on the equilibrium thermodynamics. 
Other sources of mass transfer resistance and axial dispersion are 
neglected.  
 
  
Assumes column has infinite efficiency. 
 
Equilibrium-
Dispersive   
Accounts for axial dispersion and relates it to column HETP but 
treats column efficiency as only a small correction.  
 
 Assumes mass transfer is infinitely fast.  Less useful for 
the chromatography of proteins. 
Lumped Kinetic  A simplistic model for mass transfer kinetics in which the local 
deviation from equilibrium is taken into account. Completes the 
mass balance of the ideal model by a kinetic equation (e.g. a 
linear driving force equation). 
 
 Valid for fast kinetic rates but there can be considerable 
model error at slow mass transfer rates. 
General Rate  Attempts to simultaneously deal with all sources of mass transfer 
resistance and axial dispersion by including their contributions in 
a system of partial differential equations for mass conservation 
and transport.  Two mass balance equations are written, one for 
the stagnant mobile phase inside the particle and one for the 
flowing mobile phase outside the particle. 
 
 
 Many variations of this model.  Surface diffusion and the 
rate of adsorption-desorption are sometimes neglected. 
 
Lumped Pore  Simplified version (an approximation model) of the general rate 
model. 
 Assumes the kinetics of adsorption-desorption is 
negligible.  Less accurate than the general rate model but 
useful for moderately fast mass transfer kinetics.  
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1.5.2. Goals of Microscale Bioprocessing Techniques 
The goal in implementing a microscale bioprocess technique is to gain quantitative 
bioprocess information in an efficient manner and with small quantities of material.  
This can mean either directly mimicking some aspect of larger scale performance, 
often with the use of scale-down models or empirical correlation factors, or screening 
parameters in a relative manner to guide subsequent larger-scale development.  
Examples of the former are the use of a high-speed rotating-disc device to mimic the 
shear stresses on cell suspensions in the feed zone of an industrial centrifuge 
(Hutchinson et al., 2006) or the use of small-scale columns to predict large-scale 
elution profiles (Hutchinson et al., 2009).  An example of the latter is the use of 
microwell screening platforms for the optimisation of mobile phase conditions in 
chromatographic processes (see review by Chhatre and Titchener-Hooker, 2009).    
 
While the goal of these techniques is that they be predictive of some facet of large-
scale performance, a perfect scale-down model can be difficult to achieve and 
validate in practice.  A more modest but equally effective goal is to perform high-
throughput microscale screening experiments to explore aspects of the design space 
and thereby inform subsequent laboratory-scale development.  Then, only a small 
subset of focused optimisation experiments is required at the laboratory scale, where 
scale-up effects to pilot and manufacturing scales are well understood.  Such an 
approach is outlined in Figure 1.6.  A large amount of content about the operating 
space can be rapidly acquired from microscale experiments, and since only small 
amounts of material are required, these experiments can be done very early on in 
process development.  A good example of this is the high-throughput evaluation of 
chromatographic adsorbents and mobile phase conditions in microwells (Coffman et 
al., 2008).  Although these techniques are batch methods that differ substantially in 
their operation from fixed-bed chromatography, they are useful for comparing 
adsorbent properties and selecting mobile phase conditions.  Ultimately though, it is 
advantageous to have validated scale-down models also within one's 'microscale 
toolbox'.  This balance between high throughput screening methods and validated 
scale-down techniques is explored within this thesis, particularly as it relates to 
chromatography.     
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Figure 1.6. Integration of microscale experiments into the process development workflow.  Microscale experiments can be carried out with 
higher throughput and therefore used to systematically map the parameter space.  This increases process understanding during scale-up and 
reduces the number of laboratory-scale experiments that are required.   
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1.5.3. Techniques for Cell Culture and Fermentation 
Cell culture and fermentation development involves media development, strain 
improvement, and process optimisation of operating conditions such as mixing, 
oxygen transfer, pH, and temperature.  Development of these processes can be time-
consuming and complex, requiring the optimisation of many parameters.  Therefore, 
microscale techniques can be advantageous for accelerating development and 
promoting a quality-by-design strategy.  Comprehensive reviews of microwell 
platforms, microfluidic devices, and miniature bioreactors for cell culture and 
fermentation are provided by Betts and Baganz (2006), Micheletti and Lye (2006), 
and Marques et al. (2009).  
 
Traditionally, cell culture and fermentation development is initially done in shaken 
flasks and then, later, performed in laboratory-scale bioreactors.  However, the 
results between the two formats often are not always reproducible because of 
differences in mass transfer (aeration and gas exchange) and operating control.  In a 
similar manner, microscale systems suffer from these differences in scale and format.  
Specific challenges with microwell systems include the addition and removal of 
liquids to/from the microwells, evaporation, operating control, and mixing.  Mixing 
is especially critical for the addition of small volumes of liquid and for gas-liquid 
mass transfer, and it can consequently impact the overall reproducibility of the 
method.  A number of researchers have studied the specific case of mixing in 
microwells, including Hermann et al. (2003) and Nealon et al. (2006).  Ultimately, a 
complete understanding of the phenomena that occurs in shaken microwells is 
critical to the ability of these systems to predict larger bioreactor systems (Micheletti 
et al., 2006; Marques et al., 2009). 
 
Miniature bioreactors enable a path to scale-down in which in-process monitoring, 
gas transfer, and control of key process variables can better match those of large-
scale bioreactors.  Indeed, approaches with microscale bioreactors at the millilitre 
scale have proven to be reasonably predictive of larger scale operation, although this 
has not necessarily been the case for smaller microfluidic devices, presumably 
because of mass transfer differences (Marques et al., 2009).  Key advances 
contributing to the success of miniature bioreactors and microfluidic devices are: (1) 
the development of miniaturised sensors for dissolved oxygen, pressure, and pH; (2) 
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the ability to measure optical density during shaking; and (3) improvements in 
microfabrication techniques and robotics (Marques et al., 2009).  One drawback of 
bioreactors is that they generally do not offer the same degree of parallelisation and 
automation as microwell systems and microfluidic devices, although they can 
potentially be interfaced with liquid-handling robots. 
 
1.5.4. Techniques for Cell Disruption 
Small-scale techniques for cell disruption may be developed with different objectives 
in mind.  One goal for having a microscale cell disruption technique is to predict and 
optimise large-scale operation.  Examples of this come from Varga et al. (1988) in 
which an ultra scale-down approach was used to obtain basic model parameters in 
the study of high-pressure homogenisation and from Chan et al. (2006) in which a 
small capillary device was used to study the effects of shear, time, and impact 
velocity on E. coli cell disruption.  A second goal is for the quantitative release of 
intracellular protein product for subsequent assay or purification, with the final 
purpose being to evaluate fermentation performance and/or recover purified sample 
for product characterisation.  Finally, a third goal is to generate small amounts of a 
representative feedstock for downstream process studies such as chromatographic 
development.  For these latter two goals, the cell disruption technique need not 
actually mimic the large-scale operation.  This was the case in this thesis, in which a 
microscale cell disruption technique was used to generate representative feed 
material for downstream microscale chromatography experiments (Chapter 7).  
 
A number of possibilities exist for small-scale cell disruption, although many cannot 
match the effectiveness of large-scale mechanical methods such as high-pressure 
homogenisation, especially for hard-to-break cells like yeast.  Bench-top 
homogenisers are available for 10s of millilitre-scale experiments but are generally 
not practical for volumes <10 mL.  For microscale volumes, glass beads can be used 
in which the cell slurry is vortexed with multiple on-off cycles.  Sonic or ultrasonic 
disruption can also be used (Davies, 1959; Clarke and Hill, 1970; Doulah, 1977; 
Feliu et al., 1998; Kapucu et al., 2000; Ho et al., 2006), although its use with yeast is 
somewhat limited due to the rigidity of the cell wall.  In addition, a new-generation 
ultrasonication device known as Adaptive Focused Acoustics (Laugharn and 
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Garrison, 2004) has recently emerged for cell disruption.  It is described further in 
Chapter 7.   
 
Non-mechanical approaches may involve physical disruption, the addition of 
chemical agents, and/or enzymatic degradation.  Physical methods include osmotic 
shock, in which osmotic stress is created by placing the cells in a hypotonic or 
hypertonic solution, and freeze-thawing, in which ice crystals that form during the 
freezing step mechanically disrupt the integrity of the cell wall or membrane (Garcia, 
1999; Indge, 1968).  However, these methods are relatively inefficient for cells 
having a rigid cell wall and act primarily on the cell membrane.  Therefore, they 
often are combined with enzymatic or chemical methods.  Chemical disruption 
methods involve adding reagents such as chelators, chaotropes, detergents, reducing 
agents, organic solvents, acids and/or bases (Kula and Schutte, 1987; Garcia, 1999).  
In addition, commercial reagents such as YeastBuster and BugBuster from Novagen 
(Gibbstown, NJ USA) are available for yeast and bacterial cells, respectively.  
Finally, enzymatic methods are sometimes used for microbial cells (Asenjo and 
Andrews, 1990), in which lytic enzymes act on the cell wall.  These lytic enzymes 
may be used alone or in combination with physical or chemical methods, and they 
offer the advantage of providing a more selective lysis.   
 
1.5.5. Techniques for Primary Recovery  
A number of ultra scale-down methods have been developed for the study of 
industrial centrifugation.  Hutchinson and colleagues (2006) used a high-speed 
rotating device to mimic the effect of shear stress on the cells in the feed zone of an 
industrial-scale continuous centrifuge.  These data were then used in combination 
with laboratory-scale test tube centrifuge studies to successfully predict the 
performance in the large-scale centrifuge.  Similar types of studies were done to 
define the relationship between flocculation and disc-stack centrifugation (Berrill et 
al., 2008), the centrifugal separation of high density cultures of E. coli and S. 
cerevisiae (Tustian et al., 2007), and shear damage of plasmid DNA in pump and 
centrifuge operations (Zhang et al., 2007).  In addition to centrifugation, ultra scale-
down methods have been demonstrated for expanded-bed chromatography 
(Willoughby et al., 2004), continuous filtration in solid-liquid separations (Reynolds 
et al., 2003), and microwell refolding experiments of denatured protein in inclusion 
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bodies (Mannall et al., 2008).  Jackson and co-workers (2006) used filter plates to 
quantitatively study the microfiltration of E. coli fermentation broth, finding that 
custom plates showed less variability than commercially available filter plates and 
allowed multiple membrane types to be examined.   
 
1.5.6. Techniques for Chromatography 
Conventional small-scale and ultra scale-down approaches to preparative 
chromatography development have centred on using either self-packed or 
commercially pre-packed columns (e.g. HiTrap columns from GE Healthcare) of < 
10 mL.  In one example, Hutchinson et al. (2009) used a 1-mL protein A column in 
combination with an empirical correction factor to predict the elution profile of an 
18.3-L pilot-scale column.  To automate and improve the throughput of small-scale 
column experiments, integrated chromatography systems have been used (Londo et 
al., 1998; Bhikhabhai et al., 2005; Stromberg et al., 2005; Bannister et al., 2006), as 
have HPLC systems (Nti-Gyabaah et al., 2009), although some chromatographic 
media cannot withstand the high backpressures of HPLC.  Most of the off-the-shelf 
instruments (such as the GE Healthcare AKTA purifier system or an HPLC system) 
are usually operated in a serial manner or they require custom modification for 
parallel operation.  Furthermore, even at low-millilitre column volumes, milligram 
quantities of sample mass may be required.   
 
Microscale chromatographic techniques for bioprocess study often can deviate 
considerably in scale and format from laboratory-scale fixed-bed chromatography.   
Some of the more novel microscale techniques include microfluidic packed-bed 
systems (Shapiro et al., 2009) and the use of biochip arrays carrying 
chromatographic functional groups in combination with surface-enhanced laser 
desorption-ionisation mass spectrometry (Weinberger et al., 2002; Brenac et al., 
2005).  However, the more commonly used microscale chromatographic formats are 
those carried out in a 96-well microtitre plate format because of their high degree of 
experimental parallelisation and the capability for automation on liquid-handling 
robots.  Three of these formats are reviewed by Chhatre and Titchener-Hooker 
(2009): (1) micro-batch adsorption, in which the sorbent is statically mixed within a 
microwell; (2) micro-tip columns, in which the sorbent is immobilised at the bottom 
of a pipette tip; and (3) miniature packed columns that are arrayed in a 96-well 
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format.  These formats are described schematically in Figure 1.7, and a side-by-side 
comparison is provided in Table 1.5.  Each format presents different theoretical and 
practical considerations for chromatographic study, as described below.   
 
1.5.6.1. Micro-Batch Adsorption 
The most established of the three microtitre-plate formats is micro-batch adsorption, 
having been demonstrated by a number of research groups for parameter estimation 
and the rapid screening of process chromatographic conditions (Thiemann et al., 
2004; Bensch et al., 2005; Charlton et al, 2006; Rege et al., 2006; Rios et al., 2007; 
Bergander et al., 2008; Coffman et al., 2008; Kelley, et al., 2008B; Kramarczyk et 
al., 2008; Wensel et al., 2008; Chhatre and Titchener-Hooker, 2009) as well as for 
the high throughput chromatographic purification of fusion proteins for functional 
and structural analysis (Nguyen et al., 2004; Prinz et al., 2004; Redaelli et al., 2005).  
Micro-batch adsorption is rooted in the well-established batch-binding methodology 
carried out at millilitre scales in test tubes, differing in its scale, vessel geometry, 
mixing mechanism, amenability to robotic automation, and throughput potential.   In 
this format, microlitre volumes of adsorbent, typically 100 μL or lower, are 
suspended in a liquid phase (feed sample or purification buffer) within the wells of a 
microtitre plate, thereby mimicking an agitated-tank batch system.  The sample and 
buffer volumes depend on the specific requirements of the experiment, with the 
maximum volume defined by the microwell volume capacity (typically ranging from 
300 – 2000 μL/well, depending on the plate type).  The liquid supernatant is then 
separated from the adsorbent after an experimentally defined incubation time for 
subsequent analysis (e.g. UV absorbance measurement, protein assay, or purity 
analysis).  Although standard microtitre plates have been used for micro-batch 
adsorption (Thiemann et al., 2004; Rege et al., 2006), in which the adsorbent is 
sedimented and the resulting supernatant then aspirated away, filter plates are more 
commonly used since they allow for a highly efficient separation.  With filter plates, 
liquid is drawn through the filter by centrifugation or vacuum and collected in a 
microtitre plate underneath (Fig. 1.7A), with centrifugation preferred over vacuum 
filtration since cross-mixing of individual well contents has been observed with 
vacuum filtration (Coffman et al., 2008).  One disadvantage of filter plates is that 
there may be some leakage of solution during long incubation times, requiring the 
plates to be sealed on their underside (Coffman et al., 2008).    
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Figure 1.7.  Schematic representation of three formats for carrying out chromatography in 
a microtitre plate configuration. (A) micro-batch adsorption, (B) micro-tip columns, (C) 
miniature columns.  Schematics are not to scale. Illustrations for the miniature column 
format adapted from Wiendahl et al., 2008.    
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        Table 1.5.  Comparison of three microtitre-plate formats for microscale chromatography. Details are given for use on a Tecan robot. 
 
 
 
Micro-Batch Adsorption 
 
 
Micro-Tip Column 
 
Miniature Column 
Description 
 
Mixed suspension of media in microtitre  
filter plate 
 
Immobilised adsorbent at the bottom of a 
pipette tip;  Attaches on to liquid-handling arm 
 
Microlitre-scale column that interfaces with the 
pipette tip of a liquid-handling robot 
 
Scale (adsorbent 
volume) 
2-200 μL 5 - 80 μL 
0.5 to 1.2-cm bed heights 
50 - 600 μL 
0.25 to 1.0-cm bed heights 
 
Chromatography 
 
Batch, static mixing Batch, dynamic flow Column, dynamic 
Sample 
presentation 
Batch vessel 
Plate shaking or mixing 
Pressure-driven flow 
Bi-directional flow (aspiration, dispense) 
 
Pressure-driven flow  
Unidirectional flow 
Elution 
 
Serial step elution Serial step elution Serial step elution 
Parallelisation 
 
96 8, 12, or 96 8  
Set-up User prepared or purchased (GE Healthcare) 
 
Purchased: preparation outsourced (PhyNexus) 
 
Purchased: preparation outsourced (Atoll) 
Relative Cost  
 
£-££ £££ ££££ 
Full Automation 
 
Complexity: ++++ 
Requires adsorbent manipulation and frequent 
plate transfer.  Well-suited for semi-automated 
or manual operation.   
 
Complexity:+ 
No adsorbent manipulation and minimal plate 
movement. Drops from system liquid (water) 
can be problematic. 
Complexity:+++ 
No adsorbent manipulation but some plate 
movement required. Requires specialised 
carriers. 
Key Operational 
Considerations 
 
Dispensing and mixing of adsorbent; Filtration 
efficiency; Incubation time; Evaporation; Hold-
up volume 
Flow rate; Incubation time (cycle number); Air 
bubbles; Evaporation; Hold-up volume  
Flow rate (residence time); Reproducible 
fraction collection; Plate shuttling; Wall effects 
 
Kinetic Studies  
 
Stirred tank: finite bath adsorption Finite bath adsorption or shallow bed 
 
Fixed-bed column 
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Each stage of the chromatographic purification in micro-batch adsorption, i.e. 
equilibration, load, wash, and elution, is performed sequentially within a microwell, 
with each individual stage involving the addition of liquid (sample or buffer 
solution), mixing of the resin with the liquid, and then removal of the liquid, as 
described above.  Multiple processing steps may be carried out within a particular 
stage, e.g. multiple additions of wash or elution buffer.  Continuous linear gradient 
elution is not possible with this format, although the elution can be carried out as a 
series of incremental elution steps (a so-called 'staircase elution') creating a virtual 
linear gradient (see examples by Rege et al., 2006 and Kramarczyk et al., 2008).     
 
Several key operating parameters must be considered when performing micro-batch 
adsorption.  Among the more important are resin handling (dispensing and mixing), 
microwell liquid hold-up volume, kinetics of adsorption and desorption, filter 
membrane material type and pore size, and sample evaporation.  With respect to 
resin handling, the accurate and precise dispensing of resin to each microwell is 
critical so as to minimise experimental error and variability.  The most common 
method is to pipette a resin slurry from a reservoir to each microwell, with the 
accuracy and precision of the operation depending on the determination of slurry 
concentration, how well the slurry is suspended during aliquotting, and the pipetting 
accuracy.  Coffman et al. (2008) evaluated the accuracy and precision of resin 
pipetting using a Tecan robot and found the aliquotted volume to be systematically 
4% higher on average, but within the specifications of the robot, and that the 
standard deviation was less than 1% of the total volume.  An alternative to resin 
pipetting is to employ a plaque-generating device (Herrmann et al., 2006), in which 
resin cylinders are formed by adding a resin slurry to a machined vacuum manifold 
and filtering the liquid away.  Such devices have been commercialised for resin 
plaques of 8, 21, and 51 μL by Atoll GmbH (Weingarten, Germany; MediaScout 
ResiQuot).  Furthermore, some resin manufacturers sell pre-dispensed resin filter 
plates, such as GE Healthcare (Uppsala, Sweden; PreDictor plates), with resin 
volumes ranging from 2 - 50 μL/well.   
 
Once dispensed, the thorough mixing of the liquid-resin suspension in the microwell 
is critical for representative and reproducible adsorption/desorption processes.  End-
over-end rotation, which is traditionally used for tube-based methods, is not suitable 
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for microtitre plates and robotic automation.  Therefore, orbital shaking is typically 
performed since it can be automated and is a low-shear method (Bensch et al., 2005), 
with agitation rates exceeding 1000 rpm generally required to ensure complete resin 
mixing (Bensch et al., 2005; Bergander et al., 2008; Coffman et al., 2008).  
 
In addition to robust resin handling, the incubation time (resin-liquid contact time) of 
the processing step must be carefully considered in micro-batch adsorption 
experiments.  While the kinetics of desorption and buffer exchange are relatively 
rapid, occurring on the order of minutes, protein uptake at high mass adsorbent 
loadings may take on the order of hours to achieve equilibrium, with the specific 
duration depending on the adsorbent and sample characteristics (i.e. mass transport 
properties).  Furthermore, the exact loading times will be defined by the 
experimental purpose.  When performing adsorption isotherm studies, longer 
incubation times are used to achieve equilibrium, whereas in batch uptake 
experiments, the incubation time is varied from a few minutes to several hours 
(Bensch et al., 2005; Bergander et al., 2008; Coffman et al., 2008).  For a qualitative 
estimation of column dynamic binding capacity in high throughput screening studies, 
Bergander et al. (2008) suggest that the micro-batch adsorption loading time be 
matched on a timescale that approximates the column loading time (total time the 
column is exposed to feed solution) instead of the column residence time (amount of 
time an inert solute will spend in the column).  However, these researchers caution 
that this rule holds only as long as intra-particle diffusion and not film mass transfer 
is rate determining.  Coffman et al. (2008) chose an incubation time of 20 minutes in 
their high throughput chromatographic screening studies as a time that was sufficient 
to achieve > 80% of equilibrium binding and thereby provide an approximate 
representation of column dynamic binding capacity.    
 
Finally, another key consideration in micro-batch adsorption is the liquid hold-up 
volume, especially when working at low phase ratios (ratio of liquid volume to 
adsorbent volume).  The hold-up volume may result in carryover between processing 
steps and, if not accounted for, will lead to the incorrect calculation of mass balance 
and the inaccurate optimisation of mobile phase conditions.  The resin intra-particle 
pore volume (εp), any interstitial liquid not fully evacuated, and liquid retained on the 
membrane or plate all contribute to the hold-up volume.  Microwell hold-up volumes 
 - 67 -
are estimated to range from 50-80% of the resin volume (Coffman et al., 2008; GE 
Healthcare, bulletin 28-9403-58AA).   
 
Advantages of micro-batch adsorption are that it is relatively inexpensive and offers 
a high degree of experimental parallelisation and flexibility, with sorbent type and 
amount, sample load, and solution conditions all easily varied per well.  One 
disadvantage, though, is that unlike the multiple stages of separation in column 
chromatography, each step in micro-batch adsorption represents only a single stage 
of equilibrium.   Nevertheless, micro-batch adsorption experiments can provide a 
wealth of information for the development of a process chromatography step.  As 
with conventional batch-binding methods carried out in test tubes, fundamental 
thermodynamic and kinetic information are acquired through adsorption isotherm 
and batch uptake studies, as reviewed by Bensch et al. (2005).  These data can be 
used in batch mass transport models to determine the effective pore diffusivity (De) 
and ultimately in column models to predict column behaviour, as described by Arve 
and Liapis (1987) and Bergander et al. (2008).   
 
Even in the absence of modelling, batch-binding data can be used to inform the 
development of chromatography steps by indicating relative trends in adsorbent 
capacity, recovery, selectivity and product purity under different solution conditions 
and for different chromatographic media.  In a series of four publications (Coffman 
et al., 2008; Kelley, et al., 2008B; Kramarczyk et al., 2008; Wensel et al., 2008), 
Coffman and colleagues describe the use of micro-batch adsorption for screening 
different adsorbent classes and mobile phase conditions for monoclonal antibody 
purification, including hydrophobic interaction chromatography (Kramarczyk et al., 
2008), ceramic hydroxyapatite (Wensel et al., 2008), and ion-exchange 
chromatography (Kelley et al., 2008B).  These researchers employed a parameter 
known as the partition coefficient (Kp), derived from a low mass loading (5 mg/mL 
resin), to quantify antibody and/or impurity binding.   Kp is defined as: 
  
C
qK p =         Equation 1.20 
where q is the adsorbent loading (mg protein/mL of resin) at a low mass challenge 
and C is the concentration of unbound protein (mg/mL) remaining in the supernatant 
after binding.  In their investigation, the value of Kp was well correlated with the 
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adsorbent maximum capacity (qm) for the hydroxyapatite and ion-exchange studies, 
and although the batch binding results were not identical to those of the column 
chromatography, it did allow for the trending of purity and recovery with adsorbent 
type and mobile phase condition.  Similarly, Rege et al. (2006) developed a two-step 
chromatographic purification using micro-batch adsorption in which the microscale 
elution conditions trended well with the final conditions defined for the column 
operation.   
 
In all of the micro-batch adsorption studies described above, the experiments were 
performed either manually or in a semi-automated fashion, in which many of the 
liquid-handling steps were automated, but not the plate manipulations (i.e. movement 
in and out of the centrifuge).  Indeed, the format is well suited for manual and semi-
automated operation; yet, full walk-away automation is ultimately desired to 
minimise labour and enable overnight experiments.  Full walk-away automation is 
defined here as a method requiring no manual intervention throughout its operation 
except for the initial set-up and final clean-up.  In principle, full automation is 
achievable with micro-batch adsorption since it is a plate-based format.  However, in 
practice, this can be difficult to achieve, at least in a robust manner, because of the 
frequent plate manipulations in and out of the filtration device and the requirement 
for accurate and precise resin manipulation.  As a rule of thumb, the robustness of an 
automated method decreases with increasing plate manipulation, since the 
probability of an error occurring will increase proportionally.   
 
1.5.6.2. Micro-Tip Chromatography 
The micro-tip column platform (Chapman, 2005; Smith, 2005; Shukla et al, 2007B; 
Wenger et al., 2007; Gjerde and Hanna, 2009; Chhatre and Titchener-Hooker, 2009) 
is a relatively new technique, with considerably fewer literature examples than 
micro-batch adsorption.  It is therefore the primary subject of this thesis, with a 
detailed description of the format given in Chapter 3.  Briefly, it is a method in which 
the sorbent (in microlitre quantities) is immobilised at the bottom of a pipette tip.   
Sample or mobile phase is pipetted bi-directionally (up, down) through the column, 
typically with multiple aspiration and dispense cycles to increase the loading time.   
The micro-tip columns are picked up by the liquid-handling arm of the robot and 
moved across the microtitre plate, with a new microwell used for each separation 
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stage (i.e. equilibration, load, wash, and elution), as shown in Figure 1.7B.  The 
extent of experimental parallelisation of this format depends on the configuration of 
the liquid-handling arm, with 8, 12, or 96 channels available.  It was carried out 
eight-at-a-time on a Tecan workstation (Research Triangle, NC, USA) in this thesis.   
  
Because micro-tip chromatography is a batch operation, there is only one theoretical 
plate of separation achieved per microwell stage, as with micro-batch adsorption.  
The principal chromatographic difference between the micro-tip and micro-batch 
adsorption formats has to do with the external mass transport.  Extra-particle mass 
transport occurs by flow through a packed bed in the case of micro-tip 
chromatography, whereas micro-batch adsorption involves static mixing of a resin 
suspension.  This can be particularly relevant if external mass transport is the 
dominant mass transport mechanism in protein uptake or for adsorbent lifetime 
studies where bead fouling may be influenced by the flow outside of the 
chromatographic bead.  In addition, having hydrodynamic flow allows the micro-tip 
columns to be operated in a shallow-bed format (Hahn et al., 2005A and 2005B), in 
which sample is re-circulated through a very small chromatographic bed at high flow 
rates while maintaining a constant feed concentration (infinite-bath approach).  
Alternatively, micro-tip columns may be operated in a more conventional finite-bath 
format similar to micro-batch adsorption.  These different modes of operation are 
explored in Chapter 4.  
 
Micro-tip chromatography also affords some significant operational advantages over 
micro-batch adsorption, especially with respect to automation. Specifically, with 
micro-tip chromatography there is no concern about sorbent mixing, since there is 
hydrodynamic flow through a packed bed instead of static mixing of suspended resin.  
This is particularly beneficial for dense media, such as ceramic hydroxyapatite, 
which can be difficult to suspend uniformly in batch microwell experiments.  In 
addition, there are few or no plate manipulations (i.e. movement in and out of a 
filtration device), greatly simplifying the automation and providing a simple path to 
full walk-away automation, even for groups with limited automation skill sets.   
These operational advantages combined with the external mass transport properties 
of micro-tip chromatography provided the motivation for its use in this thesis. 
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1.5.6.3.  Miniature Column Chromatography 
Of the three microtitre plate formats, the miniature (mini)-column format (Wierling 
et al., 2007; Wiendahl et al., 2008) is the most like a fixed-bed laboratory-scale 
column in its geometry and operation.  The supplier of mini-columns is Atoll GmbH 
(Weingarten, Germany), which sells pre-packed columns arrayed in a microtitre-
plate footprint for use on a Tecan workstation (RoboColumn), with bed volumes of 
50, 100, 200, or 600 μL available.  The column design and experimental set-up is 
shown in Figure 1.7C   Sample or mobile phase is pipetted through the column by 
inserting the fixed pipette tip of the Tecan (Research Triangle, NC, USA) robot into 
a needle adapter at the inlet of the column, thereby forming a primary seal around the 
tip.  A specially designed carrier (TeChrom) holds the mini-columns, under which a 
microplate is positioned to collect column fractions by incrementally stepping a 
microplate under the mini-columns.  Alternatively, this format can be performed 
manually using a column that accepts a manual pipette (PipetColumn) or in a 
centrifuge (CentriColumn).     
 
A primary advantage of the mini-column format is that it closely mimics a 
conventional packed-bed format with hydrodynamic flow, and unlike the micro-tip 
format, it is operated with unidirectional flow and has a cylindrical geometry.  This 
provides a better representation of column chromatography and allows column 
performance to be examined more directly, although column models or engineering 
correction factors may still be required for accurate prediction of larger scale 
columns.  An additional benefit over the other two microwell formats is that larger 
sample volumes (> 1 mL) are more easily loaded, since it means simply dispensing 
multiple aliquots of sample or buffer through the column. (Micro-batch adsorption is 
limited by the microwell volume, while micro-tip chromatography is limited by the 
pipette tip volume).  This is particularly advantageous for low-concentration 
samples, where high volumetric loads are required.  However, the mini-column 
format is not without some important challenges.  One limitation is that the bed 
height is very short, thereby resulting in very short residence times.  For example, the 
superficial residence time for a 200-μL column (5 mm, i.d., X 10 mm, h) operated at 
a flow rate of 3.33 μL/s (60 cm/h) is only 60 s.  Furthermore, continuous linear 
gradients are not feasible, at least not without custom modification of the liquid-
handling workstation, as with the other microscale formats.  In addition, because of 
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the low-volume operation, the reproducibility of fraction collection must be 
examined.  Finally, the effects of the smaller column diameter (i.e. wall effects) must 
be considered in the prediction of large-scale column performance, especially with 
respect to dynamic binding capacity.    
 
Wiendahl et al. (2008) used 200-μL mini-columns on a Tecan workstation for the 
determination of column dynamic binding capacity and for elution experiments in the 
separation of protein mixtures.  Breakthrough experiments were performed with 9 or 
1.5 mg/mL of bovine serum albumin (BSA) on four different anion exchange 
adsorbents, with flow rates ranging from 0.21 μL/s (residence time of 16 min) using 
a 250-μL syringe to 1000 μL/s (residence time of 0.2 s) using a 1000-μL syringe.   
With this test system, these researchers were able to predict DBC10% and DBC50% 
values that differed by less than 30% of literature values, except for POROS 
adsorbent at the high concentration loading (>45% deviation).  Despite this 
agreement, the breakthrough curves appear jagged by visual inspection, and a 
comparison of these curves to those of conventional laboratory-scale columns is not 
shown.  Elution experiments were also performed with ion-exchange 
chromatography using several test protein mixtures.  Again, this format displayed 
some promising results, with the elution profiles approximating those at the 1-mL or 
2-mL scale, but with some differences observed.   Although this microscale platform 
shows potential, more work is required, ideally with 'real-world' protein systems, to 
fully characterise the format and to better understand its advantages and limitations.   
 
With respect to robotic automation, the mini-column format can be fully automated 
on a robotic workstation, as demonstrated by Wiendahl et al. (2008).  However, full 
automation requires some relatively complex robotic scripts to be written, and with 
more plate manipulation than in micro-tip chromatography.  Furthermore, several 
specialised equipment peripherals are required as described above, including the 
TeChrom carrier and a plate shuttle (TeLink) for fraction collection.  However, as 
with micro-tip chromatography, a clear advantage is that no resin manipulation is 
required.  One limitation of the format is that the extent of parallelisation depends on 
the configuration of the liquid-handling arm, currently limited to eight on the Tecan 
workstation. 
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1.5.7. Workflow for High-Throughput Microscale Experiments 
1.5.7.1. Experimental Design 
High-throughput microscale techniques enable experiments to be carried out in a 
brute-force manner, with many conditions examined in parallel.  This is useful for 
multivariate systems and when there is little or no a priori knowledge.  Brute-force 
experimental designs have been demonstrated for adsorbent screening, parameter 
estimation, and mobile phase optimisation (Thiemann et al., 2004; Rege et al., 2006; 
Coffman et al., 2008; Kelley et al., 2008; Kramarczyk et al., 2008; Wensel et al., 
2008).  More sophisticated factorial and response surface designs (Mandenius and 
Brundin, 2008) offer a means of reducing large experimental numbers by allowing 
multiple variables to be examined simultaneously.  However, these designs are 
assisted by having some a priori knowledge about the system in order to narrow the 
parameter range.  In the absence of this information, iterative workflows like the one 
in Figure 1.8 can be used to improve the experimental efficiency, in which the design 
of one experimental iteration is aided by the results from the previous one.  This 
permits a broad parameter space to be quickly narrowed and refined around an 
optimum.  Even brute-force approaches can benefit from an iterative workflow, 
especially if experimental numbers become overwhelmingly large. Other more 
sophisticated iterative schemes for process optimisation such as simplex and genetic 
algorithms have also been applied for even greater experimental efficiency (Park et 
al., 1997; Milavec et al., 2002).  In choosing a design, the intent of the experiment 
must be considered.  If it is to fully characterise a wide operating window or for 
parameter estimation, then a brute-force approach may be chosen.  In contrast, if is to 
quickly identify a window of optimum performance, then an iterative approach may 
be preferred. 
 
1.5.7.2. High-Throughput Analytics 
While microscale techniques are enabling tools for high throughput process 
development, having a well-coordinated analytical strategy is also critical so as to not 
risk overwhelming testing and data processing resources.  The analytical strategy 
must be capable of handling high sample numbers and low microlitre sample 
volumes.  One solution is to automate pre-treatment and assay steps onto a liquid-
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Figure 1.8. Iterative experimental design for high-throughput microscale 
experiments.   
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handling robot.  When implementing an automated assay strategy, though, one 
should consider not only the hardware but also the data processing workflow in order 
to avoid bottlenecks in data reduction.  In addition to assay automation, a number of 
new analytical platforms have emerged which offer simplicity and/or higher 
analytical throughput for process monitoring.  Examples of these include SELDI-
TOF mass spectrometry (Freire et al., 2006), optical biosensors (Abdiche et al., 
2008), and microfluidic separations (Ohno et al., 2008). 
 
 
1.6. Organisation of Thesis 
This thesis seeks to fully characterise the micro-tip platform and demonstrate its use 
as a component of an accelerated process development strategy.  The materials and 
methods used throughout this thesis are provided in Chapter 2.  The specific details 
for micro-tip column operation and automation are then described in Chapter 3, with 
the critical operating parameters and flow properties of micro-tip chromatography 
defined.  In Chapter 4, procedures for performing adsorption isotherms and kinetic 
uptake studies are demonstrated, along with two data-driven models for predicting 
dynamic binding capacity from micro-tip column data.   
  
Micro-tip chromatography, as a tool for accelerated process development, is then 
applied to two different process development challenges.  In Chapter 5, a workflow 
employing micro-tip chromatography is demonstrated for the rapid development of a 
mixed-mode chromatography step in the purification of a monoclonal antibody.  In 
Chapter 6, a two-step chromatographic purification of virus-like particles (VLPs) is 
developed to provide feedback on upstream yeast fermentation development.  
However, with the miniaturisation of the VLP chromatographic purification then 
comes the need to develop a microscale cell disruption technique, since the 
laboratory-scale cell disruption method requires tens to hundreds of millilitres of cell 
slurry and is relatively low throughput.  A microscale yeast cell disruption technique 
using Adaptive Focused Acoustics is therefore developed in Chapter 7 to enhance the 
throughput of the microscale VLP purification and reduce the cell weight input.  
Finally, in Chapter 8, the conclusions of this thesis and recommendations for future 
work are presented.   
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2. MATERIALS AND METHODS 
2.1. Materials 
2.1.1. Chromatographic Separation Media 
POROS 50 HS cation exchange resin was purchased from Applied Biosystems 
(Foster City, CA, USA). Ceramic hydroxyapatite (CHT) and UNOsphere S were 
obtained from Bio-Rad (Hercules, CA, USA).  SP Sepharose FF, Q Sepharose FF, 
MabSelect, and Capto MMC were obtained from GE Healthcare (Uppsala, Sweden).  
The properties of these adsorbents are described in Table 2.1. One-millilitre cartridge 
columns containing UNOsphere S and Capto MMC were obtained from Bio-Rad and 
GE Healthcare, respectively.    
 
2.1.2. Purification Reagents 
Sodium phosphate (monobasic and dibasic), sodium acetate, sodium chloride, sodium 
sulphate, ammonium sulphate, ammonium chloride, and methanol were purchased 
from Fisher Scientific (Pittsburgh, PA, USA); HEPES, MOPS, and MES buffers 
were obtained from Sigma-Aldrich (St. Louis, MO, USA).  The nuclease Benzonase 
was purchased from EMD Chemicals, Inc. (Gibbstown, NJ, USA).  The yeast cell 
wall lytic enzyme Quantazyme ylg (β1,3-glucanase) was obtained from MP 
Biomedicals (Solon, OH, USA).   
 
 
2.2. Protein Test Systems 
2.2.1. Human Papillomavirus (HPV) Virus-like Particles (VLPs) 
Yeast cell paste containing recombinant human papillomavirus (HPV) virus-like 
particles (VLPs) was provided for use in this thesis by the Bioprocess R&D group at 
Merck & Co., Inc. (West Point, PA, USA).  Specifically, the HPV VLPs were cloned 
and expressed in Saccharomyces cerevisiae as described by Hofmann et al. (1995 
and 1996), Neeper et al. (1996), and Rossi et al. (2000).  All fermentation processes 
used a common host strain that was transformed with the expression vector 
pGAL110.  Expression was then induced by addition of galactose acting on a 
galactose-regulated GAL1 promoter.  Experiments examining cell growth and 
induction conditions were carried out at a scale of < 20 L.  Fermentation cell 
products were then harvested by either microfiltration or centrifugation, and frozen 
until use.   
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Table 2.1. Properties of the chromatographic stationary phases used in this thesis (information as supplied by vendor).  
Separation Media Class Vendor Base Matrix Functional Group Avg. Particle 
Sizea (μm) 
      
UNOsphere S 
 
 
Strong Cation Exchange Bio-Rad Cross-linked polyacryl-
amide 
 
-S03- 80 
 
SP Sepharose FF 
 
 
Strong Cation Exchange GE Healthcare Cross-linked agarose -O-CH2CHOHCH2O-   
 CH2CH2CH2S03- 
90 
POROS 50HS 
 
 
Strong Cation Exchange Applied Biosystems Cross-linked poly(styrene-
divinylbenzene) 
 
-CH2CH2CH2S03- 50 
Ceramic Hydroxy-
apatite 
 
Mixed mode Bio-Rad (Ca5(P04)3OH)2 Ca2+, P043-, OH 20, 40, 80 
Capto MMC 
 
 
Mixed mode 
 
GE Healthcare Cross-linked agarose MMC ligandb 75 
MabSelect 
 
Affinity GE Healthcare Cross-linked agarose Recombinant Protein A 85 
      
a) Average bead diameter 
b) The MMC ligand has weak cation-exchange and hydrophobic-interaction functional groups (refer to Table 5.1 for the chemical structure).   
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A laboratory-scale chromatographic purification adapted from the procedure of Cook et 
al. (1999) was used for the evaluation of fermentation changes.  20% (wet cell 
weight/volume) cell suspensions in 200 mM MOPS, pH 7.2, with 2 mM MgCl2 were 
lysed at the laboratory scale (0.1 –0.5 L) by high-pressure homogenisation using a 
Microfluidizer model 110 Y from Microfluidics, Corp. (Newton, MA, USA) at 15,000 
psi with four passes.  A heat exchanger maintained at 2-10° C was used to cool the 
lysate after each pass through the homogeniser.  Benzonase was added at 50 U/mL 
prior to homogenisation for nucleic acid degradation.  The cell disruptate was then 
incubated overnight at 2-8°C.  Following the incubation, cellular debris was removed 
by batch centrifugation carried out at 10000 g for 30 minutes using a Beckman Coulter 
(Fullerton, CA, USA) Avanti JA20 centrifuge.  Centrifugation was used in this thesis 
because it is amenable to parallel processing and microscale operation, although 
alternatives such as depth filtration would also be effective.     
 
HPV VLPs were isolated from the clarified lysate by POROS 50HS cation exchange 
chromatography (CEX) operated at 2-8°C and at a pH of 7.0.  At the laboratory scale, 
an 80-mL (2.6 cm, i.d., X 15 cm, h) column was loaded by a constant input of cell 
weight with a loading residence time of 3.6 minutes.  HPV VLPs were recovered by 
step elution with 1.25 M NaCl in 50 mM MOPS.  For additional purification, a 
polishing chromatography step employing ceramic hydroxyapatite (CHT) was carried 
out at room temperature (22 + 2 °C) using a 30-mL (1.6 cm, i.d., X 15 cm, h) column 
with a loading residence time of 2.5 minutes.  The CEX product was loaded directly 
onto the CHT column, followed by a wash with the CEX elution buffer.  The product 
was then eluted by gradient elution with sodium phosphate at pH 7.  In both 
chromatographic steps, product collection was based on UV measurements at 280 nm.  
Product recovery is expressed here as the amount of total protein recovered per input of 
wet cell weight.  In some instances in this thesis, laboratory-scale data generated by the 
Bioprocess R&D group at Merck & Co., Inc. (West Point, PA, USA) was used in the 
comparison of microscale and laboratory-scale results in the purification of HPV VLPs.    
 
2.2.2. Monoclonal Antibodies 
Human immunoglobulins (huIgG; monoclonal antibodies) were provided for use in this 
thesis by the Bioprocess R&D group at Merck & Co., Inc. (West Point, PA, USA) in a 
crude cell filtrate and/or as a final purified product.  These huIgG were expressed in 
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either CHO cells by standard processes (Wurm, 2004), or in Pichia pastoris as 
described by Li et al. (2006).  The antibodies were then purified from the clarified cell 
culture or fermentation broth by standard chromatography (protein A and ion-exchange 
chromatography) and filtration processes.  The flowthrough fractions from the protein-
A chromatographic purifications were saved and used to evaluate host-cell protein 
(impurity) binding in microscale experiments (as described in Chapter 5), since the 
antibody has been removed from this sample.   
 
2.2.3. Purchased Proteins 
Polyclonal antibody from human serum (> 95% purity) was purchased from Sigma-
Aldrich (St. Louis, MO, USA).   
 
 
2.3. Analytical Methods 
2.3.1. Protein Quantification 
2.3.1.1. Ultraviolet (UV) Spectrophotometry 
Purified antibody concentrations were determined by absorbance (280 nm) using an 
Agilent 8453 (Santa Clara, CA, USA) spectrophotometer.  Real-time absorbance (280 
nm) measurements of fractions from microscale experiments were also made using UV-
transparent 96-halfwell microplates purchased from Corning Lifesciences (Lowell, 
MA, USA) in a Tecan Ultra384 plate reader (Tecan USA, Research Triangle, NC) and 
calibrated against a standard curve.  
   
2.3.1.2. Total Protein by the BCA Assay 
Soluble total protein release was determined by analyzing the clarified lysate by the 
Bicinchoninic Acid (BCA) assay kit from Pierce (Rockford, IL, USA) in a 96-well 
format on a Tecan Genesis 150 workstation (Tecan USA, Research Triangle, NC).  The 
assay was calibrated with bovine serum albumin (BSA) using a curve from 50 to 500 
μg/mL.  Calibration standards and samples were diluted in 50 mM MOPS, pH 7.2, with 
0.15 M NaCl.  Unknown protein concentrations were then determined by interpolation 
from this curve (fit by linear regression). 
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2.3.1.3. Reversed-Phase Chromatography for HPV L1 Protein Quantification 
Reversed-phase chromatography was used to quantify the HPV L1 protein 
concentration in clarified lysate samples.  HPV VLPs were first precipitated in 35% (of 
saturation) ammonium sulphate to remove yeast proteins and then reduced and 
denatured in 0.5 M dithiothreitol and 3% (w/v) sodium dodecylsulphate.  After a 10-
minute incubation at 75° C, 100 μL was injected on to a POROS R2/H column from 
Applied Biosystems (Foster City, CA, USA) heated at 60° C and equilibrated in 
water/0.12% (v/v) trifluoroacetic acid (TFA).  The L1 protein was then eluted in a 
ternary gradient using acetonitrile and isopropanol with 0.1% (v/v) TFA.  The assay 
was calibrated using a curve from 12.5 to 500 μg/mL. 
 
2.3.1.4. Immunoassay for HPV VLP Quantification 
HPV VLP concentrations were quantified using a sandwich-type bead-based 
immunoassay with electrochemiluminescence detection carried out in a 96-well format 
on a Tecan Freedom EVO workstation (Tecan USA, Research Triangle, NC) with the 
support of the Bioprocess R&D Process Monitoring group at Merck & Co., Inc. (West 
Point, PA, USA).  In the assay, VLPs are captured on streptavidin-coated paramagnetic 
beads saturated with a biotinylated serotype-specific HPV VLP monoclonal antibody.  
The mixture is then incubated with a second ruthenium-labelled anti-VLP monoclonal 
antibody and detected with a BioVeris (Gaithersburg, MD, USA) M-Series 384 
analyzer.  Specifically, 25 μL of the pre-coated capture beads were added to each well 
of the microplate, followed by the addition of 25 μL of the diluted sample or calibration 
standard.  After a 1-hr incubation, 25 μL of the ruthenylated anti-VLP antibody 
solution was then added.  Following a second 1-hr incubation, 175 μL of assay diluent 
(Tris-Buffered Saline, pH 8, with 0.1% (w/v) polysorbate-20 and 0.1% (w/v) BSA) was 
added to the entire plate and the plate read in the BioVeris instrument.  A calibration 
curve ranging from 10 to 2000 ng/mL was generated using a four-parameter logistic fit, 
and the VLP concentration of each sample was interpolated from this standard curve. 
 
2.3.1.5. Octet Protein A Assay for IgG Quantification 
Antibody concentration in crude and purified samples was analysed by bio-layer 
interferometry using the ForteBio (Menlo, CA, USA) Octet QK system with protein A 
biosensors.  A 16-point calibration curve ranging from 1 to 300 μg/mL was prepared in 
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50 mM HEPES (pH 7.5), 150 mM NaCl, 0.05% polysorbate-20, and 1% BSA and fit 
with a 4-parameter logistic equation.  Samples were diluted 5 to 50-fold in the HEPES 
assay diluent, and the unknown sample concentrations were determined by 
interpolation from the curve.  
 
2.3.2. Purity 
2.3.2.1. SDS-PAGE 
Crude upstream process samples and chromatographic products were analysed by SDS-
PAGE for purity.  Electrophoresis was carried out under denaturing (SDS sample buffer 
and heat) and reducing conditions, using a 4 – 12% gradient NuPAGE gel system from 
Invitrogen (Carlsbad, CA, USA). The electrophoresis was carried out at 150 V and 
room temperature using the MOPS running buffer supplied by Invitrogen.  Gels were 
stained overnight with Sypro Ruby fluorescent protein stain from Invitrogen and 
scanned using a Molecular Dynamics (Sunnyvale, CA, USA) fluorescence gel imager.    
 
2.3.2.2. Residual Host-Cell Protein Immunoassay 
Host cell proteins (HCP) from the CHO and Pichia pastoris expression systems were 
quantified by ELISA on a Tecan Freedom EVO workstation with the assistance of the 
Bioprocess R&D Process Monitoring group at Merck & Co., Inc. (West Point, PA, 
USA).  These assays used anti-HCP polyclonal antibodies (pAbs) from Cygnus 
Technologies (Southport, NC, USA).  Microtitre plates were coated with 5 μg/mL of 
the anti-HCP pAbs, followed by the addition of reference standards (solubilised 
clarified lysate) and samples.  Following the capture step, biotinylated anti-HCP pAbs 
were added to the plate, forming an immune complex.  This complex was detected by 
the addition of streptavidin-alkaline-phosphatase (AP) conjugate and the fluorogenic 
substrate, 4-methylumbelliferyl phosphate (4-MUP).  A standard curve was generated 
by plotting fluorescence intensity vs. concentration.  The curve was fit with a four-
parameter logistic equation, and unknown sample concentrations were determined by 
interpolation from the curve.   
 
2.3.2.3. Quantification of Residual dsDNA with the PicoGreen Reagent 
Residual dsDNA concentration was quantified in experimental samples using the 
Quant-iT™ PicoGreen® dsDNA Assay Kit from Invitrogen (Carlsbad, CA, USA), with 
all assay steps automated on a Tecan Genesis 150 workstation.  The assay was 
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performed in Corning Costar 96-well opaque plates.  The standard curve (λ DNA) and 
samples were prepared in 1X Tris-EDTA buffer with 0.1 M NaCl and 200 μg/mL of 
proteinase K on a Tecan workstation at a final volume of 100 μL.  To each standard and 
sample, 100 μL of 1X PicoGreen reagent was added and the plate was read at excitation 
485 nm / emission 535 nm on a Tecan Ultra plate reader.  The standard curve was 
generated by linear regression of the mean of the two replicates at each point, and the 
DNA concentration of each sample was interpolated from this standard curve.   
 
2.3.3. Characterisation of Yeast Lysate from Cell Disruption Experiments 
2.3.3.1. Optical Density 
The turbidity of the clarified lysate following cell disruption was monitored at 600 nm 
to characterise the extent of cell lysis.  Samples were analysed in 96-well microplates 
from BD Biosciences (San Jose, CA, USA) using a Tecan SpectraFluor detector (Tecan 
USA, Research Triangle, NC).   
 
2.3.3.2. Light Microscopy 
Yeast cell breakage and debris size were assessed qualitatively by oil immersion light 
microscopy using an Olympus Model AX70TRF microscope (Center Valley, PA, 
USA).  Samples were diluted to the equivalent of a 1% (w/v) cell slurry solution and 
examined at 1000X magnification.  Images were taken digitally using a Spot 2 camera 
with Spot 32 software from Diagnostic Instruments (Sterling Heights, MI, USA). 
 
 
2.4. Description of Chromatographic Methods 
2.4.1. Column Chromatography 
Laboratory-scale column experiments were performed on either an Applied Biosystems 
(Carlsbad, CA, USA) Biocad 700/Vision instrument or an AKTA Explorer system (GE 
Healthcare; Uppsala, Sweden).  The column length and flow rate varied with the 
specific application.  Columns were slurry packed in glass XK16 or XK26 columns 
from GE Healthcare or 0.5-cm diameter columns from Waters (Milford, MA, USA).  
Alternatively, pre-packed 1-mL cartridge columns supplied by the adsorbent vendor 
were used.  The chromatography of HPV VLPs was performed as described in section 
2.2.1.  Breakthrough curves with huIgG were carried out by first equilibrating the 
column with >10 column volumes of loading buffer and then loading the protein at 
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varying flow rates and monitoring breakthrough by absorbance at 280 nm (refer to 
Chapter 4 for specific details).  Prior to performing the breakthrough experiment, the 
hold-up volume of the system tubing was determined to compute the delay time, and 
breakthrough curves were corrected accordingly.  Column chromatography experiments 
to validate microscale results were performed as described in Chapters 5 and 6.      
 
2.4.2. Micro-Tip Chromatography 
Micro-tip columns in 1-mL Tecan pipette tips were prepared by PhyNexus (San Jose, 
CA, USA) as a custom order as described in Chapter 3.  The set-up and operation of the 
micro-tip chromatography platform on a Tecan workstation is discussed in detail in 
Chapter 3.  Use of the micro-tip format for adsorbent characterisation and process 
development is discussed in Chapters 4-6.   The specific details of each application are 
provided in these chapters. 
 
2.4.3. Micro-Batch Adsorption 
Micro-batch adsorption experiments using adsorbent volumes less than 100 μL were 
performed either in 96-well MultiScreen filterplates (Durapore membrane; 1-micron 
pore size; 300 μL well volume) from Millipore (Billerica, MA, USA) or in 1.5-mL 
microcentrifuge tubes from Eppendorf (Westbury, NY, USA).  These experiments were 
carried out at ambient temperature (18-24 °C).  For batch experiments carried out in a 
filterplate, the adsorbent slurry, sample, and purification buffers were added to each 
well by manually pipetting each solution or suspension.  The adsorbent in the 
filterplates was suspended using a LabSystems Wellmix plate shaker from Thermo 
Scientific (Waltham, MA, USA).  Liquid volume was recovered in a collection plate by 
centrifuging the plate at 1000 x g for one minute with a Beckman (Fullerton, CA, USA) 
GS-15R plate centrifuge.  For experiments carried out in microcentrifuge tubes, the 
adsorbent was mixed by either end-over-end rotation or with gently vortexing.  Liquids 
were recovered by careful aspiration following centrifugation at 5000 x g for 5 minutes 
in an Eppendorf (Eppendorf North America; Westbury, NY, USA) 5417R 
microcentrifuge.  In many cases, to ensure the removal of resin fines, the recovered 
solution was then filtered through a Millipore MultiScreen filterplate as described 
above.   
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Resin suspensions as provided by the manufacturer were exchanged into the desired 
equilibration or storage buffer by carrying out several settle-decant steps.  The 
percentage of adsorbent (v/v) in the slurry was then determined by filtering (by gravity) 
10 mL of the resin slurry through a small 10-mL drip column.  The volume of the 
settled resin was determined from its measured bed height and then divided by the 
starting slurry volume (10 mL) to calculate the % resin slurry value.  The desired 
adsorbent volume for a particular batch experiment was calculated from this % resin 
slurry value.  Alternatively, for very low resin volumes, small resin plaques (small 
cylinders of resin) were prepared using the Atoll (Weingarten, Germany) MediaScout 
ResiQuot vacuum manifold device.  Excess adsorbent slurry was added to each well of 
the 96-well manifold and then a vacuum was applied to generate 7.8 + 0.3 μL plaques.  
Plaques were subsequently washed by applying wash buffer to each well.  The washed 
plaques were then transferred from the perforated manifold to a 96-well microplate, or 
to microcentrifuge tubes, using a pusher tool.   
 
In addition to the experiments above, batch experiments were carried out in which 
adsorbent was extracted from micro-tip columns prepared by PhyNexus (refer to 
section 2.4.2) in order to directly compare micro-tip and micro-batch operation.  This 
was performed by first washing the micro-tip columns in equilibration buffer as 
outlined in Chapter 3.  Next, the micro-tip column was cut just above the micro-tip 
column bed and the upper frit carefully removed.  A small amount of buffer was added 
to the resin and then the resin slurry was transferred to a vial containing the buffer or 
protein solution.  Finally, the emptied micro-tip column was rinsed at least three times 
to ensure complete resin transfer.     
 
2.5. Cell Disruption of Yeast 
Laboratory-scale cell disruption of yeast cells was carried out by homogenisation using 
a microfluidizer (Microfluidics International Corporation; Newton, MA, USA) as 
described above in section 2.2.1.  Microscale cell disruption was performed by 
Adaptive Focused Acoustics using the Covaris E210 instrument (Covaris, Inc.; 
Woburn, MA, USA) as described in Chapter 7. 
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2.6. Statistical and Mathematical Software 
Design-of-experiment methodologies (factorial and response surface methodologies) 
were used to optimise cell disruption and chromatographic operations.  These 
experiments were designed and analysed using the Design Expert statistical software 
from State-Ease (Minneapolis, MN, USA).  Both full and fractional designs were used 
along with central-composite and user-defined response surfaces, the details of which 
are described in Chapters 5 and 7.  The model that best fit the data was selected using 
the statistical software and verified by ANOVA and other statistical assessments.   
 
Graphs and subsequent fitting of data to equations was performed in SigmaPlot version 
10.0 (Systat Software; San Jose, CA, USA). Predictive modelling simulations of 
dynamic binding capacity were performed in Microsoft Excel and in Mathworks 
(Natick, MA, USA) MATLAB. Equations and parameters used in the modelling of 
dynamic binding capacity are described in Chapter 4.   
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3. OPERATION AND AUTOMATION OF MICRO-TIP      
    CHROMATOGRAPHY  
3.1. Introduction 
Micro-tip columns provide a platform for microscale chromatography that can be 
fully automated.  Although it can be performed manually with a pipette or syringe, it 
is difficult to consistently control the flow rate.  Consequently, it is most reliably 
performed on a liquid-handling robot.  Full walk-away automation is accomplished 
with relative ease since there is no manipulation of loose adsorbent and no solid-
liquid separation steps required.  This capability for full automation is in contrast to 
other microwell methods that are often only semi-automated or which are less robust 
in their automation because of frequent labware manipulations.  A simple path to 
automation enables that the method can be deployed among a wide range of users, 
even those with a limited skill set in robotics.  An additional operational advantage of 
micro-tip chromatography is that there is no concern about sorbent mixing, since the 
external mass transport involves flow through a packed bed.  This is particularly 
beneficial for dense media, e.g. ceramic hydroxyapatite, which can be difficult to 
suspend uniformly in batch microwell experiments. 
 
This chapter describes the set-up, automation, and operation of micro-tip columns on 
a Tecan liquid-handling robot.  Flow properties of the micro-tip columns are 
examined, and critical operating terms and parameters are defined.  In addition, a 
general outline is presented for performing micro-tip chromatographic experiments.  
Specific procedures for carrying out adsorption isotherms, kinetic studies, mobile-
phase screening experiments, and multi-step purifications are subsequently discussed 
in more detail in Chapters 4-6.    
 
 
3.2. Set-Up and Automation of Micro-Tip Chromatography  
3.2.1. Micro-Tip Column Preparation 
Micro-tip columns containing 10, 40, and 80 μL of immobilised adsorbent were 
supplied by PhyNexus (San Jose, CA USA) as a custom order in 1-mL clear-plastic 
pipette tips manufactured for the Tecan liquid-handling workstation.  These micro-tip 
columns are marketed under the name PhyTips.  Although the packed bed of the 
micro-tip column format resembles a laboratory column, the geometry is very 
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different.  The bed height is significantly reduced (0.6 cm for the 10-μL column, 0.9 
cm for the 40-μL column, and 1.2 cm for the 80-μL column) and is tapered, giving it 
a conical shape.  The dimensions for the three micro-tip column sizes used in this 
thesis are shown in Figure 3.1.  
 
The columns are prepared by PhyNexus using a proprietary procedure in which a 
pre-defined volume of adsorbent slurry is drawn up for a given column volume and 
then situated between two hydrophilic frits which are welded to the bottom of the 
pipette tip.  The accuracy of the bed volume is defined by the geometry of the pipette 
tip and the specific location of the internal frits.  During manufacturing, the bed 
volumes of the micro-tip columns are periodically verified against a standard bed 
volume for that respective column size, with an allowed variation of ± 10%.  The 
precision (n = 8 or 16) of the micro-tip column preparation was evaluated 
experimentally by overloading micro-tip columns (in the nonlinear portion of the 
adsorption isotherm) with a human monoclonal antibody (huIgG) solution and then 
determining the adsorbent load.  The specific details for micro-tip column operation 
are described later in this chapter.  This assessment was carried out with 10, 40, and 
80-μL micro-tip columns containing UNOsphere S cation exchange adsorbent, 
loaded for 30 minutes with 0.8 mL of the protein solution at 0.8, 3.1, and 6.1 mg/mL, 
respectively (in 25 mM sodium phosphate, pH 6.5).  The columns were then eluted 
with an equivalent volume of 500 mM NaCl in 25 mM sodium phosphate, pH 6.5.  
 
The adsorbent mass loading, q, (mg protein/mL packed adsorbent) was determined 
by measuring the concentration of the feed and nonbound (sample remaining after 
loading) samples by absorbance at 280 nm and then calculated by:  
  
A
pAASS
V
VVVCVC
q
])1([0 εεε −++−
=   Equation 3.1  
where C0 is the starting sample concentration (in mg/mL), C is the sample 
concentration after loading (in mg/mL), VS is the sample volume (in mL), VA is the 
adsorbent volume in mL, εp is the bed porosity, and ε is the bed void fraction. In this 
experiment, ε was estimated to be 0.4, and εp was assumed to be 0.7.  (This equation 
assumes that most or all of the pore volume is accessible to the protein given 
sufficient time for pore diffusion.) 
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Column  Volume  (μL) 10 40 80 
Column  height (h), mm 6 9 12 
Inner diameter (i.d.) – Top, mm 2 3 4 
Inner diameter (i.d.) – Bottom, mm 1 2 2 
 
Figure 3.1. (A) Schematic illustration and dimensions of the 10-, 40-, and 80-μL 
micro-tip columns (PhyTips) prepared by PhyNexus. Columns were prepared using 
1-mL Tecan pipette tips. Approximate dimensions (measured to the nearest 
millimetre) for each micro-tip size are given in the associated table.  (B) Picture 
showing 80-μL micro-tip columns.      
 
h
i.d.
i.d.
Screens attached to the 
plastic tip body
Separation media encased 
between the two screens 
A 
 
B 
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Alternatively, the adsorbent loading was determined in these experiments from the  
mass of the eluted protein, again measured by absorbance at 280 nm, and with a 
recovery of 100% assumed: 
A
pAAE
V
VVVC
q
])1([ εεε −++
= ,    Equation 3.2  
where C and VE are the concentration and volume of the eluted product, respectively.  
The precision of the loading is summarised in Table 3.1.  The coefficient of variation 
(CV) for loading is less than 5% for all three micro-tip column sizes by both methods 
for determining q, implying excellent precision in the micro-tip column preparation 
and its operation. 
 
Table 3.1. Precision study to examine the reproducibility of micro-tip column 
preparation and operation: loading of a huIgG onto UNOsphere S for three 
different micro-tip bed volumes. Columns were overloaded in each case (nonlinear 
portion of the adsorption isotherm).  The total loading time was 30 minutes.     
  Calculated from nonbound Calculated from elution 
Bed Vol.  
(μL) 
Replicates 
(n) 
q * 
(mg/mL) 
%CV q * 
 (mg/mL) 
%CV 
      
10 16 36.2 + 0.4 1.9 37.6 + 0.9 4.4 
40 8 33.7 + 0.3 1.1 39.2 + 0.7 2.0 
80 8 31.8 + 1.3 4.9 37.8 + 1.0 3.1 
      
* huIgG bound per mL of adsorbent; reported as the mean +/- 95% confidence interval 
 
In addition to precision, information about the relative accuracy of micro-tip 
preparation across the three different column sizes is obtained from this experiment.  
The protein loading is comparable between the three micro-tip bed volumes, 
differing by < 12% when determined from the nonbound fraction and by < 4% when 
determined from the eluted product.  The slight difference in q observed between the 
two methods used in its determination most likely reflects some experimental error in 
the micro-tip chromatography set-up, e.g. inaccuracies in the dispensed volumes, or 
in the absorbance measurements of the feed, nonbound, and/or eluted fractions.  
Absorbance measurements were made in a 96-well microtitre plate, which is prone to 
higher error than that of a conventional cuvette method.  One other potential source 
of error is sample evaporation, given that the samples are not covered during the 
experiment.  Specifically, evaporation of the nonbound fraction would result in a 
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slightly higher protein concentration and therefore a lower apparent adsorbent 
loading.  Nevertheless, these errors are relatively minor, and it appears that the 
micro-tip preparation is reproducible across all three micro-tip column sizes. 
 
The accuracy of micro-tip column preparation was assessed by comparing the micro-
tip column loading to that of conventional batch adsorption under equilibrium 
conditions.  The micro-tip column was again overloaded as described above.  For the 
batch adsorption experiment, 80 μL of a 50% adsorbent slurry were added to 800 μL 
of a 3.1 mg/mL huIgG solution and mixed by end-over-end rotation.  A second 
experiment was carried out in which the adsorbent was loaded in a high conductivity 
solution (0.5 M NaCl) under which the protein does not bind, with this experiment 
used to account for sample dilution resulting from the slurry addition.  A comparison 
of micro-tip and batch adsorption results is shown in Table 3.2.   There is good 
agreement between the two formats, with an observed difference of < 2%.   
 
Table 3.2. Assessment of the accuracy of micro-tip column preparation by 
comparison of micro-tip adsorbent loading (q) to that of batch adsorption.  In both 
experimental formats, 800 μL of huIgG was exposed to 40 μL of UNOsphere S 
adsorbent.  Batch adsorption was carried out in a microcentrifuge tube with end-
over-end rotation. The total loading time was 30 minutes.     
Format Replicates 
(n) 
q *                      
(mg/mL) 
%CV % difference 
from batch 
 
Micro-tip 
 
8 
 
36.5 + 0.5 
 
1.5 
 
-1.6 
 
Batch 
 
3 
 
 
37.1 + 1.8 
 
2.0 
 
------ 
* huIgG bound per mL of adsorbent; reported as the mean +/- 95% confidence interval 
 
A variety of preparative chromatography media can be used with the micro-tip 
format.  The general requirement for a new adsorbent is that its average particle size 
exceeds the nominal cut-off of the hydrophilic frits (about 30 microns) and that 
consistent flow can be achieved across the packed micro-tip column.  A flow test is 
carried out by PhyNexus for all new adsorbents to ensure that a specified volume of 
fluid (water or 20% ethanol) can reproducibly flow through the micro-tip column in a 
defined amount of time upon applying a vacuum.  In this study, preparative 
adsorbents from GE Healthcare (SP Sepharose FF, MabSelect, and Capto MMC), 
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Applied Biosystems (POROS 50HS), and Bio-Rad (UNOsphere S and ceramic 
hydroxyapatite) were successfully used in the micro-tip column format.   
 
3.2.2. Liquid-Handling Robot  
Micro-tip chromatography was automated on a Tecan Freedom EVO 200 liquid-
handling workstation (Tecan USA, Research Triangle, NC), controlled by Gemini or 
Evoware software.   The Tecan workstation (Fig. 3.2A) was equipped with a robotic 
manipulation arm (RoMa) for moving microtitre plates and an eight-channel liquid 
handling arm (LiHa).  The LiHa (Fig 3.2B) was used for transferring liquids between 
labware and for pipetting through the micro-tip columns.  It was configured with 
disposable tip (DiTi) adapters for picking up the micro-tips and a 'low-DiTi-eject' 
accessory for setting the micro-tip columns back into their racks.  Eight micro-tip 
columns were picked up at a time in each automated experiment.  A Tecan Ultra384 
plate reader (filter-based) was integrated with the system for absorbance and 
fluorescence measurements. 
 
A typical Tecan deck layout for the micro-tip experiments performed in this thesis is 
shown in Figure 3.2C, although the layout was sometimes modified for a specific 
application or for higher throughput.  In the set-up shown here, the Tecan deck is 
configured with several three- and four-position microplate carriers for holding 
microtitre plates, deepwell plates, partitioned-reservoir plates, and DiTi cans for 
holding the 200- and 1000-μL pipette tips.  In addition, there are carriers for holding 
100-mL reagent troughs, sample vials, and the micro-tip columns.  A Peltier rack 
from Gilson (Middleton, WI USA), capable of holding up to 60 sample vials, is 
located on the deck for temperature control (2 – 40° C).   
 
3.2.3. Labware 
Micro-tip chromatography was performed in BD Falcon 96-deepwell microplates 
(1.0 mL/well and 2.0 mL/well) with square pyramid bottoms purchased from Fisher 
Scientific (Pittsburgh, PA, USA).  For samples requiring temperature control, the 
chromatography was performed in two-mL Nalgene cryovials from Fisher Scientific 
on the Gilson temperature-controlled rack.   Micro-tip pre-washing steps were 
carried out in 12-column partitioned reservoir plates from Seahorse Bioscience 
(Chicopee, MA USA).  Eight-row or 12-column partitioned reservoir plates from 
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Figure 3.2. Tecan Freedom EVO 200 workstation used 
for micro-tip chromatography: (A) photograph of 
instrument; (B) close-up of the LiHa with DiTi adaptors 
(picture from Tecan);  (C) example of a deck layout for 
micro-tip chromatography. 
P
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Seahorse Bioscience and 100-mL troughs from Tecan were used for holding buffered 
solutions required for the microplate chromatography.  Samples were placed on the 
Tecan deck either in 2-mL Nalgene cryovials or in 15-mL Falcon polypropylene 
centrifuge tubes, also supplied by Fisher.  Black liquid-sensing (non-sterile) 
disposable pipette tips (200 and 1000 μL) were purchased from Tecan, MP 
Biomedical (Solon, OH USA), or Axygen (Union City, CA USA).  UV-transparent 
BD Falcon (300 μL/well) or Corning Costar (150 μL/well) 96-well microplates were 
purchased from Fisher Scientific for making absorbance readings at λ = 280 nm in 
the Tecan Ultra384 plate reader. 
 
3.2.4. Liquid-Handling Parameters (Liquid Classes)  
Liquid handling on the Tecan is defined by a set of pipetting instructions referred to 
as a liquid class.  The parameters of a liquid class include aspiration and dispense 
speeds (volumetric flow rates given in μL/s), airgaps (volumes given in μL), 
calibration settings, pipette positioning (z height) during aspiration and dispense, 
liquid detection modes, and delay times.  Parameters are defined separately within a 
liquid class for fixed and disposable pipette tips as well as for different volume 
ranges.  The Tecan software contains some predefined liquid classes for different 
liquid-handling applications and liquid types, and custom liquid classes can also be 
developed.  Having optimised liquid classes is extremely critical to the accuracy and 
precision of liquid handling. 
 
Custom liquid classes were developed for micro-tip column operation to ensure 
accurate and reproducible flow and to operate in a flow regime that matches the 
typical linear velocities of laboratory-scale column chromatography.  Specifically, 
this involved decreasing the aspiration and dispense speeds to between 2 and 20 
μL/sec, considerably lower than those normally used for pipetting fluids (100 - 600 
μL/sec). For the aspiration and dispense positions, the micro-tip column was set to 
pipette 1 mm (10 steps) above the bottom of the microwell (defined here as z-max).  
This is a critical setting since if the micro-tip is too close to the bottom, then flow can 
be obstructed and becomes non-uniform.  If positioned too high, then the hold-up 
volume in the microwell (volume that cannot be pipetted) becomes significant.   
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The Tecan tubing and syringes are filled with water (known as the system liquid) to 
ensure pipetting fidelity.  However, a trade-off for this accuracy is that droplets of 
system liquid can sometimes fall into the micro-tips, especially after many 
aspiration-dispense cycles.  To minimise this contamination, an air gap was 
positioned between the system liquid and the bottom of the DiTi adapter cone 
(referred to in the Tecan software as a system trailing air gap, or STAG).  In the 
Gemini software, this air gap is drawn prior to the first aspiration following a LiHa 
wash and after the pipette tips have been picked up.  Given that the air gap can 
breakdown after repeated pipetting steps, water flushes were performed periodically 
during micro-tip operation to replenish the air gap.  One drawback of using a STAG 
is that there is a risk of aspirating air into chromatographic bed.  Therefore, the air 
gap volume should be kept to a few microlitres.  In the more recent Evoware 
software, the air gap is drawn at the end of each wash step prior to picking up the 
pipette tip, so this risk is eliminated.  Consequently, larger air gap volumes may be 
evaluated (> 30 μL).  
  
 
3.3. General Procedure for Micro-Tip  Chromatography 
Micro-tip chromatography is performed by pipetting sample or mobile phase up and 
down through the micro-tip column.  Sample and purification reagents (pre-wash, 
equilibration, wash, and elution buffers) are presented in a 96-well microplate, and 
the micro-tip columns are then moved across the plate using the LiHa.  No separate 
collection plate or plate manipulation by the RoMa is required.  This differs from 
micro-batch adsorption where the chromatography sorbent remains in its respective 
microwell, and the sample and reagents are sequentially added to it, mixed, and then 
filtered.  The micro-tip columns should be periodically set back into their rack during 
a purification run, and the Tecan LiHa then flushed with water to avoid dripping of 
system liquid into the micro-tip as discussed above.  A good rule of thumb is to 
perform a system flush after about ten aspiration-dispense cycles and in between 
purification stages (i.e. equilibration, load, wash, and elution).   
 
Figure 3.3 shows an example of a typical 96-deepwell plate layout for a protein 
purification having equilibration, load, wash, and elution steps.  Multiple aliquots of 
buffer can be used within a purification stage to ensure sufficient equilibration, 
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Figure 3.3. Example of pre-wash and purification plate layouts for a typical micro-tip column purification.  Purification reagents 
(sample and mobile phase solutions) are transferred into the plates prior to the micro-tip chromatography.  In this example, a 
different purification plate is used for every eight-column (micro-tip) run. 
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washing, and elution.  Micro-tip columns may also require a series of pre-wash steps 
(alcohol, water, and/or pre-wash buffer) prior to equilibration, which can be carried 
out in a 12-column partitioned-reservoir plate or in a 100-mL trough.  Purification 
buffers are sourced from 100-mL troughs if the same buffer is used across all eight 
micro-tip columns within an experimental run, or from eight-row partitioned-
reservoir plates if the buffer differs with each micro-tip column.  The preparation of 
buffers, particularly for screening experiments in which there may be many different 
buffer matrices, and the subsequent dispensing of these solutions into purification 
plates can itself be a bottleneck in high-throughput microscale experiments.  
Therefore, it can be advantageous to prepare batches of purification plates off-line 
prior to the purification experiment.  Methods for preparing different buffer matrices 
in microtitre plates on a liquid-handling workstation from stock solutions have been 
developed for crystallography studies (Aguero, 2003), and such methods can 
potentially be applied to microscale purification experiments.   
 
The specific volume of each aliquot is an operating parameter that is defined for a 
particular purification.  To avoid introducing air into the micro-tip bed, the aspiration 
volume through the micro-tip column should always be less than or equal to the total 
aliquot volume minus the hold-up volume of the microwell.  The hold-up volume is 
defined by the well geometry and the position of the micro-tip column in the well.  
For the BD Falcon pyramid-bottom deepwell plates used for this project, it was about 
25 μL when the micro-tip column was positioned one millimetre from the plate 
bottom.  Evaporation of samples and purification solutions must also be considered 
since the microplates are uncovered during the course of an experiment.  Strategies 
for minimising evaporation include using chilled carriers and/or placing lids on top 
of the microplates after completion of the purification sequence.  In addition, an 
aliquot volume (per well) of less than 100 μL is generally not recommended if 
uncovered for long periods of time. 
 
 
3.4. Considerations for Micro-Tip Column Operation 
3.4.1. Glossary of Key Operating Terms 
Cycle number (cyc).  The total number of aspiration-dispense (up, down) cycles.  
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Delay time (TD). Total wait time after each aspiration and dispense step to 
compensate for an initial lag in fluid flow.  The delay time is experimentally 
determined by: 
 TD = Tactual – Tcalc       Equation 3.3 
where Tactual is defined here as the actual time taken to aspirate 97% of the target 
volume through the micro-tip column, and Tcalc, is the calculated aspiration time 
when there is no chromatography matrix (equal to the target volume divided by the 
volumetric flow rate).  This definition allows for a 3% inaccuracy in pipetting.   
 
Residence time (TR): The apparent residence time during the loading of a micro-tip 
column is defined as the product of the total number of pipetting steps (i.e. the sum 
of all aspiration and dispense steps; equal to two times the cycle number) and the 
ratio of the adsorbent volume (VA, in μL) and the Tecan volumetric flow rate (Q, in 
μL/s): 
 2××= cyc
Q
VT AR .      Equation 3.4 
Note that delay times are not accounted for in this term. 
 
Contact time (TC): The total time that the sorbent is in contact with the liquid for a 
particular purification step.  The contact time may also be referred to as the total 
loading or incubation time.  It is defined here as: 
  ⎟⎟⎠
⎞
⎜⎜⎝
⎛
++⎟⎟⎠
⎞
⎜⎜⎝
⎛
××= dispDaspD
S
C TTQ
V
cycT ,,2    Equation 3.5 
where VS is the sample volume in μL, TD,asp and TD,disp are the wait times (in s) after 
each aspiration step and dispense step, respectively, and cyc is the total number of 
aspiration-dispense cycles.  If delays times are not used after each aspiration and 
dispense step (as in the case of batch kinetic studies), then this equation reduces to:
  2××= cyc
Q
VT SC .     Equation 3.6 
 
 
  
 - 97 - 
 
Relationship between TR and TC: The relationship of TR to TC is defined by: 
  ( )( )dispDaspDC
S
A
R TTcycTV
VT ,, +×−×= .   Equation 3.7 
Note that the TR term does not account for delay times.  Where delay times are not 
used, as is often the case in kinetic studies, the relationship reduces to: 
  C
S
A
R TV
VT ×=  .      Equation 3.8 
Average linear velocity (µavg): The relationship of the Tecan volumetric flow rate to 
the superficial linear velocity through the micro-tip column (cm/h) is defined here as: 
3600××=
A
avg V
QLμ        Equation 3.9 
where µavg is the average linear velocity in cm/h, L and VA are the length (cm) and 
adsorbent (bed) volume (μL) of the micro-tip column, and Q is the volumetric flow 
rate (μL/s).  Because of the tapered shape of the micro-tip column, the linear velocity 
is represented here as an average since it will change across the column length.   
      
3.4.2. Flow Properties of Micro-Tip Chromatography 
3.4.2.1. Fundamental Characterisation of Micro-Tip Flow 
Micro-tip chromatography is operated optimally at pipetting speeds between 2 and 
20 μL/sec (0.12 – 1.2 mL/min).  This allows superficial linear velocities that are in 
the range of process chromatography to be achieved and ensures a reproducible flow 
profile.  At these flow rates, μavg (Equation 3.9) ranges from 432-4320 cm/h for the 
10-μL column, 162-1620 cm/h for the 40-μL column, and 108-1080 cm/h for the 80-
μL column.  Although these values are expressed as average velocities, in reality the 
linear velocity changes down the length of the micro-tip column, being lowest at the 
top of the column, where the diameter is the widest, and highest at the bottom, where 
the diameter is the narrowest.  This change in linear velocity with the axial position 
in the micro-tip column is shown in Figure 3.4A for the 10-, 40-, and 80-μL columns 
when flowing at 5 μL/s.  Here, each column is divided into 0.3 mm slices (for a total 
of 20, 30, and 40 slices for the 10-, 40-, and 80-μL columns, respectively), with μavg 
calculated for each slice.  The linear velocity ranges from 588 cm/h at the top of the 
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column to 2181 cm/h at the bottom for the 10-μL column, 258 to 564 cm/h for the 
40- μL column, and 145 to 559 cm/h for the 80-μL column.  
 
The Reynolds number (Re; Reynolds, 1883) is a dimensionless number used to 
characterise the nature of flow in flowing systems, providing a ratio between inertial 
and viscous forces.  For flow in a packed chromatographic bed, Re is given by 
(LeVan et al., 2008): 
υ
εvd p
=Re ,       Equation 1.17 
where v is the interstitial linear velocity in cm/s, ε is the column voidage, dp is the 
average particle diameter (cm), and υ  is the kinematic viscosity of the mobile phase 
(cm2/s).  Alternatively, Re can be expressed as a function of the superficial linear 
velocity, μ: 
 
υ
μpd
=Re .       Equation 3.10 
Because the linear velocity changes axially down the micro-tip column, the Reynolds 
number changes as well.  This is shown in Figure 3.4B for the 10-, 40-, and 80-uL 
micro-tip columns when flowing at 5 μL/s.  Here, dp is 0.008 cm, and υ  is assumed 
to be the same as water, at 0.01 cm2/s.  At 5 μL/s, the Re values range from 0.13 at 
the top of the column to 0.48 at the bottom for the 10-μL column, from 0.06 to 0.13 
for the 40- μL column, and from 0.03 to 0.12 for the 80 μL column.  Flow conditions 
are generally considered laminar at Re <10 and fully turbulent at Re >2000 (Rhodes, 
2008).  Therefore, micro-tip chromatography is operated under laminar flow 
conditions.  As shown in Figure 3.4B (refer to dashed horizontal lines), this is within 
the same range as a conventional cylindrical column operated between 100 and 1000 
cm/h under the same conditions (dp = 0.008 cm; υ =  0.01 cm2/s), although this range 
is exceeded for the 10-μL column midway down the column.   
 
The Biot number is another dimensionless number used to characterise mass 
transport properties in column chromatography.  Specifically, in the case of porous 
adsorbents, it provides an indication of whether film mass transfer or intra-particle 
diffusion is rate determining.  In packed bed chromatography, the Biot number (Bi) 
is defined by (Carta, 2005), 
  
 - 99 - 
 
ep D
DShBi
ε2
=       Equation 3.11 
Where Sh is the dimensionless Sherwood number, D is the molecular diffusivity, De 
is the effective pore diffusivity, and εp is the particle porosity.  In adsorption beds 
where 0.0015<Re<55, the Sherwood number can be calculated from the Reynolds 
number and Schmidt number (Sc) using the following expression (Wilson and 
Geankoplis, 1996), 
33.033.0Re09.1 ScSh
ε
=       Equation 1.16 
where ε is the column voidage (assumed to be 0.4 here) and Sc is defined by,  
  
D
Sc υ= .       Equation 1.18 
The molecular diffusivity for a protein in water can be calculated by (Polson, 1950) 
 3/151074.2 −−= MXD       Equation 3.12 
where M is the molecular weight of the protein.   The calculated Biot number for a 
huIgG (M = 150,000 Da) flowing at 5 μL/s is shown in Figure 3.4C for the 10-, 40-, 
and 80-μL micro-tip columns.  In this case, a porous adsorbent with an average 
particle size of 80 μm and an εp of 0.9 is assumed.  De is assumed to 0.1 of the 
calculated molecular diffusivity (D = 5.1 X 10-7 cm2/s; De = 5.1 X 10-8 cm2).  At a 
flow rate of 5 μL/s, the Biot number ranges from 202 at the top of the column to 311 
at the bottom for the 10-μL column, from 154 to 199 for the 40-μL column, and from 
127 to 198 for the 80-μL column.  Therefore, Bi >> 1 under these conditions, 
indicating that pore diffusion is rate determining and that the film resistance is 
negligible.       
 
3.4.2.2. Volumetric Flow Profile and Determination of Delay Times 
An initial resistance to flow is observed through the micro-tip column because of the 
back-pressure generated by the packed bed.  The flow profile through a 40-μL 
UNOsphere S micro-tip column is shown in Figure 3.5, in which 900 μL of water 
was aspirated at 8 μL/s.  The aspirated volume was determined by gravimetric 
measurement of the liquid before and after aspiration at different time intervals.  
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Figure 3.4.  (A) Superficial linear velocity (μ), (B) Re number, and (C) Biot number as 
a function of column axial position for the 10- (●), 40- (▼), and 80-μL (■) micro-tip 
columns at a flow rate of 5 μL/s.   The column bed i.d. changes from 2 mm, at its top, to 
1 mm, at its bottom, for the 10-μL column, 3 to 2 mm for the 40-μL column, and 4 to 2 
mm for the 80-μL column. Each column is divided into 0.3 mm slices, with μ, Re, and 
Biot calculated for each slice.  The dashed lines represent the calculated values under the 
same conditions for a conventional cylindrical column operated at 100 and 1000 cm/h.     
Top      Bottom
Parameter inputs:  
υ  = 0.01 cm2/s 
dp = 80 μm 
εp = 0.9 
D =  5.1 X 10-7 cm2/s 
De = 5.1 X 10-8 cm2/s. 
Parameter inputs:  
υ  = 0.01 cm2/s  
dp = 80 μm 
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Figure 3.5. Volumetric flow profile through a 40-μL UNOsphere S micro-tip 
column at an aspiration speed of 8 μL s-1.  (A) Aspiration of 900 μL of water as a 
function of time.  The delay time was calculated as the difference between the 
observed time required to aspirate 97% of the target volume (143 s) and the 
calculated time taken to aspirate through an empty pipette tip assuming no delay 
(112.5 s).  (B) The flow profile in the linear portion of the flow curve.  The slope of 
this line is 7.98 μL/sec, demonstrating that the flow rate is accurate.  
B 
Delay 
Time 
A 
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Following the initial delay in fluid flow, the flow becomes linear and is very 
accurate, within 99.8% of the target flow rate.  However, if the targeted aspiration 
volume is to be achieved, a delay time is required to compensate for the initial lag in 
flow and to allow the pressure to re-equilibrate across the chromatography bed.  This 
delay time is defined by Equation 3.3 as the difference between the time taken to 
aspirate 97% of the target volume (900 μL * 0.97 = 873 μL) through the micro-tip 
column and the calculated time taken to aspirate that same volume through an empty 
pipette tip (900 μL / 8 μL s-1 = 112.5 s).   An aspiration volume that is within 97% of 
the target volume was selected to allow for any experimental error and variability 
(3% error is within the specifications of the Tecan robot) and to avoid extremely 
lengthy delay times.  In the example in Figure 3.5, a delay time of 30.5 s was 
calculated.   
 
Similar flow profiles were observed at 4 μL/s and 16 μL/s, with the flow rate in the 
linear portion of the profile at 102.5% and 98.8% of target, respectively.  
Furthermore, the experimentally determined delay time did not change significantly 
with flow rate: 27 sec at 4 μL/s and 21 sec at 16 μL/s.  The delay time might be 
expected to vary slightly with column size and adsorbent type, depending on the 
extent of backpressure generated.  However, the delay times for a 40-μL ceramic 
hydroxyapatite column and an 80-μL POROS 50HS column were both determined to 
be about 30 sec.  Therefore, a delay time of 30 s at the end of each aspiration and 
dispense step was typically used in this thesis, and it is recommended as a default 
setting for most micro-tip column applications.  Since the liquid-class setting of the 
Tecan software allows only a maximum delay time of 10 s, delay times were instead 
incorporated into the Tecan (Gemini) script using the timer function.   
 
An alternative to using a delay time to compensate for the initial lag in flow is to 
incorporate a flow-rate correction factor.  In this approach, the flow rate is multiplied 
by an empirically determined correction factor while the load time is based on the 
original (uncorrected) flow rate.  For example, if a 10% correction (correction factor 
= 1.10) is required for aspirating 900 μL at a flow rate of 10 μL/s, then the flow rate 
would be increased to 11 μL/s but the load time would be maintained at 90 s (900 μL 
/ 10 μL s-1).  In this way, the Tecan is instructed to aspirate 990 μL, but because of 
the delay in fluid flow, it only aspirates 900 μL.  This approach is advantageous for 
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kinetics studies since continuous flow is maintained through the micro-tip column 
and error from delay times as a percentage of contact time is minimised. 
Disadvantages of this approach, however, are that the correction factor varies with 
load volume and flow rate and must be empirically determined.  Correction factors 
for dispensing 800 μL of water through a 40-μL UNOsphere S micro-tip column at 
three different flow rates are given in Table 3.3. 
 
Table 3.3. Flow-rate correction factors to compensate for the lag in fluid flow 
through a micro-tip column: Aspiration of 800 μL of water through a 40-μL 
UNOsphere S micro-tip column at three different flow rates. 
Flow rate  
(μL/s) 
Aspiration Time 
(s) 
Correction Factor 
(X) 
Corrected Flow Rate 
(μL/s) 
 
4 
 
200 
 
1.038 
 
4.15 
 
8 
 
100 
 
1.062 
 
8.50 
 
16 
 
50 
 
1.106 
 
17.7 
 
      
Although a large change (+ 10 s) in delay time was not observed with flow rate, at 
least up to 16 μL/s, the flow profiles do become increasingly more variable.  
Therefore, slower flow rates are generally preferred for uniform, reproducible flow.  
The lower limit for accurate flow on the Tecan Freedom EVO 200, however, is 
approximately 2 μL/s.  Given these constraints, an operating range between 2 and 10 
μL/s was used for the majority of experiments in this thesis. 
 
3.4.3. Micro-Tip Column Hold-Up Volume  
The hold-up volume of liquid remaining in the micro-tip column after the dispense 
step is an important consideration since it may impact the next stage of the 
purification, resulting in dilution and/or sample carry-over.  Specifically, this has 
implications for the design of the equilibration, load, and elution steps.  When 
performing micro-tip experiments, a head volume above the column was not 
typically observed after the dispense step as long as there was a sufficiently long 
delay time.  Therefore, the hold-up volume should approximate that of an evacuated 
(centrifugation or filtration) micro-batch experiment.  Coffman et al. (2008) indicates 
that the liquid hold-up volume in micro-batch experiments results primarily from 
liquid in the adsorbent pores which cannot be removed because centrifugal forces 
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cannot overcome the surface tension within the pores.  Accordingly, these 
researchers estimate that the pore hold-up volume is between 44 and 56 μL per 100 
μL of resin, assuming a bed voidage of 0.38 and an intra-particle porosity of 0.7-0.9.  
Consistent with these estimates, the researchers found that the carryover volume in 
micro-batch adsorption experiments for eight different preparative resins ranged 
from 52-76 μL per 100 μL of resin, with the slightly higher volumes attributed to 
some remaining interstitial liquid. 
 
 In the case of micro-tip columns, the interstitial liquid may not necessarily evacuate 
as efficiently as in centrifugation.  Therefore, any extra-particle fluid remaining in 
the column will increase the hold-up volume over those observed in the micro-batch 
experiments.  If the full volume of extra-particle fluid is included along with the pore 
volume as a worst-case estimate, then the hold-up volume would be 81-94 μL per 
100 μL of adsorbent, assuming again a bed voidage fraction of 0.38 and an intra-
particle porosity of 0.7-0.9.  Using the low-end of the carry-over observed in micro-
batch adsorption experiments (by Coffman et al., 2008) as a best-case estimate and 
the high-end of the combined intra- and extra-particle volume as a worst-case 
estimate, then the hold-up volume resulting from the 10, 40, and 80-μL micro-tip 
columns would range from 5-9, 21-38, and 42-75 μL, respectively.  However, the 
specific hold-up volume will depend on the adsorbent properties (i.e. adsorbent 
porosity) and the solution properties (i.e. viscosity and surface tension) that affect the 
evacuation efficiency of the extra-particle volume.      
 
The contribution of carryover on a solute concentration can be determined for a 
particular equilibrium stage, n, as described by Coffman et al. (2008), 
   
nuphold
nupholdn
n VV
CVCV
C
+
+
=
−
−− 1      Equation 3.13 
where Vn is the aliquot volume in microwell n, C is the solute concentration of that 
aliquot volume, Vhold-up is the hold-up volume from the micro-tip column, and  Cn-1 is 
the solute concentration of the micro-tip hold-up volume (from the previous 
microwell, n-1).  The effect of the carry-over volume on the next equilibrium stage 
will then depend on the sample aliquot volume, the micro-tip bed volume, and the 
solute concentration in the previous n-1 stage.  Therefore, the effect of the hold-up 
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volume is minimised by using larger microwell aliquot volumes and smaller micro-
tip column volumes.  For example, when using an aliquot volume of 800 μL, the 
worst-case errors from carry-over are < 1, 5, and 9% for the 10, 40, and 80-μL micro-
tip columns, respectively.  However, these errors become much more significant, 
especially for the 40 and 80-μL micro-tip columns, when using an aliquot volume of 
200 μL (5, 19, and 38%, respectively, for the 10, 40, and 80-μL micro-tip columns). 
 
 
3.4.4.  Pre-Wash and Equilibration 
Micro-tip columns are typically supplied by PhyNexus in a glycerol solution, 
although sometimes they are supplied as a dry packed bed (as in the case of the 
ceramic hydroxyapatite and POROS 50HS columns used in thesis).  The columns 
therefore need to be washed in water or in an alcohol solution, such as 50% 
methanol, to remove the glycerol and/or wet the chromatography adsorbent.  If 
alcohol is used, a water wash should then be performed to remove it.  In this thesis, 
following the water and alcohol washes, the micro-tip columns were also pre-washed 
with either a packing buffer, an elution buffer, or a regeneration buffer, depending on 
the chromatography.  Generally, one aliquot of each pre-wash step (alcohol, water, 
pre-wash buffer) was performed, with one cycle carried out per aliquot.  An 
aspiration volume of > 750 μL was generally used for the water washes, whereas 
volumes of 200-500 μL were used for the other pre-wash steps.   
 
For micro-tip column equilibration, three to four aliquots were used to ensure that the 
columns were fully equilibrated and that all residual wash buffer components was 
removed.  The specific aliquot volume was determined by both the volume required 
for sufficient column equilibration (e.g. 10 times the column volume) and the carry-
over volume between equilibration stages, with larger volumes minimising carry-
over effects.  Aliquot volumes > 0.5 mL were typically used in this thesis.  Since the 
mass transport of buffer ions is relatively rapid, one aspiration-dispense cycle 
(passage through the micro-tip) per equilibration aliquot was sufficient.  In this 
thesis, the pre-wash and equilibration steps were carried out in a 12-column 
partitioned reservoir plate (as shown in Figure 3.3) if the solutions were the same for 
all eight micro-tips, or in a 96-well deepwell plate if they were different.      
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3.4.5. Adsorption (Sample Loading) 
In conventional laboratory-scale column chromatography, dynamic binding capacity 
is influenced by the column residence time (TR), with the capacity being a dynamic 
measure defined by a specific breakthrough point (e.g. 1, 5, or 10%) from frontal 
chromatography experiments.  Residence times are usually between 2 and 20 min for 
most bioprocess chromatographic purifications, whereas the total loading times can 
be on the order of hours.  Batch adsorption, in contrast, is typically operated with 
incubation times that will achieve equilibrium.  In this case, total contact time with 
the solution (TC) is the critical operating parameter affecting binding capacity 
(Bergander et al., 2008; Coffman et al., 2008), with the specific time required to 
achieve equilibrium depending on the mass transport properties of the adsorbent and 
the associating biomolecule.  Batch uptake experiments can be carried out to describe 
the kinetics of mass transport (e.g. with a pore diffusion model) and to model 
dynamic binding capacity in column chromatography (Chase, 1984; Arve and Liapis, 
1987; Bergander et al., 2008).  This is discussed more in Chapter 4. 
 
Micro-tip chromatography is a batch operation like micro-batch adsorption, yet 
instead of static mixing, it has dynamic flow through the micro-tip column, as in 
conventional column chromatography.  Thus, both residence time and contact time 
must be considered.  Micro-tip residence time is affected by the column size, flow 
rate, and the number of aspiration-dispense cycles (equation 3.4).  These residence 
times are generally short per aspiration-dispense cycle due to the short bed heights (< 
12 mm), even at the slowest aspiration speeds, but can be extended by increasing the 
aspiration-dispense cycle number.  Micro-tip contact time is controlled by the sample 
load volume, flow rate, cycle number, and delay time, as described by Equation 3.5.  
The relationship between sorbent contact time and residence time is a function of the 
micro-tip column size and the sample load volume as described by Equations 3.8.  
Therefore, at fixed contact time, the residence time of the 80-μL micro-tip column is 
two times greater than that of the 40-μL column and eight times greater than that of 
the 10-μL column.  Conversely, at constant residence time, the contact time of the 
80-μL micro-tip column is two times less than that of the 40-μL column and eight 
times less than that of the 10-μL column. 
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The loading step in micro-tip chromatography is therefore optimised by a 
consideration of both residence and contact times, of which the contribution of each 
is explored further in the Chapter 4.  This means that for a particular column size, the 
volumetric flow rate, sample volume, and number of aspiration-dispense cycles are 
manipulated to achieve the desired residence and contact times.  Uptake experiments 
like those described in Chapter 4 can be conducted to optimise the loading time.  In 
these experiments, each micro-tip column is loaded at the same flow rate and sample 
volume, but for a different number of cycles.  Generally, 20 to 40 minutes is 
sufficient for a loading that approximates equilibrium binding (i.e. within 80% of 
equilibrium), although the exact time will vary with the adsorbent, protein, sample 
concentration, and mobile phase conditions.  A compromise must often be made, 
however, between experimental throughput and the extent of adsorbent binding.  For 
example, Coffman et al. (2008) used a 20-min incubation time in their micro-batch 
adsorption studies as a representation of binding time for a column operation, 
although binding had not always fully achieved equilibrium (i.e. > 80% complete).  
Another example of this trade-off is shown in Chapter 6 for the hydroxyapatite 
chromatography in the multi-step VLP purification.   
 
In addition to loading time, optimisation of the load step should also consider the 
error resulting from the micro-tip column and microwell hold-up volumes.  Larger 
sample volumes, as discussed above, will minimise these errors.  In addition to hold-
up volume, the number of aspiration-dispense cycles should also be considered.  For 
example, three aspiration-dispense cycles at 9 μL/s is preferred over one cycle at 3 
μL/s, since more cycles will minimise the effect of the microwell hold-up volume by 
allowing for sample mixing.   
 
3.4.6. Wash and Elution 
In a typical purification, the sample loading step is followed by a wash step to 
remove any residual sample that is held up in the column and to elute weakly bound 
impurities.  Generally, two aliquots of ≥ 5 column volumes were used in this thesis 
(or a minimum volume of 200 μL), with one cycle carried out per aliquot.  
Additional washes may sometimes be performed, depending on the chromatography, 
to selectively elute impurities from the column.  This is an especially useful strategy 
for micro-tip chromatography given that a continuous linear gradient elution is not 
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feasible, at least not without custom modification to the liquid-handling robot.  The 
number of aliquots, the aliquot volume, and the cycle number for these washes are 
experimentally optimised for impurity clearance.  
 
As with adsorption, elution conditions are optimised by considering micro-tip contact 
time and residence time.  An example is shown in Figure 3.6, in which a huIgG is 
eluted from a 40-μL SP Sepharose FF column as a function of aspiration cycle (at 
constant sample volume and flow rate).  The mass transport for desorption is 
typically much faster than for adsorption, since there is a high concentration gradient 
between the inside and outside of the resin pore, resulting in rapid diffusion out of 
the pore.  This is evidenced in Figure 3.6, in which complete desorption occurs 
within two minutes.  Therefore, short contact times (≤ 5 minutes) were performed 
throughout this thesis and were found to be sufficient for micro-tip elution.  Longer 
elution times, however, may be required if the mobile-phase conditions do not 
strongly favour desorption, or if size-exclusion effects within the pores become 
significant, as can be the case for polyacrylamide-based hydrogels with high intra-
pore polymer concentrations (Lewus and Carta, 2001).  In addition, where the 
desorption thermodynamics are unfavourable, additional elution aliquots can be 
beneficial to push the equilibrium fully towards desorption.  A second elution aliquot 
was typically performed in this thesis to ensure complete product desorption and to 
recover any eluted protein that was held-up in the column following the first elution 
aliquot.   
 
It has been shown by other researchers, notably by Coffman and colleagues (Kelley 
et al. 2008B; Kramarczyk et al., 2008), that stepwise elution procedures can be used 
for micro-batch adsorption to mimic a linear gradient elution.  The same approach 
can also be applied here to micro-tip chromatography, with an example shown in 
Figure 3.7.  This approach allows wash and elution conditions to be efficiently 
optimised so that impurities can be resolved from the product peak.   
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Figure 3.6. Desorption of a huIgG from SP Sepharose FF.  Experiments were 
performed with 40-μL micro-tip columns as a function of the aspiration-dispense 
cycle number at a constant volume (200 μL) and flow rate (10.7 μL/s). Recovery is 
normalised to that of complete desorption. One aspiration-dispense cycle = 0.625 
min.  In this example, desorption is complete in about two minutes. 
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Figure 3.7. "Staircase" elution of a huIgG (product) and host-cell impurities from a 
40-μL Capto MMC micro-tip column.  The column was eluted at pH 6.5 in 10 
incremental elution steps from 0 to 1.8 M NaCl. 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 - 111 -
3.5. Throughput of a Micro-Tip Purification 
The throughput of a micro-tip chromatographic purification depends on the time 
required for dispensing the purification reagents as well as the time for each stage of 
the separation.  Table 3.4 shows the breakdown of time for each step in a typical 
purification sequence with pre-wash, equilibration, load, wash, and elution steps.  
The overall run time is 71 minutes but can be reduced if any of the stages are omitted 
(as in screening experiments).  In addition, run times can be shortened by pre-
dispensing purification buffers off-line, by decreasing the contact time of a specific 
stage, and/or by reducing the number of equilibration, wash, and elution aliquots 
performed per stage.  However, these throughput enhancements may require some 
trade-off in performance and robustness.  For example, decreasing the loading time 
may reduce the amount of product binding, depending on its uptake rate.  A 
correction factor could, however, then be applied to compensate for this offset in 
order to predict laboratory-scale column performance.  An example of this is 
described in Chapter 6. 
 
Table 3.4. Breakdown of the run time for each step in an example eight-column 
micro-tip purification.  In this example, the aspiration-dispense volume is 800 μL for 
all steps except elution, where the aspiration-dispense volume is 400 μL.  The flow 
rate is 10 μL/s, and the aspiration-dispense delay time is 30 s.  
 
Step 
 
Liquid-
handling 
 
Pre-
Wash 
 
Equili-
bration 
 
 
Load 
 
Wash 
 
Elution 
 
Total 
 
Operation 
 
 
Dispense 
aliquotsa 
 
3 aliquots 
x 1 cycle  
 
4 aliquots 
x 1 cycle  
 
1 aliquot 
x 6 cycles 
 
2 aliquots 
x 1 cycle  
 
2 aliquots 
x 2 cycles 
 
--------- 
 
Time 
(min) 
 
 
5 
 
11 
 
15 
 
22 
 
8 
 
10 
 
71 
a) Dispensing of aliquots can be performed off-line to improve throughput.   
 
The experiments performed in this thesis used an eight-channel Tecan LiHa, 
allowing eight experiments to be carried out in parallel.  This is significantly less 
than the parallelisation possible with 96-well micro-batch adsorption.  However, in 
practice, this difference is much lower when the analytical overhead and capability of 
micro-tip chromatography for full automation are considered.  Significant throughput 
enhancements are achieved with micro-tip chromatography because no time is 
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required for manipulation of the chromatography media (dispensing and filtration) 
and because the method can be fully automated, allowing robust walk-away 
automation with no manual intervention.  96-channel pipetting arms are available for 
200-μL sized pipette tips, although this significantly confines microscale operating 
ranges.  Recently, new options for 96-channel pipetting have become available that 
can accommodate a 1-mL pipette tip, providing the possibility of significantly higher 
experimental throughput.  Future work should centre on the evaluation of these new 
pipetting arms for micro-tip chromatography while considering the impact that 
higher experimental throughput will have on the assay load.   
 
 
3.6. Summary 
Micro-tip columns offer a platform for microscale chromatography that can be fully 
automated on a liquid-handling workstation, with little or no manual intervention 
required following set-up.  Although the format is column-like, it is operated in batch 
mode, with its data output more analogous to that of micro-batch adsorption than to a 
laboratory-scale column.  There are, however, some key operational differences 
between micro-tip and micro-batch adsorption.  Principally, there is dynamic flow 
through the micro-tip columns.  Parameters like residence time and contact time must 
therefore both be considered in its operation.  Cycle number, aliquot volume (sample 
or mobile phase), and flow rate all contribute to the completeness of binding and 
desorption.  In addition, an initial lag in fluid flow, the tapered geometry of the 
column, and the constraint on sample volume (< 1 mL that can be aspirated) make 
this method distinct from other column-based methods.  These considerations are 
explored further in Chapter 4 in the context of binding kinetics and the determination 
of binding capacity (equilibrium and dynamic).   
 
Some suggested (default) operating ranges when setting up a new micro-tip 
chromatography experiment on a Tecan workstation are given in Table 3.6.  
Parameters should eventually be optimised for each protein and chromatographic 
sorbent as well as for differences in liquid-handling platforms.  Examples of this 
optimisation are described in Chapters 5 and 6, in which the micro-tip 
chromatography platform is applied to two different process development challenges.    
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Table 3.5. Suggested (default) operating ranges for micro-tip chromatography (using 
10-, 40-, or 80-μL columns). 
  
Suggested Operating Values or Ranges 
 
Step Aspiration 
Speed (μL/s) 
Aliquots / 
Step 
Cycles / 
Aliquot 
Volume / 
Aliquot a 
Contact time 
(TC) / Aliquot 
 
 
Pre-Wash  
              
 
10-20 
 
1-4 
 
1 
 
200 – 900 μLb,c 
 
> 1 min 
Equilibration 
 
5-20 3-4 1 > 10X CV c,d > 1 min 
Load 
 
2-10 1e > 3 200 – 900 μL 20-40 minf 
Wash 
 
5-10 2-3 1 > 5X CV d > 1 min 
Elution, Single 
Step 
 
5-10 2 > 2 > 5X CV d 2-5 min 
Elution, 
Staircaseg 
5-10 
 
 
2-12 > 2 > 5X CV d 2-5 min 
a)   Microwell hold-up volume for the BD Falcon pyramid-bottom deepwell plate is ~25 μL. Maximum aspiration 
volume is ~900 μL for a 1-mL micro-tip pipette size. 
b) For water wash, > 750 μL wash is recommended; for other pre-washes, volumes between 200 and 500 μL are 
usually sufficient.   
c) May be carried out in a partitioned reservoir plate, with a minimum volume of 10 mL/reservoir well.   
d) CV = micro-tip column volume. Minimum recommended aliquot volume is 200 μL; therefore, use > 20 CV 
for a 10-μL column.  Maximum aspiration volume is 900 μL. 
e) Multiple aliquots can be used if load volume exceeds 900 μL. 
f) Refers to contact time and is optimised for sample type.  20-40 min is generally sufficient to approach 
equilibrium binding but will vary with protein and adsorbent. 
g) Sequential multi-step elution series of increasing elution strength. 
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4. ADSORBENT CHARACTERISATION BY MICRO-TIP 
CHROMATOGRAPHY 
4.1. Introduction 
An understanding of the retention and mass transport properties of an adsorbent 
facilitates the development of a robust process chromatography step.  The 
thermodynamics of adsorption can be determined from adsorption isotherms, while 
the kinetics of mass transfer can be studied from batch uptake experiments.  These 
data can then be used qualitatively in adsorbent screening or quantitatively to predict 
column adsorption using an appropriate adsorption model.  Scale-down 
chromatographic methods like those reviewed in Chapter 1 (section 1.5.6) 
significantly increase the experimental throughput and decrease the sample volume 
requirement for carrying out adsorption isotherm and kinetic experiments.  
Performing these studies by micro-batch adsorption or with mini-column cartridges 
is relatively straightforward, since these formats are scaled down from well 
established laboratory-scale methods.  Bergander et al. (2008) describes both the 
qualitative and quantitative determination of dynamic binding capacity (DBC) from 
micro-batch adsorption experiments in microtitre filter plates.  Wiendahl et al. (2008) 
demonstrates the use of 200-μL mini-columns on a Tecan workstation for generating 
breakthrough curves.  In contrast to these microscale formats, micro-tip 
chromatography does not have an analogous laboratory-scale technique upon which 
to model the adsorption and kinetic experiments.  This chapter examines how micro-
tip columns can be operated for carrying out equilibrium adsorption and kinetic 
experiments.  Two data-driven modelling approaches for predicting dynamic binding 
capacity from micro-tip data are then evaluated. 
 
 
4.2. Equilibrium Adsorption Isotherms  
Adsorption isotherms are used to describe the thermodynamics of a chromatographic 
separation and are required for modelling to describe the system state at equilibrium.  
A conventional approach for single- and multi-component isotherm determination is 
to carry out static batch adsorption experiments in a mixed vessel.  Alternatively, 
dynamic methods such as frontal analysis and pulse methods have been employed 
(Guiochon et al., 2006).   In the batch adsorption approach, either the initial sample 
(adsorbate) concentration (C0), the sample volume (VS), or the adsorbent volume 
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(VA) is varied, while keeping the other two parameters constant.  The concentration 
of the adsorbate (C) in the liquid phase is then measured following a specified 
incubation time with mixing (usually ranging from one hour to overnight).  The 
amount of adsorbate associated with the adsorbent (q) is then calculated as described 
in Chapter 3: 
A
pAASS
V
VVVCVC
q
])1([0 εεε −++−
= .     Equation 3.1 
The calculation of micro-tip hold-up volume (εVA + pAV εε )1( − ) in this equation 
assumes that most or all of the pore volume is accessible to the protein adsorbate 
given sufficient time for pore diffusion (i.e. at equilibrium).  It, however, was 
generally neglected in this thesis when it was ≤ 5% of the sample volume (VS). 
 
Adsorption isotherms are performed by micro-tip chromatography in a manner that is 
analogous to micro-batch adsorption, although with some important distinctions.  As 
discussed in Chapters 1 and 3, the external mass transport differs between the 
formats, with convective flow through a packed bed in the case of micro-tip columns 
and static mixing of loose adsorbent in the case of micro-batch adsorption.  This 
difference can potentially have some effect on the film mass transfer resistance, with 
convective flow providing a possible benefit over static mixing in the efficiency of 
protein uptake.  However, this potential improvement depends largely on the nature 
of the adsorbent and the associating protein, with an improvement more likely when 
adsorption occurs primarily on the adsorbent particle surface (i.e. with non-porous 
resins or for very large proteins which cannot access much of the adsorbent pore 
volume).  In this case, mass transport is dictated largely by the film mass transfer rate 
as opposed to intra-particle diffusion.  The effect of the mass transport difference 
between micro-tip and micro-batch adsorption, however, becomes negligible in 
adsorption isotherm experiments which approach equilibrium, although it does 
potentially have implications for kinetic studies, as discussed in the sections below. 
 
As in batch static-mixing experiments, adsorption isotherms by micro-tip 
chromatography are performed by varying C0, VS, or VA.  However, there are some 
constraints on the operating ranges imposed by the micro-tip platform, as outlined in 
Table 4.1.  The adsorbent bed volume in this thesis was limited to 10, 40, and 80 μL 
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in a Tecan pipette tip, although other volumes such as 5, 20, 160 and 320 μL are 
possible.  Furthermore, the maximum sample volume that can be aspirated into the 1-
mL Tecan pipette tip is about 900 μL since the adsorbent occupies some of the 
pipette volume and some of the Tecan syringe volume (1 mL) is occupied by the 
system trailing air gap (STAG).  This means that for volumes greater than 900 μL, 
not all of the sample volume will be aspirated into the pipette during any one 
aspiration-dispense cycle.  The number of aspiration-dispense cycles and the loading 
time in these cases must be sufficiently high to ensure complete mixing and sample 
contact during the loading step. 
 
Table 4.1. Allowed variable ranges for carrying out adsorption isotherms with 
micro-tip columns (1-mL Tecan pipette format) on a Tecan workstation using the 
platform defined in Chapter 3.  One of three parameters is varied while the other two 
are held constant.   
 
Variable Parameter 
 
Range 
 
Notes 
 
 
Sorbent Volume 
(VA) 
 
10, 40, or 80a μL 
 
Phase ratio varied by VA 
Sample volume constant 
C0 constant 
Flow rate and cycle number constant 
 
Sample Volume  
(VS)  
 
50 – 900b μL 
 
Sorbent volume constant 
Phase ratio varied by VS 
C0 constant  
Flow rate and cycle number constantc 
 
Starting Sample 
Conc. (C0) 
 
Limited only by 
sample solubility 
 
Phase ratio constant (VA and VS constant) 
C0 varied  
Flow rate and cycle number constant 
 
a)  The specific adsorbent volumes available depend on the type of pipette tip being used.  For the Tecan 1-mL 
pipette tip used in this thesis, other volumes are available such as 5, 20, 160 and 320 μL but require further 
collaboration with PhyNexus. 
b)   900 uL is the upper aspiration volume for the 1-mL Tecan micro-tip format.  However, sample volumes 
>900 μL may be placed in the sample tube or microwell.   
c) Under this approach, the time in which the sample is actually flowing through the micro-tip column will 
vary with sample volume. 
 
The determination of adsorption isotherms by micro-tip chromatography is illustrated 
in Figure 4.1.  In the shown set-up, the sample volume, flow rate, aspiration-dispense 
cycle number, and adsorbent bed volume are held constant, while C0 is varied across 
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each micro-tip column.  The adsorbate concentration (C) is measured after a 
specified incubation time and the respective adsorbent loading (q) is calculated by 
Equation 3.1.  The incubation time is controlled by the number of aspiration-dispense 
cycles performed.  It is generally not practical to carry out overnight incubation by 
micro-tip chromatography due to sample evaporation; however, incubations of one to 
three hours are usually sufficient to achieve conditions close to equilibrium.  Another 
consideration when using the Tecan is that the STAG may break down over time, 
which can lead to the formation of droplets of system liquid (water) along the sides 
of the pipette tip.  To minimise the risk of system liquid contamination, especially 
during lengthy load times, it can be beneficial to set the micro-tips down and then 
wash the LiHa in order to re-establish the STAG (as described in Chapter 3). 
 
Although there are sample and adsorbent volume constraints, a clear advantage of 
using the micro-tip format for determining adsorption isotherms is that it is highly 
amenable to automation on a liquid-handling workstation, with no peripheral devices 
for mixing or filtration required.  Furthermore, there is no concern about incomplete 
mixing, particularly for high density adsorbents, which could otherwise decrease the 
rate of protein uptake (Bensch et al., 2005; Bergander et al., 2008) and, hence, the 
experimental efficiency.  The choice of how to best carry out adsorption isotherms 
(i.e. which parameter to vary), depends primarily on the sample type and 
experimental goal.  For single-component (purified) samples, varying the starting 
sample concentration, as shown in Figure 4.1, is the simplest approach.  On the other 
hand, for multi-component (crude) samples, it is usually better to keep the starting 
sample composition the same so that the competitive interaction of the components is 
representative of typical feed conditions.  In these cases, the sample or adsorbent 
volume is varied.   
 
The micro-tip adsorption isotherm method was evaluated by examining the binding 
of a test human immunoglobulin (huIgG) to the UNOsphere S cation-exchange 
adsorbent.  The isotherm data are shown as a function of incubation time in Figure 
4.1B.  Also shown is an overnight incubation by micro-batch adsorption, in which 
equilibrium has been fully achieved.  These adsorption isotherm data are fit with a 
Langmuir model.  In this example, an approach towards equilibrium is evident, with 
equilibrium conditions approximated (less than a 10% difference from that of the 
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Figure 4.1. Determination of adsorption isotherms using micro-tip columns on a 
Tecan robotic workstation.  (A) Schematic of the set-up:  the micro-tip column 
volume, sample volume, flow rate, and aspiration-dispense cycle number are held 
constant as the protein concentration is varied across the eight micro-tips.  (B) 
Adsorption isotherms of a test huIgG on to the UNOsphere S cation exchange 
adsorbent (pH 6.5; conductivity ≤ 3 mS/cm) as a function of contact time.  Ten-
microlitre micro-tip columns were used in this experiment, with 900 μL of 
sample loaded onto each column (μavg = 400 cm/h). For the batch mixing 
experiment, 10 μL of adsorbent was quantitatively extracted from a micro-tip 
column (repeated for each data point) and mixed overnight with 900 μL of 
sample on an end-over-end rotator.   
A 
B 
1.1 0.8 0.7 0.6 0.20.4 0.3 0.1
Vary sample [C0, mg/mL] per micro-tip column
Constant volume
Variable [C0]
Constant cycle no. 
Constant flow rate
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overnight batch incubation) in > 45 min but ≤ 180 min.  In addition to the 
equilibrium data, qualitative information about the adsorption kinetics can be derived 
from the adsorption isotherm measurements made prior to equilibrium.  The use of 
these pre-equilibrium, or 'dynamic', adsorption isotherms, for the evaluation of mass 
transport properties is discussed later in this chapter. 
 
The maximum adsorbent binding capacity (qm parameter of the Langmuir model) of 
UNOsphere S for the test huIgG was determined by batch mixing (overnight 
incubation) and micro-tip chromatography at several different scales and phase 
ratios.  These data are compared in Table 4.2.  Also shown as a measurement of total 
adsorbent capacity is the DBC50% when loading the antibody onto a 1-mL column at 
60 cm/h (TR = 5 minutes) at a concentration of 1 mg/mL.  The capacities determined 
from the batch experiments range from 38.9 mg/mL using 8-μL resin plaques 
(prepared by the Atoll ResiQuot device as described in Chapter 2) to 53.5 mg/mL 
using 10 μL of adsorbent extracted from a micro-tip column.  The capacity 
determined from the overnight batch experiment with 90 μL of adsorbent agrees well 
with the column DBC50% (<1% difference) as do the capacities determined by micro-
tip adsorption (<16% difference).  It is also worth noting that the static capacity 
determined with the 10-μL micro-tip column procedure is within 7 % of the micro-
tip batch experiment in which the adsorbent was extracted from the 10-uL micro-tip 
column and then mixed with the protein solution in a microcentrifuge tube.  This 
suggests that despite their operating differences, the micro-tip and micro-batch 
formats yield comparable results given sufficient incubation time and accurate 
determination of adsorbent volume.    
 
The binding capacities determined from the micro-tip experiments do, however, vary 
slightly with scale, trending lower with increasing micro-tip bed volume.  This trend 
is most likely attributed to slight inaccuracies in the determination of adsorbent 
volumes, which may be exacerbated at very low adsorbent volumes.  For example, 
an error of only two microlitres for a nominal bed volume of 10 μL will translate into 
a 20% error.  This error would be a systematic but consistent and therefore should be 
considered when doing microscale experiments at very low adsorbent volumes.  The 
observed differences may also be partially explained by differences in the sample 
concentration and its determination as well as by differences in the phase ratio.   
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Table 4.2. Determination of the maximum equilibrium binding capacity (qm) for 
huIgG on UNOphere S by micro-tip and micro-batch adsorption methods.  Also 
compared is the approximate maximum binding capacity (DBC50%) as determined by 
column chromatography for a 1 mg/mL antibody solution flowing at 60 cm/h (TR = 5 
minutes).     
 
Method 
 
Scale  
(μL adsorbent) 
 
Phase Ratio 
(μL sample /          
μL adsorbent) 
 
 
Adsorbent 
Capacity  
(mg/mL) 
 
Batch Mixing 
 
7.7a 
 
90 
 
38.9 +  0.6   
 
Batch Mixing 
 
10b 
 
90 
 
53.5 +  1.0   
 
Batch Mixing 
 
90c 
 
11 
 
44.4 + 4.4 
    
 
Micro-Tip 
 
10 
 
90 
 
49.8 + 1.7 
 
Micro-Tip 
 
40 
 
20 
 
44.6 + 1.1 
 
Micro-Tip 
 
80 
 
10 
 
37.5 + 4.1 
    
 
DBC50%d  
(1-mL column) 
 
 
1000 
 
N/A 
 
         44.3 
a)  Resin volume determined using the Atoll ResiQuot device (7.7-μL resin plaques). 
b)  Adsorbent quantitatively extracted from the 10-μL micro-tip column and used for batch 
adsorption. 
c)  180 μL of a 50% (v/v) slurry in loading buffer was pipetted to achieve a resin volume of 90 μL. 
d)    DBC50% represents the approximate equilibrium adsorbent loading. 
    
 
4.3. Batch Uptake Experiments  
4.3.1. Finite-Bath Experiments 
The mass transport properties of an adsorbent are often studied by performing batch 
uptake experiments in a well-mixed vessel, such as a stirred tank or agitated 
microwell.  In these experiments, a small volume of sample (generally <3% over the 
course of the experiment) is withdrawn at different time intervals to determine the 
adsorbate concentration, or a small solution stream is passed through an in-line 
concentration detector such as a UV spectrophotometer.  Alternatively, these 
experiments can be carried out in parallel using a 96-well microtitre filterplate, in 
which a different timepoint is represented per well (Bergander et al., 2008).  The 
ratio of adsorbent volume to sample mass in these experimental set-ups is such that 
the mass of sample available to bind is moderately in excess; consequently, the 
  
 - 121 -
sample concentration decreases over the course of the experiment.  This set-up is 
therefore referred to as a finite-bath approach, in contrast to an infinite bath 
approach, where the concentration changes only negligibly throughout the 
experiment.  The protein uptake (described as C/C0; or fractional approach to 
equilibrium, q/qm or F; or solid-phase concentration, q) is then plotted as a function 
of time.  These data can be used qualitatively for screening resins or quantitatively 
for studying mass transport and modelling column DBC (Chase, 1984; Arve and 
Liapis, 1987; Skidmore et al., 1990; Chang and Lenhoff, 1998; Hahn et al., 2005B; 
Bak et al., 2007; Bergander et al., 2008). 
 
An experimental design for carrying out batch uptake experiments with micro-tip 
columns is illustrated in Figure 4.2.   In this set-up, the sample volume, flow rate, and 
starting concentration are held constant, while the number of aspiration-dispense 
cycles for each micro-tip column is varied from high to low to generate a range of 
loading times.  Delay times were not used when carrying out these uptake 
experiments so as to maintain continuous flow during loading.  (The flow-rate 
correction strategy described in Section 3.4.2.2 was used to adjust for the initial 
delay in flow.)  The experiment is carried out such that the micro-tip column being 
exposed to the longest load time (most cycles) begins first (tip one in Figure 4.2A).  
After a specified number of cycles (sixteen in Fig. 4.2A), the second tip begins, and 
then after an additional number of cycles (eight in Fig. 4.2A), tip three begins, and so 
on.  An example of an uptake curve generated using micro-tip columns is shown in 
Figure 4.2B.  In this example, each cycle represents a contact time (TC) of 0.625 min 
and a column residence time (TR) of 7.5 s.  
 
Residence time and contact time must both be considered in micro-tip 
chromatography because of its packed-bed format, as discussed in Chapter 3.  Micro-
tip residence time, as defined by Equation 3.4, is the ratio between the micro-tip bed 
volume and the volumetric flow rate multiplied by the total number of pipetting 
steps, whereas contact time (Equation 3.5) is the total incubation time that the 
sorbent is in contact with the sample (total loading time).  The contribution of micro-
tip contact time and residence time to the overall binding kinetics can be assessed 
from experiments using different bed volumes since the ratio of TC:TR will vary as 
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Figure 4.2. Micro-tip method for performing batch uptake experiments (carried 
out on a Tecan workstation).  (A) Schematic of set-up. The micro-tip column 
volume, sample volume, sample concentration, and pipetting flow rate are held 
constant, while the number of aspiration-dispense cycle is varied across the eight 
tips.  (B) Uptake curve of a 10 mg/mL huIgG solution (volume = 0.2 mL) onto 
the Sepharose FF cation exchange adsorbent.  Forty-microlitre columns were 
used in this experiment, flowing at an average linear velocity of 864 cm/h (0.64 
mL/min).  The contact time (load time) per cycle is 0.625 minute, while the 
residence time is 7.5 s.    The uptake curve is fit with an empirical equation (3-
parameter hyperbolic decay equation):   
 
xb
aby
C
C
+
+= 0
0
. 
A 
B 
Vary cycle number per column to vary contact time
Constant volume 
Constant [C0]
40     24    16      10       8        6       4        2
8 identical sample aliquots
Constant flow rate
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defined by Equation 3.8: 
  C
S
A
R TV
VT ×=  .               Equation 3.8 
For example, at a fixed contact time, flow rate, and sample volume, the residence 
time of the 40-μL column is four times longer than that of the 10-μL column.  In 
Figure 4.3, the fractional approach to equilibrium (q/qequil) for the test huIgG onto 
UNOsphere S is shown as a function of residence time (Fig. 4.3A) and of contact 
time (Fig. 4.3B) at both the 10- and 40-μL scales.  Here, q is the binding capacity at 
each pre-equilibrium time point (i.e. derived from the pre-equilibrium adsorption 
isotherm), whereas qequil is the capacity determined from the adsorption isotherm at 
60 minutes (contact time).  As observed in Figure 4.3, when uptake is plotted as a 
function of residence time, the uptake curves differ significantly between the 
between the 10- and 40-μL scales, with the uptake seemingly faster at the 10-μL 
scale.  However, the expectation is that the fractional approach to equilibrium should 
be comparable between the two scales given that the selected binding conditions for 
each are in the nonlinear portion of the adsorption isotherm.  In contrast, when 
plotted as a function of contact time, the curves overlay closely, despite the four-fold 
difference in residence time.   
 
These data imply that contact time, not residence time, is the more critical parameter 
for carrying out kinetic experiments by micro-tip chromatography, at least in the case 
of a globular protein such as an immunoglobulin binding to a porous cation-
exchange adsorbent.  This agrees with the observations by Bergander et al. (2008) in 
their batch adsorption studies in microwells, where equating the batch incubation 
time to the total column loading time was found to be critical for predicting column 
dynamic binding capacity.  Furthermore, this is consistent with many quantitative 
studies of protein transport in porous ion-exchange adsorbents in which protein 
uptake is best described by diffusive theories (Helfferich, 1965; Ruthven, 2000; 
Dziennik et al, 2003 and 2005), with the most commonly employed being the pore 
diffusion and homogeneous diffusion (solid diffusion) models (Lenhoff, 1987; 
Skidmore et al., 1990; Fernandez et al., 1996; Chang and Lenhoff, 1998; Carta et al., 
2005; Dziennik et al, 2005).  
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 A              
     
 B 
      
Figure 4.3. Binding of a huIgG on UNOsphere S as a function of (A) residence time 
and (B) contact time using 10- and 40-μL micro-tip columns.  The ratio of residence 
time (TR) to contact time (Tc) between the 10- and 40- μL columns varies by 4-fold: 
0.75 s TR / min Tc for the 10-μL column and 3.0 s TR / min Tc for the 40-μL column.  
Here, q is the capacity at each pre-equilibrium timepoint, whereas qequil is the 
capacity of the equilibrium adsorption isotherm (estimated from 60-min timepoint).  
Data is fit with an empirical equation (bi-exponential equation, exponential rise to 
maximum): )1()1( 21
dxbx eAeAF −− −+−= . 
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Given a diffusive mechanism, the rate of intra-particle mass transport should be 
proportional to the effective pore diffusivity (De) of the protein within the adsorbent 
pore network as defined in Equation 1.19: 
 
τ
ε D
kD ppe = ,       Equation 1.19 
where kp is the pore hindrance parameter (<1), εp is the intra-particle void fraction, D 
is the protein diffusivity, and τ is the tortuosity factor (>1). The pore hindrance 
parameter depends on the ratio of protein size to pore size, generally decreasing with 
increasing molecular size due to steric hindrance and viscous drag.  Therefore, it 
should be lower for the ~150 kDa huIgG protein than for smaller globular proteins 
like lysozyme or ribonuclease, resulting in a lower value of De.  For even a larger 
protein macromolecule such a virus-like particle (VLP), the hindrance parameter 
may be such that much of the pore volume becomes essentially inaccessible, 
especially since most commercial resins are optimised for proteins having diameters 
less than 5 nm.  As a rule of thumb, resins with a pore size ten times larger than the 
biomolecule adsorbate are recommended for fast mass transfer (Muller, 2005).  
DePhillips and Lenhoff (2000) investigated the mean pore diameters of 14 cation 
exchange resins by inverse size exclusion chromatography and found that they 
ranged from 20-150 nm.  Therefore, for VLPs, much of the adsorption presumably 
occurs only on the external surface of the adsorbent bead, potentially making micro-
tip residence time a more significant factor in protein uptake than is the case for the 
test huIgG shown in Figure 4.3.    
 
For the majority of monomeric and comparatively smaller multimeric proteins such 
as immunoglobulin, mass transfer rates are, however, primarily driven by intra-pore 
diffusive mechanisms when binding to porous preparative adsorbents.  Therefore, 
batch uptake curves generated by micro-tip chromatography would be expected to 
approximate those of micro-batch adsorption even though the external mass transport 
properties differ.  This indeed appears to be the case for the test huIgG used in this 
thesis, as observed in Figure 4.4.  Although a slight difference (10.6%) in the 
maximum equilibrium adsorbent concentration (qm) is observed between the two 
formats, this is attributed more to experimental error in the determination of resin 
volume than to any operational differences.  As stated before, an advantage of the 
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Figure 4.4. Comparison of batch uptake curves generated by micro-batch 
adsorption and micro-tip chromatography.  In this experiment, 200 μL of a 10 
mg/mL solution of huIgG was applied to 40 μL of UNOsphere S.  The average flow 
rate of the micro-tip column was 864 cm/h (0.640 mL/min), with the duration 
(contact time) of one aspiration-dispense cycle equal to 37.5 s.  A slight difference 
(10.6%) in the maximum equilibrium adsorbent concentration, qm, was observed 
between the two formats.  This is attributed to experimental error in the 
determination of adsorbent volume.  Data is fit with an empirical equation of best fit 
(2-parameter, single rectangular hyperbolic function):   
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micro-tip column format is that mixing concerns are alleviated.  This is particularly 
important for kinetic studies using dense adsorbents.  The effects of agitation 
intensity on uptake rates in microwell adsorption experiments have been noted by a 
number of research groups (Bensch et al., 2005; Bergander et al., 2008; Kramarczyk 
et al., 2008), with the optimal intensity depending on well geometry, sample volume 
and viscosity, adsorbent particle density, and orbital amplitude.  Incomplete 
adsorbent mixing can confound uptake measurements since the transfer from the 
bulk liquid to the chromatographic particles may become rate limiting when mixing 
is inadequate.  This problem is avoided with micro-tip columns so long as the flow is 
evenly distributed through the packed bed.    
 
Another potential advantage of micro-tip chromatography is that the effect of flow 
rate can be assessed independently of contact and residence time since the number of 
aspiration-dispense cycles can be adjusted with changing flow rate so as to keep TC 
and TR constant.  The effect of a four-fold difference in linear velocity on the batch 
uptake kinetics of the test huIgG onto three different cation exchange adsorbents is 
shown in Figure 4.5.  The uptake rate does appear to increase slightly at the higher 
flow rate for each adsorbent, most noticeably with SP Sepharose FF.  This may be 
explained by the fact that the thickness of the laminar sublayer (δ) around the 
stationary phase particle should decrease with increasing flow rate, thereby reducing 
the external film mass transfer resistance.  In addition, in the case of the POROS 
adsorbent, which has a bimodal pore distribution (Regnier, 1991), convective flow 
through the transecting macropores (600-800 nm in size) is promoted at higher 
superficial flow velocities, although some researchers have challenged this claim 
(Weaver and Carta, 1996).  In the examples shown in Figure 4.5, the overall 
difference in uptake kinetics is minor, presumably because mass transfer in the 
network of diffusive pores is rate limiting.  
 
An important caveat, however, to the observations above is that differences in 
microwell mixing and cycle number might also explain the observed differences with 
flow rate, and these effects would be most significant at very short contact times 
where the differences are their greatest.  For the example shown in Figure 4.5, only 
two cycles are performed to obtain a contact time of five minutes (residence time of 
1 minute) at the slower flow rate, whereas eight cycles are performed at the faster 
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Figure 4.5. The effect of a four-fold difference in flow rate (μavg = 216 cm/h, solid circles; and 864 cm/h, open circles) on protein uptake 
for three different cation-exchange adsorbents: (A) SP Sepharose FF, (B) UNOsphere S, (C) POROS 50 HS.  In these experiments, 200 
μL of a 10 mg/mL huIgG solution (pH 6.5 and conductivity < 3 mS/cm) was loaded onto 40-μL micro-tip columns.  The aspiration-
dispense cycle number is four times greater at the faster flow rate to maintain an equivalent contact time to that of the slower flow rate.  
The uptake curves are fit with an empirical equation (3-parameter hyperbolic decay equation):  
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flow rate.  The error from the microwell hold-up volume (volume not aspirated) 
contributes more significantly when only two cycles are performed as opposed to 
eight.  Furthermore, mixing should be more efficient at faster flow rates since flow   
is more turbulent and because more cycles are performed per unit time.  Whether or 
not these differences in uptake rates are attributable to operating conditions such as 
well mixing or due to difference in mass transfer resistance is not clear.  However, 
given that pore diffusion appears to be the dominant mass transport resistance, it 
seems preferable to perform uptake experiments at higher flow rates than those 
recommended in Chapter 3 (i.e. perform at  > 10 μL/s).  Although the flow may be 
more variable from column-to-column, higher flow rates allow for shorter time 
intervals to be studied, provide better microwell mixing, and ensure that fresh sample 
is continuously delivered to the chromatographic bead surface.  
 
Batch uptake curves like the ones shown in Figure 4.6 are useful for making 
qualitative comparisons about the mass transport properties of adsorbents during 
resin screening.  For the huIgG test system used in this thesis, the uptake onto the 
three CEX adsorbents is comparable when normalised for mass uptake (Fig. 4.6B), 
although the adsorbent capacities vary slightly (Fig. 4.6A).   However, differences 
might be more apparent for other adsorbents or proteins.  Quantitative approaches for 
modelling micro-tip batch uptake data for the prediction of DBC are described later 
in this chapter. 
 
4.3.2. Pre-Equilibrium Adsorption Isotherms 
The micro-tip method for adsorption isotherms allows data to be easily obtained as a 
function of time (TC or TR), thereby providing an alternative perspective on mass 
transport in which uptake is examined across the entire concentration range of the 
isotherm.  A modelling approach for predicting DBC from these pre-equilibrium data 
is discussed later in this chapter.  These results can also be used qualitatively to 
compare adsorbent or mobile phase conditions, as shown in Figure 4.7.  In this 
example, the binding of the test huIgG protein to UNOsphere S and POROS 50HS is 
examined.  By visual assessment, the uptake rate appears to be slightly higher for the 
POROS adsorbent, as evidenced by the earliest timepoint.  The average linear 
velocity is 3600 cm/h in these micro-tip experiments, which is well within the 
perfusive regime of the adsorbent and considerably higher than that used in Figure 
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Figure 4.6. (A) Uptake (C/C0) of the huIgG test protein onto three different 
cation exchange adsorbents as a function of contact time (TC) using 40-μL 
micro-tip columns. One aspiration-dispense cycle = 0.62 minutes; flow rate = 
864 cm/h (0.64 mL/min).  The uptake curves are fit with an empirical equation 
(3-parameter hyperbolic decay equation):   
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 (B) Normalised uptake curves (normalised to the uptake at final timepoint, 45 
min, for each adsorbent).  Inset provides a close-up view of the first ten minutes 
of uptake.   
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Figure 4.7. Pre-equilibrium ('dynamic') adsorption isotherms of the 
binding of the test huIgG to (A) UNOsphere S and (B) POROS 50HS 
strong cation exchange adsorbents.  Ten-microlitre micro-tip columns 
were used in these experiments, loaded with 800 μL of sample at varying 
starting concentrations (C0) and flowing at 18 μL/s (3600 cm/h).   The 
adsorption isotherms for the UNOsphere S adsorbent are best fit with a 
Langmuir model (Equation 1.3), while those for POROS 50HS are best fit 
with a Freundlich model (Equation 1.2).  The data are normalised to the 
maximum adsorbent capacity (qm) determined from the 60-min timepoint.    
A 
Time
Time
B 
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4.6.  It is interesting to note that the UNOsphere S isotherms are fit well with a 
Langmuir model, while those of the POROS 50HS are better fit with a Freundlich 
model.  This presumably reflects differences in the binding mechanism and/or the 
uptake kinetics, and could perhaps be related to the bimodal pore distribution of the 
POROS adsorbent. 
 
Pre-equilibrium adsorption isotherms can be graphed as either a function of contact 
time or residence time.  However, as demonstrated in the batch uptake experiments in 
the previous section, the more relevant parameter is contact time, at least for the test 
system used in this thesis (huIgG binding to porous cation-exchange adsorbents).  
This finding is evident from the pre-equilibrium adsorption isotherm data shown in 
Figure 4.8.  In these experiments, the micro-tip columns were operated at two 
different scales, 10-μL and 40-μL, such that the ratio of residence-time-to-contact-
time varies by four-fold at constant load volume, flow rate, and cycle number.  When 
controlling for residence time (30 s), the apparent protein uptake is considerably 
higher for the 10-μL column (40 min contact time) than for the 40-μL column (10 
min contact time).  However, when controlling for contact time (10 min), the dynamic 
adsorption isotherms overlay almost exactly despite a four-fold difference in 
residence time (7.5 s and 30 s, respectively).   
 
4.3.3. Shallow-Bed Adsorption 
An alternative to the finite-bath set-up described above is shallow-bed adsorption 
(Hahn et al., 2005A) in which the sample is re-circulated through a very small 
packed-bed column, usually of ≤ 10 μL.  Shallow-bed chromatography is operated in 
an infinite-bath format, which means that the feed sample is of a sufficiently high 
volume or concentration so that the sample concentration changes negligibly during 
protein uptake onto the adsorbent (i.e. C ≈ C0 throughout the experiment).  
Specifically, according to Carta et al. (2005), the outlet concentration should be no 
less than 80% of the inlet concentration.   
 
In a conventional shallow-bed experimental set-up, as shown in Figure 4.9A, a 10-μL 
packed bed is connected to a pump which re-circulates the sample or buffer solution 
through the bed.  Two valves are positioned in the flow circuit. One switches (nearly 
instantaneously) between the sample and equilibration, wash, and elution buffers, and 
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Figure 4.8. Pre-equilibrium adsorption isotherms (huIgG adsorption to 
UNOsphere S) using 10- and 40-μL columns as a function of (A) constant 
residence time (TR) = 30 s and (B) constant contact time (TC) = 10 min.  The 
ratio of TR: TC is 4-fold higher for the 40-μL micro-tip column than for the 
10-μL column, when loading at constant sample volume and flow rate.  Data 
is fit with an empirical equation (2-parameter, single rectangular hyperbolic 
function):  
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Figure 4.9. Conventional shallow-bed set-up and uptake curves: (A) 
Schematic of the shallow-bed set-up (figure from Hahn et al., 2005A); (B) 
Uptake curves of polyclonal IgG on Protein A affinity media from Hahn et 
al. (2005B).  F is the fractional uptake to equilibrium (q/qm). 
B 
A 
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a second alternates between a UV detector and a waste outlet.  The shallow-bed 
column is first equilibrated in loading buffer and then loaded with sample, which is 
re-circulated at a high flow rate for a specified amount of time.  The high flow rate 
ensures that the feed concentration in the mobile phase remains constant throughout 
the run (C ≈ C0).  Carta (2005) indicates that under typical shallow-bed conditions, 
this usually requires flow velocities of > 600 cm/h.   Hahn et al. (2005B) used flow 
velocities of 1224 cm/h, and Fernandez et al. (1996) used flow velocities from 2250 
to 5940 cm/h.  After the specified loading time, the sample is washed out and then the 
column is eluted with an appropriate elution buffer.  The amount of bound sample 
determined from elution is then plotted as a function of loading time to construct 
uptake curves and adsorption isotherms.  Some examples from the literature (Hahn et 
al., 2005B) of uptake curves derived from shallow-bed experiments are shown in 
Figure 4.9B.   
  
The micro-tip format appears to meet the critical conditions of shallow-bed 
chromatography.  First, the 10-μL micro-tip column is suitably sized for these 
experiments, and the protein concentration can be held constant during loading (C ≈ 
C0) if a sufficiently high concentration is used.  Second, the high linear velocities 
required for shallow-bed chromatography are well within the operating range of the 
micro-tip format (400 – 4000 cm/h for the 10-μL column).  Third, micro-tip 
chromatography also allows for rapid switching between column feeds by moving 
the pipette tip from one microwell to another, much like that of an in-line valve, 
although it may take a fraction of a second longer.   
 
A schematic of the experimental set-up for carrying out shallow-bed adsorption with 
micro-tip columns is shown in Figure 4.10.  Movement of the micro-tip columns 
between the microwells (containing equilibration buffer, sample, wash buffer, and 
elution buffer) serves essentially as a virtual valve in this set-up.  Experiments can be 
carried out in parallel (eight-at-a-time), with a different loading time examined per 
micro-tip column.  The contact times for the equilibration, wash, and elution steps 
are the same between micro-tip columns.  The shallow-bed experiment is in many 
ways performed analogously to a finite-bath batch uptake experiment with the key 
distinction being that a higher sample concentration is required to ensure that the  
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 A) Micro-Tip Operation:             B) Plate Layout:     
 
 
           
   
 
 
 
 
 
 
 
 
Figure 4.10.   Scheme for performing shallow-bed adsorption (infinite-bath format) by micro-tip chromatography.  (A) A constant volume is 
aspirated and dispensed rapidly through a 10-μL column at μavg > 1000 cm/h.  Contact time is varied by varying the aspiration-dispense cycle 
number.  The starting sample concentration (mass challenge) must be sufficiently high so that it remains approximately constant throughout 
adsorption (<20% decrease).  (B) The micro-tip columns can be rapidly switched between the equilibration (columns 1-4), load (column 5), wash 
(column 6) and elution (columns 7-8) by moving into a new microwell.  The amount of adsorbed product is then determined by quantifying the 
amount of eluted product. 
Vary cycle number per column to vary contact time
Constant volume 
Constant C (C ≈ C0)
40     20    15      10       8        6       4        2
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starting concentration does not change significantly (<20%) during adsorption.  In   
addition, it is the eluted product, not the nonbound fraction that is assayed to 
determine the amount of protein uptake per unit time. 
 
A limitation, however, of the micro-tip format for shallow-bed chromatography is 
that only a maximum of 0.9 mL can be aspirated into the micro-tip column.  This in 
turn limits the low end of the sample concentration range that can be evaluated.  In a 
conventional shallow-bed set-up, lower sample concentrations can be examined by 
increasing the re-circulating volume through the column, so that the total mass 
challenge to the adsorbent remains high.  The high flow rate ensures that the local 
sample concentration around the chromatographic beads does not decrease 
significantly during loading.  Although volumes greater than 0.9 mL can be placed in 
the microwell in micro-tip chromatography, only 0.9 mL can be aspirated through 
the pipette tip.  Consequently, the full volume is not effectively re-circulated, since 
the sample, whose concentration may decrease across the aspiration step, must pass 
through the column again a second time during the dispense step before being 
returned to the remaining volume in the microwell.    
 
Results from a micro-tip shallow-bed experiment examining the uptake of a 
polyclonal antibody from human serum onto a 10-μL protein A (MabSelect) column 
is shown in Figure 4.11.  The experiment was carried out with an antibody 
concentration of 10 mg/mL and a volume in the microwell of 1.0 mL (total mass = 
10 mg).  The flow rate was 1.2 mL/min (μavg = 3960 cm/h).  The qm of the adsorbent 
for this huIgG is about 65 mg/mL under these conditions.  As a result, the feed 
concentration cannot theoretically decrease by more than 7%, even at the longest 
timepoint.  The shape of the micro-tip uptake curve resembles those of the literature 
reference shown in Figure 4.9B (Hahn et al., 2005B).  However, the literature 
example for MabSelect could not be reproduced identically because of several 
experimental constraints.  First, the antibody concentration is more than three-fold 
higher in the micro-tip experiment (10 mg/mL) than in the literature example (3 
mg/mL) because of the volume limitation of the micro-tip format (maximum 
aspiration volume of 0.9 mL requires a higher concentration to ensure that the 
sample concentration changes only minimally throughout the experiment).  Second, 
the exact human polyclonal antibody sample used in the literature example could not  
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Figure 4.11.  Uptake curve from a shallow-bed experiment using micro-tip columns.  
10 mg/mL of polyclonal antibody from human serum (1.0 mL in well; 0.9 mL 
aspirated) was re-circulated through a 10-μL MabSelect Protein A column at a flow 
rate of 20 μL/s (average linear velocity of 3960 cm/h).  Uptake data (F, fractional 
uptake to equilibrium capacity, equal to q/qm) fit with an empirical equation (3-
parameter hyperbola):  
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be obtained for the micro-tip experiment.  The antibody was sourced from Sigma-
Aldrich (St. Louis, MO, USA) in the micro-tip experiment and from Octapharma 
Pharmazeutische Produkte (Vienna, Austria) in the literature example.  
Consequently, these samples display somewhat different binding behaviour.  
 
Shallow-bed operation appears to be a feasible format for use with micro-tip 
chromatography, although there are limitations with respect to sample concentration 
and volume.  A key advantage in using micro-tip chromatography is its ability to be 
carried out in parallel on a robotic workstation.  Acquiring shallow-bed experimental 
data then provides a path to predict DBC, using the appropriate models as reviewed 
by Hahn et al. (2005A).  The shallow-bed approach, however, was not pursued 
further in this thesis, principally because of the constraint on sample concentration.  
Instead, two modelling approaches using finite-bath micro-tip data were examined 
for the prediction of column DBC.  These are discussed in the sections below. 
 
 
4.4. Prediction of Dynamic Binding Capacity from Micro-Tip Column Data 
Predictive modelling of column adsorption offers the potential for reducing the 
sample amounts and experimental numbers that are required for the determination of 
dynamic binding capacity (DBC).  Column breakthrough experiments, even when 
using small laboratory-scale columns, can consume gram quantities of product.  The 
determination of DBC and its relationship to mobile phase composition, feed 
concentration, and flow rate is critical to characterising the productivity and 
economics of the chromatographic unit operation.  A multitude of models have been 
applied to the prediction of DBC, ranging from simple staged equilibrium models to 
complex general rate models.  Non-dispersive models such as those employed by 
Chase (1984), using the Thomas solution (Thomas, 1944), and Arnold et al. (1985), 
using the solutions by Hall et al. (1966), have been applied to predict adsorption 
processes for affinity chromatography.  These models assume that a single rate-
limiting step is driving the overall mass transport, such as the reaction kinetics of 
binding or pore diffusion.  In contrast, multi-component general rate models, such as 
those by Arve and Liapis (1987), Gu et al (1993), and Kempe et al. (1999), attempt 
to account for multiple mass transfer resistances including film diffusion, pore 
diffusion, and reaction kinetics.    
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The rigorous evaluation and development of models for predicting column 
adsorption processes is outside the scope of this thesis.  However, two data-driven 
approaches are examined below to demonstrate how micro-tip data might be applied 
to the prediction of DBC.  The goal here is a pragmatic one, that being to predict 
laboratory-scale column DBC upon scale-up from micro-tip columns, rather than to 
elucidate mass transport mechanisms or predict the full shape of the breakthrough 
curve.  The first model applies an approach used by Bergander et al. (2008), in which 
model parameters are estimated from batch uptake experiments using a shrinking-
core pore diffusion model (Helfferich, 1965; Teo and Ruthven, 1986; Helfferich, 
1990; Weaver and Carta, 1996; 2005; Dziennik et al., 2005).  In this approach, the 
external mass transfer resistance is considered negligible in comparison to pore 
diffusion.  The second modelling approach employs a simple staged-reaction model, 
in which adsorption is described by a series of batch adsorption stages, with the 
parameters from the pre-equilibrium Langmuir adsorption isotherms (qm and KD as a 
function of contact time) used to account for the adsorption kinetics.    
 
4.4.1. Modelling Data from Batch Uptake Experiments 
4.4.1.1. Modelling Approach 
Bergander et al. (2008) were able to predict the DBC of a human polyclonal IgG on a 
MabSelect SuRe column (1-mL HiTrap) from microwell batch uptake data with good 
agreement.  By doing so, the micro-batch adsorption format yielded a ten-fold 
savings in time and a fifty-fold savings in sample consumption.  In their approach, 
they used a shrinking core model to approximate intra-particle mass transfer by pore 
diffusion, while external mass transfer resistances were assumed to be negligible.  
The shrinking core model assumes a favourable rectangular adsorption isotherm, and 
therefore pore binding occurs with a sharp uptake front, with this front moving 
inward with increasing load.  Uptake (q/qm) is then modelled by (Teo and Ruthven, 
1986; Weaver and Carta, 1996):  
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In these equations, De is the effective pore diffusivity, Rp is the particle radius, kf is 
the film mass transfer coefficient, VM is the volume of the matrix particles, VS is the 
volume of the supernatant (mobile phase), qm is the maximum adsorption capacity 
(equilibrium adsorption capacity), q is the concentration of the bound protein, and C0 
is the feed concentration.   
 
The column DBC using this approach is then predicted using the following equation 
(Carta et al., 2005; LeVan et al., 2008):  
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where DBC10% is the dynamic binding capacity at 10% breakthrough and KD is the 
equilibrium dissociation constant, respectively.  N is the number of pore transfer 
units as defined by: 
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where ε is the bed void fraction, and TR is the apparent residence time in a column 
defined as the ratio between the column length and superficial velocity of the mobile 
phase. 
 
4.4.1.2. Application of Model to Micro-Tip Data 
The modelling approach of Bergander et al. (2008) described above was applied to 
data from finite-bath micro-tip experiments for the prediction of DBC10% in the test 
0.364N -0.0612N2 + 0.0042N3   for  N<2.75        Equation 4.2 
 
1 – 1.03N-1            for N>2.75 
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case of the binding of huIgG to a 1-mL UNOsphere S column.  Micro-tip adsorption 
isotherm and batch uptake experiments like those shown in Figures 4.1 and 4.2 were 
performed.  The adsorption isotherm was favourable under the conditions of loading 
(pH 6.5 and conductivity ≤ 3 mS/cm) and, as recommended by Bergander et al. 
(2008), the phase ratio and initial protein concentration in the batch uptake 
experiments were such that the decrease in bulk protein concentration was ≤ 80%.  
The effective pore diffusivity was approximated at different feed concentrations and 
flow rates using the shrinking core model as described above, and the DBC10% was 
then predicted.  The key model inputs are given in Table 4.3.  MATLAB version 7 
(The Math Works Inc., MA, USA) was used for the model computations.  The feed 
concentration in the experimental column experiments was 1.0 mg/mL, and the 
column was run at five different flow rates.  No correction was made for column bed 
compression given the rigidity of the UNOsphere resin.   
 
Table 4.3.  Key model parameter inputs to predict DBC10% from micro-tip data using 
the approach outlined by Bergander et al. (2008).   
Input Parameter Definition Value  Source 
 
qm Equilibrium binding 
capacity 
46.1 mg/mL Adsorption isotherm from 
micro-tip chromatography 
 
KD Isotherm dissociation 
constant 
0.058 mg/mL Adsorption isotherm from 
micro-tip chromatography 
 
Rp Particle radius 0.004 cm Vendor (Bio-Rad) literature  
 
ε Bed voidage fraction 0.4 Standard assumption from 
literature 
 
VS 
 
Supernatant feed 
volume 
 
0.8 cm3 Original data set 
Vm 
 
Volume of matrix 
particles 
 
0.01333 cm3  Original data set 
MW Molecular weight 150,000 Assumed for IgG 
 
μavg Micro-tip superficial 
average linear velocity  
 
0.82 cm/s Original data set 
υ Kinematic viscosity 0.01 cm2/s Assumed to be the same as 
water 
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In Table 4.4, the predicted values are compared to the experimentally generated 
breakthrough data from a 1-mL column having a 0.5 cm internal diameter (i.d.) and a 
5.0 cm height (h). These results are also depicted graphically in a parity plot, shown 
in Figure 4.12.   The prediction of DBC is adequate across the range examined, with 
the slope of the line almost equal to one, although the parity appears to diverge most 
at the limits of this range.  This suggests some inaccuracies in the assumptions used 
in the model.  The error is highest at conditions of low binding capacity (29% at TR = 
0.5 min, but is <20% across the remainder of the capacity range).  If the data is not fit 
through the origin, a good empirical correlation is observed (dashed line in Fig. 4.12; 
R2 = 0.95).  However, the use of an empirical correction factor would require one or 
more column breakthrough experiments to be carried out to establish this 
relationship.  
 
 
Table 4.4. Comparison of predicted DBC10% modelled from micro-tip data 
to that of the experimental column data (1-mL column; 0.5 cm, i.d., x 5.0 
cm, h; C0 = 1 mg/mL) for binding of huIgG to UNOsphere S.  The 
modelling approach used by Bergander et al. (2008) for micro-batch 
adsorption was applied here.  Model parameters are given in Table 4.3. 
Using the shrinking core modela, De = 5 X10-8 cm2/s.  
Flow 
Rate 
 
mL/min 
Linear 
Velocity 
 
cm/h 
TR 
 
 
min 
Predicted 
DBC10% 
 
mg/mL 
Experimental 
DBC10% 
 
mg/mL 
Δ 
 
2.0 
 
600 
 
0.5 
 
10.9 
 
15.4 
 
-29% 
 
1.0 
 
300 
 
1.0 
 
18.7 
 
23.1 
 
-19% 
 
0.67 
 
200 
 
1.5 
 
24.0 
 
27.3 
 
-12% 
 
0.50 
 
150 
 
2.0 
 
30.3 
 
28.9 
 
5% 
 
0.20 
 
60 
 
5.0 
 
38.3 
 
33.1 
 
 
16% 
a)  De was determined using a shrinking core model described by Carta and Weaver (1996) by 
iterating upon its value in the simulated uptake curve across a range of 10-8 to 10-4.  The final 
De value selected was that which minimised the root mean square between the experimental 
(micro-tip batch data) and modelled values.    
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Figure 4.12.  Parity plot comparing the predicted DBC10% of huIgG on 
UNOsphere S to experimental column breakthrough data (from data 
shown in Table 4.4).  Modelling was performed using the approach by 
Bergander et al., 2008. The experimental DBC10% was generated using a 
1-mL column (0.5 cm, i.d., x 5 cm, h) with a huIgG concentration of 1 
mg/mL.  The effective pore diffusivity (De = 5 X 10-8) was determined 
from micro-tip batch uptake data using the shrinking-core model.  The 
solid line is the linear fit constrained through the origin, yielding a slope of 
0.99.  The dashed line is the linear fit with no constraints: y = 1.52x -14.43  
(R2 = 0.95). 
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There are some important limitations to this approach because of the simplifying 
assumptions of the model. The shrinking core model implies a highly favourable 
rectangular isotherm.  This requirement appears to be met for the binding of huIgG 
on UNOsphere S in the mobile phase conditions examined (Fig. 4.1B).  This may not 
always be the case though for varying mobile phase compositions, i.e. higher salt 
concentration, or different proteins.  Ruthven (2000), however, suggests that a 
rectangular model may still provide a useful approximation for many situations, even 
when the form of the actual isotherm is not rectangular.  The modelling approach 
here is also less useful at low protein concentration and/or low phase ratios (as 
discussed by Bergander et al., 2008), since some of the terms of the model 
breakdown.  Specifically, the model requires that the numerator in the following term 
used in the shrinking core model match or exceed the value of the denominator:  
    
mm
S
qV
CV 01
=
Λ
 > 1 . 
In other words, this means that the total amount that could ever bind under saturation 
in the prevailing buffer conditions should be exceeded or equalled by the quantity 
initially present in the bulk phase.  In the test system examined here, where V was 
0.8 cm3 and Vm was 0.01333 cm3, this condition was not met when C0 was <0.8 
mg/mL.  Despite these limitations, this modelling approach shows a reasonable 
agreement to the experimental data across the flow rate ranges examined. 
  
4.4.2. Modelling Data from Pre-Equilibrium Adsorption Isotherms 
4.4.2.1. Modelling Approach 
A staged reaction model was evaluated as a second approach for predicting DBC 
from micro-tip data, using the Langmuir parameters of qm and KD from pre-
equilibrium isotherm data to account for the kinetics of adsorption.  A staged 
reaction model simplistically relates a chromatographic column to a series of stirred 
tank reactors (STRs), in which the column is divided into n batch adsorption stages.  
The column feed is then treated incrementally in stages, with each element 
equivalent to the flow velocity multiplied by the STR residence time.  The residence 
time of each STR is calculated from the vessel height, bed voidage, and linear 
velocity.  The mass balance equation and the adsorption isotherm relationship are 
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then used to calculate the bound adsorbate concentration for the residence time of 
each stage.      
 
For example, as was done in this thesis, the model can be used to treat a 1-mL 
packed column as four 0.25-mL STRs having Langmuir adsorption behaviour.  
Increasing the number of stages beyond four did not significantly change the shape 
of the modelled breakthrough curve for the test system (huIgG binding to 
UNOsphere S) used in this thesis.  The sample concentration, C, is obtained by 
treating each STR as a batch adsorption with C0 being the concentration of the 
starting material for the first stage and then of the preceding stage for all subsequent 
stages.  The adsorbent loading, q, is also obtained for each STR by mass balance.  
Each 0.25-mL addition of starting material to the first STR then takes into account 
the material already adsorbed and is iterated accordingly.  A modified version of the 
batch adsorption equation is used for each sample volume addition as follows,  
 
2
4 0
2
⎟⎟⎠
⎞
⎜⎜⎝
⎛
⎟⎟⎠
⎞
⎜⎜⎝
⎛
+++−
=
D
o
T
A KCq
V
Vbb
C    Equation 4.3 
 
⎟⎟⎠
⎞
⎜⎜⎝
⎛
−−+= 0)( CqqV
VKb om
T
A
D ,     Equation 4.3a 
 
where qo = q from the previous iteration (sample volume addition), C0 = C from the 
previous STR, KD and qm are derived from the Langmuir adsorption isotherm, VA is 
the volume of adsorbent used, and VT is the total tank volume (liquid + adsorbent).   
In this thesis, since a packed bed system using a highly porous adsorbent is being 
modelled, VA/VT was assumed to be one.  The breakthrough curve is then plotted as 
the protein concentration leaving the final STR (y-axis) against the loading volume 
(x-axis).  An example of this is shown in Figure 4.13, in which KD is varied.   
 
A somewhat similar approach was taken by Howard Chase (1984) in the prediction 
of packed column adsorption for preparative affinity chromatography (adsorption of 
lysozyme to Cibacron Blue-Sepharose and β-galactosidase to an immobilised 
antibody column).  To model column adsorption rates and account for mass 
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Figure 4.13. Example of data output when modelling column breakthrough with a 
staged reaction model.  In this example, the effect of varying the Langmuir constant 
of KD (mg adsorbate/mL mobile phase) is examined while qm (mg adsorbate/mL 
adsorbent) remains constant.  The feed concentration is 1.0 mg/mL and the column 
volume is 1.0 mL.  The column is treated as four 0.25-mL stirred tank reactors (STR) 
having Langmuir adsorption behaviour.   
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resistances, Chase used a lumped kinetic approach in which the adsorption and 
desorption processes are described by second-order Langmuir kinetics: 
qkqqCkR m 21 )( −−= ,     Equation 4.4 
where R is the rate of interface mass transfer, k1 is the forward rate constant and k2 is 
the reverse rate constant.  The rate constant k1 is then determined from experimental 
batch uptake data, while KD and qm are derived from batch adsorption isotherms.  In 
this model, axial dispersion is assumed to be negligible (ideal model).  Thomas 
(1944) provides an analytical solution to the differential mass balance and rate 
equations used in this modelling approach.  Chase was able to predict the column 
performance of his test systems with reasonable success despite the fact that this 
modelling approach does not treat all potential sources of mass transfer resistance.   
 
The modelling approach applied in this thesis accounts for the adsorption kinetics in 
a different manner.  Here, the parameters of KD and qm from the pre-equilibrium 
adsorption isotherms are inputted into the model to account for the non-equilibrium 
behaviour from mass transfer resistances during column adsorption.  As shown 
previously, the uptake of the test huIgG protein on UNOsphere S in micro-tip 
chromatography is primarily a function of contact time.  However, micro-tip contact 
time is not necessarily an equivalent term to either contact or residence time in 
conventional column chromatography, since column operation is dynamic with 
unidirectional flow while micro-tip chromatography is a batch operation.  Hence, the 
relationship between the contact time of the micro-tip data and the residence time 
and/or contact time of the column chromatography must be established. 
 
The result of matching the micro-tip contact time (TC-microtip) to the column residence 
time (TR-column) and then using the KD and qm parameters of that contact time in the 
staged reaction model is shown in Figure 4.14A.  As expected, this approach does 
not adequately predict the column DBC since the two terms do not reflect equivalent 
operations.  In the micro-tip experiment, the adsorbent is exposed to the entire 
sample for a short contact time (five minutes in the example in Figure 4.14A).  In the 
column experiment, although the residence time is only 5 min, the entire loading 
(contact) time of the column to the feed is much longer (>20 min until breakthrough  
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Figure 4.14.  Breakthrough curves modelled from micro-tip pre-equilibrium adsorption isotherm data using a staged reaction model.  
The experimental breakthrough curves were generated by loading 0.5 mg/mL huIgG onto a 1-mL (0.56 cm, i.d., X 4 cm, h) 
UNOsphere S column at a buffer pH of 6.5 and a conductivity of < 3 mS/cm.    (A) Breakthrough curve derived from matching the 
residence time of the experimental column (TR-column; in this case, 2 min) to the micro-tip contact time (TC-microtip) of the pre-
equilibrium adsorption isotherm used for determination of KD and qm in the staged reaction model.  (B) Breakthrough curve derived 
from matching the column contact time (TC-column, as defined by Equation 4.5; in this case, 88.6 min) to the micro-tip contact time (TC-
microtip) of the pre-equilibrium adsorption isotherm used for determination of KD and qm in the staged reaction model.  
A B 
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and >60 min until adsorbent saturation), allowing sufficiently more time for pore 
diffusion and protein uptake.  Likewise, matching the micro-tip contact time (TC-
microtip) to the column contact time (TC-column) does not adequately predict the column 
DBC (Fig. 4.14B).  TC-column is defined here as the time required to challenge the 
column with a mass loading equivalent to the maximum adsorbent capacity (qm 
determined from the equilibrium adsorption isotherm): 
 
( )
0
column-C *
*
T
CQ
Vq Am
=  ,      Equation 4.5 
where qm is the equilibrium adsorbent capacity in mg/mL, VA is the adsorbent 
(column) volume in mL, Q is the volumetric flow rate in mL/min, and C0 is the feed 
concentration in mg/mL.  Again, the lack of agreement here is presumably because 
these two times (TC-microtip and TC-column) do not reflect equivalent operations.   
 
If a calibration experiment, however, is first performed to determine an empirical  
correction factor (α10%) which relates TC-microtip to TC-column, the DBC10% can be 
predicted with high accuracy for different loading conditions (flow rate, feed 
concentration, and slight changes in column geometry) as demonstrated below.  
Although this approach requires a column experiment to be performed, a single 
column breakthrough experiment is sufficient for predicting changes in feed 
concentration and flow rate.  In this way, the number of breakthrough experiments is 
significantly reduced.  The correction factor α10% is determined by: 
  
columnC
microtipC
T
T
−
−
=%10α ,      Equation 4.6 
where TC-microtip is the pre-equilibrium adsorption isotherm contact time used (to 
determine KD and qm) to model a breakthrough curve which produces a DBC10%  that 
is equal to that of the calibration run.  An example of this determination is shown in 
Figure 4.15.  After determining α10%, a corrected column contact time, T'C-column, can 
be used to model changes in feed concentration and flow rate.  T'C-column is 
determined by: 
   columnCcolumnC TT −− = *' %10α      Equation 4.7 
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Figure 4.15.  Example of a calibration experiment used to relate micro-tip contact 
time (TC-microtip) to column contact time (TC-column).  (A) Experimental breakthrough 
curve from the calibration run, in which 0.5 mg/mL huIgG was loaded onto a 1-mL 
UNOsphere S column (pH 6.5, conductivity < 3 mS/cm) at 1 mL/min.  Also shown is 
the modelled curve which yielded an equivalent DBC10% to that of the column 
experiment.  TC-microtip represents the micro-tip batch contact time used for modelling 
(i.e. the contact time of the pre-equilibrium adsorption isotherm used to determine 
KD and qm for the model).  (B) Calculation of the correction factor, α10%, which 
relates micro-tip contact time to column contact time. TC-column is the time required to 
challenge the column with a mass loading equivalent to qm. 
 
TC-column  =
(qm * Vcolumn)
(Q * C0)
=
44.3 mg/mL * 1 mL
1 mL/min * 0.5 mg/mL
= 88.6 min
= 
11.0 min
88.6 min
=  0.124
α10% = 
TC-microtip
TC-column
A 
B 
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4.4.2.2.  Application of Model to Micro-Tip Data 
The modelling approach described above is summarised in Figure 4.16.  This 
approach was demonstrated in this thesis with the test huIgG protein binding to 
UNOsphere S (pH 6.5 and conductivity < 3 mS/cm).  The KD and qm parameters 
were determined as a function of contact time from pre-equilibrium adsorption 
isotherm experiments, with the data fit with an empirical equation of best fit (Fig. 
4.17).  These terms were then used in the staged reaction model as described above.   
The calibration run and determination of α10% were performed (Figure 4.15) to relate 
TC-microtip to TC-column.  The prediction of column dynamic binding capacity at 
different loading concentrations (0.5 and 1.0 mg/mL) and flow rates (from 0.2 to 4.0 
mL/min) is given in Table 4.5 for two 1-mL columns having slightly different 
geometries (pre-packed cartridge column and in-lab packed column). 
  
Table 4.5. Prediction of column DBC10% using a staged reaction model and micro-tip 
pre-equilibrium adsorption isotherm data for the binding of huIgG to UNOsphere S.  
TR = column retention time; T'C = corrected column contact time used for modelling 
column DBC10%.  The correction factor, α10%, is 0.124 in this test case. 
Column 
Size 
i.d. x h 
cm 
[Feed]  
 
 
mg/mL 
Flow 
Rate 
 
mL/min 
Linear 
Velocity 
 
cm/h 
TR 
 
 
min 
T'C 
 
 
min 
Predicted 
DBC10% 
 
mg/mL 
Column 
DBC10% 
 
mg/mL 
Δ 
 
0.5 X 5 
 
1.0 
 
2.00 
 
600 
 
0.5 
 
2.75 
 
14.5 
 
15.4 
 
-5.8% 
 
0.5 X 5 
 
1.0 
 
1.00 
 
300 
 
1.0 
 
5.50 
 
22.5 
 
23.1 
 
-2.6% 
 
0.5 X 5 
 
1.0 
 
0.67 
 
200 
 
1.5 
 
8.20 
 
27.0 
 
27.3 
 
-1.1% 
 
0.5 X 5 
 
1.0 
 
0.50 
 
150 
 
2.0 
 
11.0 
 
30.0 
 
28.9 
 
3.8% 
 
0.5 X 5 
 
1.0 
 
0.20 
 
60 
 
5.0 
 
27.5 
 
37.2 
 
33.1 
 
12.4% 
         
 
0.56 X 4 
 
0.5 
 
4.00 
 
960 
 
0.25 
 
2.75 
 
9.90 
 
11.0 
 
-10.0% 
 
0.56 X 4 
 
0.5 
 
2.00 
 
480 
 
0.5 
 
5.50 
 
17.1 
 
17.5 
 
-2.3% 
 
0.56 X 4a 
 
0.5 
 
1.00 
 
240 
 
1.0 
 
11.0 
 
25.0 
 
25.2 
 
-0.8% 
 
0.56 X 4 
 
 
0.5 
 
0.50 
 
120 
 
2.0 
 
22.0 
 
31.8 
 
29.5 
 
7.8% 
a) calibration experiment (shown in bold) 
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Figure 4.16. Outline of the staged-reaction modelling approach for the prediction of 
column DBC10% from micro-tip pre-equilibrium adsorption isotherm data. 
 
 
 
 
 
 
Perform pre-equilibrium adsorption 
isotherm experiments with micro-tip 
columns as a function of contact time  
(TC-microtip). 
Plot KD and qm from pre-equilibrium 
adsorption isotherms as a function of micro-
tip TC. Fit graphs with empirical equation of 
best fit. 
Perform a column breakthrough calibration 
experiment:   Determine a correction 
factor (α10%) for column TC which relates it 
to the micro-tip TC used to model DBC10%. 
Model DBC10% using the corrected column 
contact time (T’C) for each loading 
condition to determine the KD and qm 
parameters to be used in the model. 
Input KD and qm values into a Staged 
Reaction Model. Determine modeled 
DBC10% as function of micro-tip TC. 
KD qm
T’c-column=  α10% * TC-column
DBC10% 
TC-column =  (adsorbent static capacity) * (column volume)
(flow rate) * (feed conc.)
Modeled TC-microtip yielding DBC10% equivalent 
to calibration run 
TC-column of calibration run
α10% =  
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Figure 4.17. (A) KD (mg huIgG/mL mobile phase) and (B) qm (mg huIgG/mL 
adsorbent) constants as a function of micro-tip contact time derived from micro-tip 
pre-equilibrium adsorption isotherms (Langmuir model) in the binding of huIgG to 
UNOsphere S (pH 6.5; < 3 mS/cm conductivity).  The data are fit empirically with 
an inverse third order polynomial (R2 = 0.86) in (A) and with a two-parameter, 
single rectangular hyperbolic function (R2 = 0.73) in (B). 
A 
B 
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Agreement between the predicted DBC10% value and the experimental data is 
observed, with differences ≤ 12 % across the range of conditions examined.  This 
close agreement is also evident in the parity plot shown in Figure 4.18B, with the 
slope of the linear regression line equal to 0.97.  The DBC10% is also shown as a 
function of flow rate in Figure 4.18A.  Interestingly, the DBC10% values for the 
column loaded at 0.5 mg/mL are slightly higher at any given flow rate than for the 
1.0 mg/mL loading, even though the adsorption equilibrium should be favoured at 
higher concentrations.  However, this may be explained by the fact that the column 
contact time doubles when decreasing the feed concentration from 1.0 mg/mL to 0.5 
mg/mL.  This, in turn, improves the mass transfer by allowing for more contact time 
for intra-particle diffusion.  This may also potentially allow for a more favourable 
concentration gradient to be established across the particle surface and within its 
pores. 
 
A key advantage of this modelling approach is that it is primarily data driven and 
requires very few assumptions of model parameters.  DBC10% was predicted with 
high accuracy for the test system examined here.  An area of future work would be to 
evaluate this modelling approach with other adsorbents and proteins.  A disadvantage 
of this approach is that it requires a calibration experiment and therefore does not 
fully eliminate the need to carry out a column breakthrough experiment.  Yet, 
assuming this approach is transferable to other adsorbents and protein systems, it 
does reduce the laboratory-scale experimental numbers to a single breakthrough 
experiment.  It could be argued that a single breakthrough curve is sufficient in and 
of itself (i.e. in the absence of micro-tip data) to estimate the effect of residence time 
on DBC.  However, having micro-tip data in combination with this data should allow 
this prediction to be done with higher fidelity, as evidenced by the very accurate 
predictions in Table 4.5.  
 
For future work, it would be interesting to examine if a single calibration run is still 
sufficient when examining a range of different mobile phase conditions (e.g. salt and 
pH) since this was not examined here.  An additional consideration is that of scale.  
In the work presented here, both the calibration run and dynamic column 
experiments were performed at the same scale (1 mL).  It is not clear whether or not 
this approach would be predictive of the DBC for say a 10-mL or 1-L column, if a 1-  
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Figure 4.18. Comparison of predicted dynamic binding capacities (at 10% 
breakthrough) from micro-tip experiments using a staged reaction model to those of 
the experimental column.  (A) DBC10% as a function of flow rate (CV/h).  The 
modelled data is fit with an empirical equation of best fit (3-parameter exponential 
decay).  (B) Correlation between column and predicted values (linear regression, fit 
through origin).  
B 
A 
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mL column was used for the calibration experiment.  However, changes in DBC with 
scale are always a key consideration, even for conventional DBC determination by 
frontal analysis.  These differences are associated more with differences in wall 
effects, packing efficiency, and column geometry, which are not considered in the 
staged reaction model.  
 
Although not surprising, it is worth noting that the modelling approach applied here 
does not accurately predict the full shape of the breakthrough curve, as evidenced in 
Figure 4.15A.  Here, the experimental curve is significantly more distended than the 
modelled curve, deviating most significantly in the latter half of the curve.  This 
observation reveals some of the shortcomings of the model; specifically, it 
oversimplifies the adsorption process.  Even though the model attempts to account 
for the deviation from equilibrium in column operation by using pre-equilibrium 
adsorption isotherm parameters, it does not account for axial dispersion nor does it 
rigorously deal with the multiple components of mass transfer resistance.  More 
complex, multi-component general rate models (Arve and Liapis, 1987; Gu et al., 
1993; Kempe et al., 1999) are better suited for this purpose.  The error, then, of this 
model in predicting the full breakthrough curve has more to do with its simplifying 
assumptions than in the quality of the data generated by the micro-tip columns.  
However, the goal in this thesis was not to predict the full breakthrough curve or 
elucidate the underlying mechanisms of mass transfer.  Rather, it was a practical one, 
that being to have a simple, data-driven model for efficiently predicting column DBC 
from micro-tip data for the purpose of process development.          
 
 
4.5. Summary 
The results presented here demonstrate the utility of the micro-tip format for 
adsorbent characterisation.  Furthermore, they provide insight into the mass transport 
properties of micro-tip chromatography and how this format compares with other 
microwell formats.  Although micro-tip chromatography is unique in its operation, it 
is, in many ways, similar to micro-batch adsorption and can often be used 
analogously in the characterisation of a chromatographic step.  However, micro-tip 
columns offers the advantage of not requiring an adsorbent mixing step, thereby 
ensuring efficient mass transport even for very dense adsorbents.  In this thesis, the 
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adsorption isotherms that were carried out by micro-tip chromatography were in 
good agreement with those by conventional batch methods, although slight 
differences were observed between micro-tip column scales.  These differences are 
presumed to be due to slight inaccuracies in the adsorbent bed volume from column 
preparation.  Micro-tip methods for studying adsorption kinetics were also 
demonstrated using both finite-bath and infinite-bath (shallow bed) formats.  
Although shallow-bed chromatography appears to be a valid option for micro-tip 
chromatography, it was not chosen for further study because of the constraint on 
sample concentration.  In addition to these conventional formats, pre-equilibrium 
adsorption isotherms were generated as an alternative approach for examining mass 
transport properties.  In all of these formats for kinetic study, it was the sorbent 
contact (incubation) time and not the residence time that most influenced protein 
uptake onto the adsorbent.  This is consistent with intra-particle diffusive 
mechanisms being rate-determining for uptake of a globular protein such as huIgG 
onto a porous resin.    
 
Batch uptake data can be used qualitatively when screening different adsorbents and 
mobile phase conditions, or quantitatively for the prediction of column DBC.  Many 
models have been developed for describing the adsorption process and the prediction 
of DBC, ranging from nondispersive reaction models to general rate ones.  Two data-
driven models were evaluated here for predicting initial breakthrough (DBC10%) from 
micro-tip experimental data. The first applied a shrinking core model to batch 
adsorption data and assumed that external mass transfer is negligible.  The second 
employed a staged reaction model, but instead of determining reaction kinetics it 
used pre-equilibrium adsorption isotherm data to account for the adsorption kinetics.  
Each showed reasonable agreement to the experimental data in the prediction of 
DBC but did not necessarily predict the full shape of the breakthrough curve.
    
 
 - 159 -
5. CAPTURING THE POTENTIAL OF MIXED-MODE LIGANDS WITH 
MICRO-TIP CHROMATOGRAPHY 
5.1. Introduction 
New multi-modal chromatography ligands offer the potential for a next generation of 
protein purification processes.  However, the development of mixed mode 
chromatography steps imposes a heavy burden on process development since multi-
parameter screening is required for their optimisation.  High-throughput methods 
such as micro-tip chromatography offer a solution to this problem by allowing a 
thorough, yet timely, exploration of the parameter space.  A microscale workflow 
using micro-tip chromatography is demonstrated in this chapter for the development 
of a multimodal weak cation-exchange (Capto MMC) chromatography step in the 
purification of a monoclonal antibody from Pichia pastoris cell filtrate.  This 
workflow allowed the chromatography step to be developed with less time and 
labour.  The final optimised conditions predicted by the microscale development 
were subsequently confirmed with a small laboratory-scale column.  This approach is 
potentially adaptable to other chromatography types beyond mixed-mode, providing 
a path for the logical development of process chromatography steps. 
 
 
5.2. Mixed Mode Chromatography: New Opportunities and Challenges 
Mixed mode chromatography presents the opportunity of replacing a more costly 
affinity capture step with a mixed-mode one, consolidating two chromatography 
steps (e.g. intermediate and polishing) into one, providing a strategy for purifying 
away difficult-to-remove impurities, and/or carrying out ion-exchange 
chromatography at higher ionic strength.  Advances in bioinformatic and 
combinatorial tools (Roque et al., 2005; Clonis, 2006) have enabled the rapid and 
cost-effective design of new ligands, increasing the options for mixed-mode 
chromatography.  A list of some commercially available mixed-mode adsorbents is 
given in Table 5.1.   
 
Ceramic hydroxyapatite is a classically used mixed-mode chromatography, in which 
protein retention is driven by a cation-exchange mechanism between phosphate 
groups on the adsorbent and amino groups on the protein, and by metal affinity, 
between calcium sites on the adsorbent and protein carboxyl groups (Ng et 
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Table 5.1.  Some commercially available mixed-mode chromatographic media. 
Adsorbent 
Name 
Proposed  Binding 
Mechanism 
 
Base Matrix Ligand Chemistry 
Bio-Rad 
Ceramic 
Hydroxyapatite 
 
Cation-exchange 
and coordination 
bonds 
 
Hydroxy-
apatite 
Ca10 (PO4)6 (OH)2 
Pall MEP 
Hypercel 
Hydrophobic 
charge induction 
(pKa = 4.8, 
antibody selective 
ligand) 
 
Cellulose  
O S
N  
 
4-mercapto-ethyl-pyridine 
Pall HEA 
HyperCel 
 
 
Hydrophobic 
charge induction 
(pKa = 8.0, 
aliphatic 
substituent) 
 
Cellulose  
N
H  
 
Hexylamine 
Pall PPA 
HyperCel 
 
Hydrophobic 
charge induction 
(pKa = 8.0, 
aromatic 
substituent) 
 
Cellulose  
N
H
 
Phenylpropylamine 
GE Healthcare 
Capto MMC  
Weak cation-
exchange and 
hydrophobic 
interaction 
Agarose 
 
2-benzamido-4-mercaptobutanoic 
acid 
GE Healthcare 
Capto Adhere 
Strong anion-
exchange and 
hydrophobic 
interaction 
 
 
Agarose  
O O
OH OH
N+
OH
 
N-benzyl-N-methyl ethanolamine 
BakerBond ABx Weak cation 
exchange with 
weak anion 
exchange 
 
Silica or 
polymeric 
-COOH and polyethylene imine  
(-C2H5N) 
 
 
al., 2007).  Recently, several new multimodal ligands have been developed that 
combine hydrophobic and ion-exchange mechanisms (Table 5.1).  The MEP, HEA, 
and PPA Hypercel adsorbents from Pall (Port Washington, NY, USA) utilise a 
hydrophobic charge induction mechanism, in which a pH shift is used during elution 
to weaken hydrophobic interactions via electrostatic repulsion (Burton and Harding, 
1998; Chen et al., 2008A).  Prototypes of anion and cation-exchange multimodal 
O O S NH
OH O H 
O-O 
O 
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ligands were prepared on an agarose-based porous resin (Sepharose 6 Fast Flow) by 
Johansson et al. (2003A and 2003B) and evaluated for their ability to capture 
proteins at high ionic strength (28 mS/cm).  It was found that the multimodal anion-
exchange ligands that were optimal for protein capture at high salt concentration 
were non-aromatic and based on a primary and/or secondary amine with a nearby 
hydrogen donor.  For multimodal cation exchange, aromatic ligands with a 
carboxylic acid group worked best, particularly when there was a hydrogen accepter 
close to the carboxylic group.  Two multimodal ion exchange adsorbents on highly 
cross-linked agarose media are now commercially available from GE Healthcare 
(Table 5.1), employing the N-benzyl-N-methyl-ethanolamine ligand (Capto Adhere) 
for multimodal strong anion exchange and the MMC ligand (Capto MMC) for 
multimodal weak cation exchange.  In contrast to the findings of Johansson et al. 
(2003A), the Adhere ligand does have an aromatic group, but it is recommended as 
an intermediate or polishing step to be operated in a flow-through mode rather than 
as a capture step.  Another adsorbent, BakerBond ABx sold by Mallinckrodt Baker 
(Phillipsburg, NJ, USA; Table 5.1), combines a carboxyl group with a polyethylene 
imine, thereby providing weak anion exchange with weak cation exchange. 
 
Although mixed mode adsorbents offer the potential for increased selectivity and 
more salt-tolerant loading conditions, their design spaces are considerably more 
complex and the conditions for optimal operation less intuitive.  This is evidenced in 
Figure 5.1, in which the binding capacity of two different purified monoclonal 
antibodies (referred hereafter as mAb-1 and mAb-2) on Capto MMC is shown as a 
function of pH and NaCl concentration (derived from screening experiments as 
described in the sections below).  Although the test antibodies used here are both 
human IgG1 antibodies having an isoelectric point (pI) of 9, their binding behaviour 
is comparatively different.  For mAb-1, the binding profile is relatively flat, with a 
shallow decline in capacity observed with increasing pH (> 6) and NaCl 
concentration.  Meanwhile, for mAb-2, this decline in capacity is significantly 
steeper and begins at around pH 5, with clear binding optima at pH 4 and 7.  For both 
mAbs, binding is tolerant of higher salt concentrations at low pH (< 5).  The 
observed differences in binding behaviour are presumably due to differences in the 
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Figure 5.1. Binding capacity of two human monoclonal antibodies (huIgG) to Capto 
MMC as a function of sodium chloride (0 to 1 M) and pH (4 to 7): (A) mAb-1 and 
(B) mAb-2.   Experiments were carried out by micro-tip chromatography using the 
screening methods as outlined in sections 5.3 and 5.4.  The isoelectric point (pI) of 
both antibodies is 9.   
 
 
A 
B 
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hydrophobic properties of the antibodies and/or differences in their charge 
distribution (i.e. local patches of charge), since their pIs are approximately the same. 
 
 
5.3. High-Throughput Development of Mixed Mode Chromatography 
Mixed mode chromatography is usually optimised empirically because of the 
complexity of the adsorption mechanism.  Consequently, this development must be 
repeated for each new, unique biomolecule.  A large component of such development 
centres on the screening of mobile phase conditions, including pH, ionic strength, 
and salt/buffer type and concentration.  To obtain a comprehensive characterisation 
of the design space requires many experiments to be performed, a number that is 
usually not feasible at the laboratory scale because of material and resources 
constraints.  Microscale methods like micro-tip chromatography are well suited for 
this development because of their high degree of experimental parallelisation and 
low volume requirements.   
 
5.3.1. Developmental Workflow Using Micro-tip Chromatography 
A high-throughput workflow using micro-tip chromatography is described in Figure 
5.2 for the development of mixed mode chromatography.  This workflow employs a 
sequence which is analogous to that of high-throughput drug discovery.  A primary 
evaluation of mobile phase parameters affecting adsorption (capture) of the target 
protein and its impurities is first carried out.  In Figure 5.2, this includes pH, salt 
type, and salt concentration but may include additional parameters, if necessary.  
When there is little or no prior experimental knowledge, a range-finding study may 
first be required to estimate parameter ranges and eliminate parameters that are not 
critical.  Response maps of adsorbent capacity, recovery, and impurity binding 
obtained from the primary evaluation are then used to select the operating mode 
(flow through or bind-and-elute), the process function (capture, intermediate, or 
polishing step), and the optimal mobile phase conditions.  A secondary evaluation is 
then performed to define and optimise each stage (loading, wash, and elution) of the 
chromatographic purification in order to predict process-scale column performance.  
The microscale results are subsequently verified at the laboratory scale, as scale-up 
from this point is well established. 
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Screen Parameter Ranges
 
Variables: pH, [salt], salt type, [feed]
Responses: Capacity, Solubility
Experiment: Factorial
2° Evaluation
Wash/Elution Study and Load Optimisation
Variables:  mass load, pH, [salt], and salt type
Responses: Recovery and Purity
Experiment: Staircase elution or DoE at different loading conditions
Analyse 1°Evaluation
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Figure 5.2. High-throughput workflow using microscale 
chromatography for the development of a mixed-mode chromatography 
process step. 
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5.3.2.Design of High-Throughput Experiments 
Despite their high throughput, the design and implementation of microscale 
chromatographic experiments must still be strategic so as to not overwhelm 
analytical testing and data processing resources.  A well-designed workflow, 
therefore, considers experimental efficiency and the concomitant analytical strategy.   
For the workflow used in this thesis, high-throughput analytical platforms were 
applied, including absorbance measurements in microtitre plates, product mass 
quantitation with a parallel biosensor technique (ForteBio Octet), and impurity 
detection (host-cell protein ELISA and a dye-binding DNA method) using fully 
automated 96-well microplate-based assays.  The details of these analytical 
techniques are described in Chapter 2. 
 
With respect to the experimental design of the microscale workflow, a brute-force 
design is proposed for the primary evaluation when the variable number is such that 
the microscale experiments can be completed with high throughput and reasonable 
experimental numbers.  This was the case in this study, in which three parameters 
(pH, salt type, and salt concentration) were studied.  More efficient response surface 
methodologies, such as central composite, Box-Behnken, and D-optimal designs, or 
iterative methods, such as simplex or genetic algorithms, become more advantageous 
when the number of parameters is such that it will overwhelm experimental and 
analytical resources.  However, a caveat with using these more sophisticated designs 
is that they may not provide the resolution necessary to fully characterise a complex 
and broad operating space like mixed mode chromatography.  Consequently, a 
follow-up examination focusing on areas of interest may be required.  No matter 
which design is selected, a factorial design is usually advantageous as a pre-screen 
prior to a response-surface or brute-force design to identify main effects, eliminate 
those parameters which are less critical, and establish approximate parameter ranges.  
Such a pre-screen was performed in this study to establish parameter ranges.   
 
 
5.4. Demonstration of the High-Throughput Developmental Workflow 
The microscale workflow outlined in Figure 5.2 was demonstrated with multimodal 
weak cation-exchange chromatography (Capto MMC) for the capture of mAb-1 from 
a crude clarified Pichia pastoris filtrate.  The Capto MMC adsorbent consists of a 
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highly cross-linked agarose base matrix with a multi-modal ligand as shown in Table 
5.1, having cation-exchange, hydrophobic interaction, and hydrogen-bonding 
properties.  Typically in monoclonal antibody purifications, Protein A 
chromatography is used as the capture step because of its very high purification 
efficiency.  Protein A is a 42 kDa cell wall protein from Staphylococcus aureus 
which binds with high affinity to the Fc region of most antibodies.  However, there 
are some disadvantages associated with its use.  Firstly, protein A chromatography is 
relatively expensive; therefore, it must be capable of being re-used for many cycles 
to make it cost-effective.  However, it usually cannot be cleaned with sodium 
hydroxide, a standard cleaning agent in preparative scale chromatography, thereby 
adding to the associated cost of the step.  A second potential disadvantage of protein 
A chromatography is that it requires elution at low pH, which can result in product 
aggregation and/or precipitation.  Finally, for antibodies produced in yeast host cells, 
the protein A ligand itself is susceptible to yeast proteases, resulting in potentially 
higher levels of leached protein A and column deterioration.  
 
For the primary evaluation with Capto MMC, three mobile phase parameters were 
examined for their effect on binding: pH, salt concentration, and salt type.  Because 
of the hydrophobic properties of the MMC ligand (see Table 5.1), four different salt 
types were evaluated by varying two cations, NH4+ and Na+, with two anions, SO42- 
and Cl-.  These ion pairs were selected based on their location in the Hofmeister 
series (Hofmeister, 1888; Zhang and Cremer, 2006), with NH4+ being more lyotropic 
than Na+, and SO42- being more lyotropic than Cl-.  The contribution of the buffer 
(used for pH control) on the chromatography was neglected to minimise the number 
of experiments.  This was done by using an universal buffer mixture of 10 mM 
sodium acetate, 10 mM sodium phosphate, and 10 mM HEPES, spanning a broad pH 
range from 4 to 8.  If necessary, buffer effects can be subsequently explored upon 
defining a narrower pH range.  Using the response maps of mAb-1 capacity and 
impurity binding from the primary evaluation as a guide, the secondary evaluation 
then centred on optimising the full chromatographic sequence that included the 
loading, wash, and elution steps.  For the development of wash and elution strategies, 
a 'staircase' method was employed, in which small incremental steps of increasing 
elution strength were made by moving the micro-tip columns across the microplate 
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into wells of varying eluent concentration (or pH).  The optimised micro-tip 
purification was then verified with a 1-mL HiTrap Capto MMC column experiment.   
 
5.4.1. Experimental Details of Micro-Tip Chromatography 
Micro-tip chromatographic experiments were performed with 10-μL Capto MMC 
columns on a Tecan workstation as described in Chapter 3.  Prior to their use, the 
Capto MMC columns were pre-washed in 12-column reservoir plates using the 
following sequence: (1) 0.5 mL of 50% methanol, (2) 0.8 mL of water, (3) 0.2 mL of 
50 mM HEPES, pH 8.5, with 0.5 M NaCl (elution buffer), and (4) 0.8 mL of water.  
The micro-tips columns were then equilibrated with four 0.85-mL aliquots of loading 
buffer.  Experiments were performed at flow rates between 2 and 20 μL/s and delay 
times between 10 and 30 s, with a flow rate of 5 μL/s (μavg = 990 cm/h) used for the 
loading, wash, and elution steps.  These conditions are within the recommended 
ranges as defined in Chapters 3 and 4.  For the pre-wash, equilibration, and post-
loading wash steps, a single aspiration-dispense cycle was performed per well 
(aliquot).  For the loading and elution steps, multiple aspiration-dispense cycles were 
carried out per well (aliquot) to increase the contact time at a fixed linear velocity.  A 
loading (contact) time of 40 minutes was used in this study to ensure semi-
equilibrium binding (>80% of equilibrium binding), while allowing for sufficient 
experimental throughput.  Elution times were > 5 minutes per elution step (of 
increasing elution strength) to ensure complete desorption, with 2-3 elution steps 
performed for the capture studies and 9 steps (staircase elution) performed for the 
elution studies.  Samples from micro-tip chromatography experiments were then 
assayed by optical measurements in microtitre plates (λ = 280 nm or 600 nm), Octet 
protein-A biosensors for antibody detection, the PicoGreen DNA assay, SDS-PAGE, 
and an anti-Pichia pastoris host-cell protein (HCP) ELISA (see Chapter 2 for 
details).  The specific experimental details for each stage of the experimental 
workflow are discussed below.   
 
5.4.2. Range-Finding Study 
Although it was known that mAb-1 is an IgG1 with a pI of around 9, this information 
was insufficient to predict a priori its binding behaviour on the multimodal weak 
cation-exchange adsorbent (Capto MMC).  Therefore, range-finding experiments 
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were carried out with protein-A purified material (> 90% purity) to establish the 
approximate parameter ranges, ensure product solubility under these conditions, 
estimate adsorbent capacity, and identify preliminary conditions for product elution 
(i.e. a 'strip' elution buffer to examine recovery).   Specifically, a 22 factorial design 
examining pH (5, 7) and salt concentration (0, 1M) with two categorical factors 
(sodium chloride, ammonium sulphate) was performed to establish the appropriate 
parameter ranges for the primary evaluation (capture study) and estimate the 
maximum adsorbent binding capacity.  The results from these two salts were 
considered to be approximately representative of the other two salts to be used in the 
capture study (ammonium chloride and sodium sulphate).  Purified mAb-1 was 
exchanged into each mobile phase condition (buffered with 12.5 mM sodium acetate 
and 12.5 mM sodium phosphate at the desired pH) by performing a 10-fold dilution 
from a concentrated feedstock.  Each column was then challenged with 65 mg of 
purified mAb-1 per mL of Capto MMC.  Adsorbent capacity (q) was determined by 
measuring the concentration of the starting feed sample and the nonbound fraction 
after loading (by absorbance at 280 nm) and calculated by: 
  
A
SS
V
CVVCq −= 0      Equation 5.1  
where C0 is the starting sample concentration (mg/mL), C is the concentration of the 
nonbound fraction after loading (mg/mL), VS is the sample volume (in mL), and VA 
is the adsorbent volume in mL.  In these experiments, the micro-tip column hold-up 
volume ( pAA VV εεε )1( −+ ; see equation 3.1) was assumed to be negligible since VA 
is 10 μL while Vs is 800 μL (micro-tip hold-up is <1% of Vs). 
 
The results of the factorial experiments are shown in Figure 5.3.  The maximum 
adsorbent capacity observed under these mobile phase conditions was 51 mg of 
mAb-1 per mL of adsorbent.  From these results, a wider pH range (4-8) and salt 
concentration (0-2 M) was selected for further examination in the primary 
evaluation.  However, to ensure that mAb-1 was soluble at these higher salt 
concentrations, particularly in the case of ammonium sulphate, a solubility screen 
was performed by diluting the mAb-1 feedstock ten-fold to 0.8 mg/mL (the 
concentration at which the primary evaluation was to be carried out) into solutions 
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Figure 5.3.  Factorial design (22) to establish parameter ranges (pH, salt 
concentration) for the examination of mAb-1 (purified) binding to the multimodal 
weak cation-exchange adsorbent (Capto MMC) in sodium chloride and ammonium 
sulphate salts.  Binding capacity (q) is shown as a function of salt concentratrion (0,  
1 M) and pH (5, 7).    
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buffered at pH 5 or pH 7 and at salt concentrations up to 2.0 M.  Solubility was then 
assessed by monitoring each sample at 600 nm, with signals three times above 
background (> 0.04 absorbance units) considered to be indicative of aggregation 
and/or precipitation.  The solubility screen showed that mAb-1 does begin to 
aggregate and/or precipitate at ammonium sulphate concentrations >1.5 M (Table 
5.2), and this occurs with a slight pH dependency.  Therefore, the upper salt 
concentration was constrained to 1.25 M for the subsequent primary evaluation to 
ensure mAb-1 solubility across the pH range examined. 
 
Table 5.2.  Examination of mAb-1 solubility across a salt range from 0 to 
2 M for multimodal weak cation-exchange (Capto MMC) chromatography 
development.  Absorbance at λ = 600 nm was measured in microtitre 
plates.  Concentration of mAb-1 after dilution into the salt solution is 0.8 
mg/mL.  Absorbance values > 0.04 (3 times above background; shown in 
bold) were considered indicative of aggregation and/or precipitation.  
  
 
[Salt], M 
 
0.00 
 
0.50 
 
1.00 
 
1.25 
 
1.50 
 
2.00 
 
 
NaCl,  pH 5 
 
0.0213 
 
0.0138 
 
0.0121 
 
0.0111 
 
------- 
 
------- 
 
NaCl,  pH 7 
 
0.0185 
 
0.0166 
 
0.0130 
 
0.0129 
 
------- 
 
------- 
 
(NH4)2SO4, pH 5 
 
0.0169 
 
0.0113 
 
0.0136 
 
0.0162 
 
0.0207 
 
1.2765 
 
(NH4)2SO4, pH 7 
 
0.0177 
 
0.0112 
 
0.0129 
 
0.0175 
 
0.0938 
 
1.2936 
 
 
 
In addition to defining the parameter ranges for loading, the results from the factorial 
experiment also indicate that mAb-1 binding decreases with increasing pH and ionic 
strength.  From these data, a strip elution solution consisting of 0.5 M NaCl in 50 
mM HEPES, pH 8.5, was subsequently tested and shown to be sufficient (>80% 
recovery) for the elution of mAb-1 from Capto MMC.  This strip buffer was used 
during the primary evaluation to examine the reversibility of binding under different 
loading conditions. 
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5.4.3.  Primary Evaluation: Capture Study 
5.4.3.1. Experimental Layout 
A primary evaluation was subsequently carried out using the ranges determined from 
the range-finding study to evaluate the adsorption capacity and selectivity of the 
multimodal weak cation-exchange adsorbent (Capto MMC) for mAb-1 and the host 
cell protein impurities.  Thirty-two chromatography experiments (4 runs X 8 
experiments/run) were carried out for each salt type in a single fully automated 
method, in which pH and salt concentration were varied.  The pH was studied at five 
points (4.0, 5.0, 6.0, 7.0, and 8.0) and the salt concentration at six points (0, 0.25, 
0.50, 0.75, 1.0, and 1.25), with one point (pH 7.0, 0 M NaCl) replicated three times 
to estimate the experimental precision.  As indicated above, a universal buffer 
mixture of 10 mM sodium acetate, 10 mM sodium phosphate, and 10 mM HEPES 
was used, spanning the entire pH range.  The column feed was exchanged into each 
loading mobile-phase condition by dilution (10-fold or higher) from a concentrated 
feedstock.  In each experiment, the adsorbent was overloaded with mAb-1, at 73 mg 
per mL of adsorbent, to provide an estimate of binding capacity under each 
condition.  Adsorbent capacity for mAb-1 was then determined as in the range-
finding study and calculated using equation 5.1.   Product recovery was evaluated by 
carrying out a strip elution with 0.5 M NaCl in 50 mM HEPES, pH 8.5, for the 
purpose of ensuring that binding was reversible.  The recovery was calculated by: 
  100cov% ×=
captured
eluted
m
meryre  ,    Equation 5.2 
in which meluted is the mass eluted from the column with the strip elution buffer and 
mcaptured is the mass that bound to the micro-tip column (as calculated by equation 
5.1).  
 
The 96-deepwell plate used in these experiments was configured as shown in Figure 
5.4, with columns 1-4 for equilibration, column 5 for dilution of the feedstock, 
column 6 for loading the desired volume of diluted sample, columns 7-8 for washing 
the column post-loading, and columns 9-10 for elution.  The micro-tip columns (at 
positions A-H) were moved across the plate from left to right to complete the 
experiment, as described in section 5.4.1.  Absorbance measurements at 280 nm were 
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Figure 5.4.  Plate layout (2-mL deepwell microtitre plate) for the primary evaluation 
of product (mAb-1) and host-cell impurity binding.  Prior to the micro-tip 
chromatography, the purification solutions are pre-dispensed into the 96-well plate 
by the Tecan robot using standard disposable pipette tips, and the sample is pre-
diluted into the desired mobile phase in Column 5 (with excess volume prepared for 
analytical testing). The desired volume of diluted sample for loading is then 
transferred to Column 6 for the micro-tip experiment.  For the micro-tip 
chromatography, the micro-tip columns were first pre-washed in separate 
microplates (not shown), and then the micro-tip experiment was performed, with 
Columns 1-4 for equilibration, Column 6 for loading the sample (transferred from 
Column 5), Columns 7-8 for washing the micro-tip columns post-loading, and 
columns 9-10 for elution.   
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made in a 96-halfwell UV transparent microtitre plate for the determination of 
adsorbent binding (q) and recovery.   
 
In this study, experiments were performed first with purified mAb-1 and then, for a 
subset of conditions, with a sample containing representative host-cell contaminants 
in order to assess the binding behaviour of these impurities.  Two strategies are 
available for assessing impurity binding.  As was done for the test case used in this 
thesis, if purified product and a representative impurity sample are available, then 
their binding can each be screened separately and their response surfaces overlaid.  
Specifically, purified mAb-1 (> 90% purity) was obtained in this study by an 
alternative purification with protein A chromatography.  Meanwhile, the flow-
through fraction from this same protein A chromatography served as a representative 
impurity sample, given that most of the antibody binds to the protein A column and 
is therefore removed from the flow-through fraction.  This approach has the 
advantage of greatly simplifying both the experimental design and the analytical 
testing.  Instead of examining multiple loading amounts, the micro-tip columns are 
overloaded with either purified antibody or an impurity sample at a single point on 
the asymptotic (nonlinear) portion of the adsorption isotherm, providing an estimate 
of maximum equilibrium capacity (qm).  This may also serve as a qualitative 
surrogate for retention in cases where adsorbent capacity trends with binding affinity.  
Such a trend was observed in some of the work performed in this thesis with cation 
exchange chromatography and was noted by Kelley et al. (2008) in their high 
throughput micro-batch adsorption studies.  An additional advantage is that 
absorbance (at 280 nm) can be used as a rapid measure of product and impurity 
binding instead of requiring separate analyses that are specific for both, significantly 
reducing the analytical burden.  The disadvantage though is that it increases the 
number of micro-tip experiments.  Moreover, no direct information about the 
competition between the product and impurities is obtained, which could alter the 
conclusions, especially in the case of strongly competing impurities.  However, at 
this initial stage of development, the primary goal is to rapidly identify the best local 
region in the design space for maximising product binding and minimising impurity 
binding, so some error can be tolerated.  The impact of competitive binding between 
the antibody and its impurities can be examined later during the secondary 
evaluation. 
    
 
 - 174 -
Separate samples of purified product and representative impurities are not always 
available, however, especially early in a program, or if an alternative purification 
procedure like protein A is not available.  Furthermore, sometimes it may be critical 
to examine the competitive binding between product and impurities early on.  In 
these cases, a representative feed stream is loaded, preferably at two (high, low) or 
more loading amounts to better understand the competitive binding behaviour.  
Coffman and co-workers (2008), studying the binding of monoclonal antibodies onto 
hydroxyapatite, ion-exchange, and hydrophobic-interaction adsorbents, performed a 
low challenge at 5 mg/mL of adsorbent, in the linear portion of the adsorption 
isotherm, and a high challenge at 30 mg/mL (or higher), which is more typical of an 
overloaded process operation.  However, two points may not always be sufficient to 
fully characterise the binding interaction and competition between impurities.  In this 
approach, assays for the specific detection of product and host cell impurities are 
required since absorbance at 280 nm cannot distinguish between them. 
 
5.4.3.2. Results of the Capture Study 
Three-dimensional response maps of Capto MMC adsorbent capacity (estimate of 
qm) for purified mAb-1 in each of the four salts are shown in Figure 5.5.  The shape 
of these response maps are affected most by the anion type, with the map of sodium 
sulphate resembling ammonium sulphate and that of sodium chloride resembling 
ammonium chloride.  This is consistent with the observation that the Hofmeister 
effect is more pronounced with anions (Zhang and Cremer, 2006).  The small 
deviations in the response surfaces are presumed to be from experimental variability.  
An estimation of the experimental variability was determined from the data points 
replicated across each experimental set (pH 4, 5, 6, 7, and 8 with no added salt), with 
the CV < 9% (n = 4 to 10) in all cases.   For the chloride salts, binding is weakened 
by increasing salt concentration at higher pH (> 6), suggesting that electrostatic 
interactions dominate in this pH range.  However, at lower pH (< 6), binding is less 
affected by salt concentration, implying that hydrophobic interactions also play a 
role.  In contrast to the chloride salts, increasing the salt concentration for the 
sulphate ions at higher pH weakens binding only to a certain point (approximately 
0.5 M of the cation).  Then, binding increases again, forming a valley in the response 
surface.  This suggests that hydrophobic interactions are overwhelming electrostatic 
effects at higher salt concentrations.  Binding capacity is the same or increases at 
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Figure 5.5. Response surface graphs of capacity 
(q) of the multimodal weak cation-exchange 
adsorbent (Capto MMC) for purified mAb-1 in 
four salt types as a function of salt concentration 
and pH:  (A) sodium chloride, (B)  ammonium 
chloride, (C) sodium sulphate, (D) ammonium 
sulphate. 
A B 
C D 
    
 
 - 176 -
lower pH, similar to the chloride ions, with one exception.  A second valley is 
observed at pH 6 and high salt concentration, being more prominent for sodium 
sulphate, which indicates that the cation type has some influence on binding at this 
pH.  Another difference between the chloride and sulphate salts is that the sulphate 
salts approach a binding capacity of 55 mg/mL whereas the chloride salts approach 
40 mg/mL. 
 
Only the ammonium sulphate and sodium chloride salts were carried forward for the 
evaluation of host cell protein binding because of the similarity between the anion 
pairs.  In this case, a representative impurity sample containing no mAb-1 (protein A 
chromatography flow-through fraction) was used to evaluate host-cell protein 
binding.  The contour plots of impurity binding (HCP ELISA) are compared with 
those of mAb-1 binding in Figure 5.6.  Here, the impurity binding is represented as a 
fraction of the maximum impurity binding observed.  Four lead mobile-phase 
conditions were identified for mAb-1 capture: (1) pH 6.6 + 0.2 and no added salt; (2) 
pH 7.1 + 0.2 and no added salt; (3) pH 5.5 + 0.2 and 0.25 M ammonium sulphate; 
and (4) pH 7.0 + 0.2 and 0.9 M ammonium sulphate).  These conditions were 
selected because they provided sufficiently high mAb-1 capacity (> 40 mg/mL) and 
low impurity binding (≤ 0.2 relative host cell protein binding).  Of these, the 
condition yielding the highest capacity was the pH 7.0, 0.9 M ammonium sulphate 
point (51 mg/mL adsorbent).  An additional criterion that was considered was the 
robustness of the operating range around each point (i.e. insensitivity to small 
changes in pH or salt concentration).  Specifically, the pH 5.5, 0.25 M ammonium 
sulphate condition was chosen because of its very robust operating window (wide 
range of insensitivity to changes in pH and salt concentration).  Overall, given the 
potential for very high impurity clearance, the Capto MMC adsorbent appears to be 
well suited for use as a capture step in the purification of mAb-1 from Pichia 
Pastoris cell filtrate, when operated in a bind-and-elute mode.   
 
5.4.3.3. Use of Statistical Software for Selecting Lead Conditions 
A statistical DoE software package can greatly facilitate data analysis, even if it is 
not used for the experimental design, by enabling multiple variables and response 
factors to be evaluated simultaneously, particularly in cases where the evaluation 
    
 
 -177- 
   
   
Figure 5.6. Contour plots showing the capacity (q) of the multimodal weak cation-
exchange adsorbent (Capto MMC) for purified mAb-1 and host cell proteins (HCP) 
as a function of pH and salt concentration: (A) purified mAb-1 capacity (mg/mL 
adsorbent) in sodium chloride; (B) impurity sample in sodium chloride (fraction of 
maximum impurity binding); (C) purified mAb-1 capacity (mg/mL adsorbent) in 
ammonium sulphate; (D) impurity sample in ammonium sulphate (fraction of 
maximum impurity binding).  Binding optima selected for examination in secondary 
experiments: α, pH 6.6 + 0.2 and no added salt; β, pH 7.1 + 0.2 and no added salt;  
χ, pH 5.5 + 0.2 with 0.25 M ammonium sulphate; and δ, pH 7.0 + 0.2 with 0.90 M 
ammonium sulphate. 
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cannot be done easily by visual inspection.  In addition, these software packages 
typically allow specifications to be placed on the data, such as limiting the 
parameters used or their range, requiring a result to be between a minimum or 
maximum value, and weighting the responses (e.g. capacity, purification factor, and 
recovery) according to their importance to the purification (process function).  
 
In this study, Design Expert software (version 7.1.3) from Stat-Ease (Minneapolis, 
MN, USA) was used to analyse the data from the sodium-chloride and ammonium-
sulphate capture study.  These data, because of their complex response surface, were 
fit with a cubic polynomial model (the highest order model available in the 
software).  The responses of mAb-1 capacity (set to maximise this response), 
impurity binding (set to minimise this response), and recovery (set to exceed a 
minimum threshold of 65%) were evaluated in the statistical analysis.  The capacity 
and impurity binding responses were equally weighted with high importance.  No 
constraints were placed on the parameter input ranges (pH 4 to 8; salt concentration 0 
to 1.25 M).  A 'desirability' plot for optimal loading, which balances capacity with 
the extent of purification, is shown in Figure 5.7, with 0 being the least desirable 
condition, and 1, the most desirable.  The most favourable loading regions from this 
statistical evaluation agree well with the visual assessment made in Figure 5.6. 
 
5.4.4. Secondary Evaluation: Elution Study and Loading Optimisation 
The purpose of the primary capture study is not only to maximise the binding 
capacity but also to attempt to achieve some selectivity on the adsorption side of the 
chromatographic separation.  This is particularly desirable for a capture 
chromatography step in order to reduce the burden of separation during elution and 
on the purification in subsequent process steps.  In the study here, binding conditions 
were identified for the multimodal weak cation-exchange adsorbent (Capto MMC) 
that showed very good selectivity for mAb-1, in which many of the Pichia pastoris 
host-cell protein impurities were not retained.  A secondary evaluation was then 
performed to optimise the lead loading conditions and define the wash and elution 
strategies, with the ultimate goal being to have a purification sequence that is 
predictive of laboratory- and process-scale operation.  The response maps from the 
primary evaluation were used to guide the selection of ranges for elution pH and salt 
concentration.   
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Figure 5.7. Determination of desirable loading conditions from the ammonium 
sulphate screen using statistical software (Design-Expert from Stat-Ease).  Contour 
lines represent the desirability of the load conditions, with 1 be most optimal and 0 
being the least optimal.  Capacity and purification factor were weighted with equal 
importance, and a minimum recovery of 65% was required.  Response surfaces for 
capacity and purification factor are fit with a cubic polynomial model.  The optimal 
conditions chosen by visual inspection from the contour plots (Fig. 5.6) are 
designated on this graph by α, β, χ, and δ. 
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5.4.4.1. Experimental Layout  
The experimental methods used here for the secondary evaluation were also fully 
automated, having loading, wash, and elution steps.  In contrast to the primary 
capture study, the micro-tip columns were loaded with crude sample (clarified cell 
supernatant) and generally were not overloaded, except to estimate binding capacity 
under the optimised conditions.  Feed samples were exchanged into different mobile 
phase conditions by either membrane dialysis or dilution of a concentrated feedstock.  
A staircase elution method was used as a means to efficiently develop the product 
elution, in which incremental steps of increasing eluent strength were made.  The 
layout of the 96-deepwell purification plate for the secondary evaluation experiments 
is shown in Figure 5.8.  For each experiment (micro-tip columns A-H), the sample 
was diluted into the loading buffer in column 1 (if necessary), loaded with the 
desired volume in column 2, washed in column 3, and then eluted in columns 4-12.  
Sodium phosphate was used as a buffer for solutions with a pH of 6.2-7.8, and 
HEPES buffer was used for all solutions above this range (up to pH 8.5).   
 
5.4.4.2. Results of the Elution Study  
As observed from the response maps shown in Figure 5.5 and 5.6, mAb-1 adsorption 
is weakened at higher pH and ionic strength, although binding strength begins to 
increase again for the sulphate salts at concentrations greater than 0.25 M (cation 
concentration of 0.5M).  Figure 5.9 shows the effect of elution buffer pH (6.5 – 8), 
salt type, and cation concentration (0 to 1.6 M NH4+ or Na+) on mAb-1 elution.  In 
these experiments, the columns were loaded with cell filtrate to 30 mg mAb-1 per 
mL of Capto MMC adsorbent at pH 7.1 + 0.2 and no added salt.  Higher elution pH 
resulted in a more efficient elution, presumably because of increased charge 
repulsion and disruption of electrostatic interactions.  In addition, the sodium salts 
yielded a slightly higher recovery, most likely because sodium does not promote as 
much hydrophobic interaction as ammonium.  Furthermore, sodium chloride is 
preferred over sodium sulphate since hydrophobic interactions at higher 
concentrations are not favoured.  Therefore, sodium chloride was used as the eluent 
for the remainder of the secondary evaluation. 
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Figure 5.8. Plate layout (2-mL deepwell microtitre plate) for the secondary 
evaluation study (elution and loading optimisation) in the development of a mixed-
mode chromatography step.  Micro-tips were pre-washed and equilibrated in separate 
microplates.  The sample and purification solutions were pre-dispensed into the 96-
well plate by the Tecan workstation from troughs and/or reservoir plates prior to the 
micro-tip column chromatography.  For each experiment (micro-tip columns A-H), 
the feed sample was diluted into the loading buffer in column 1 (if necessary), 
allowing for excess volume for analytical testing, then loaded with the desired feed 
volume in column 2, washed in column 3, and eluted in columns 4-12.   
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Figure 5.9. Evaluation of mobile phase conditions for the elution of mAb-1 from the 
multimodal weak cation-exchange adsorbent (Capto MMC): (A) effect of pH 
(elution with NaCl); (B) effect of salt concentration and salt type at pH 8.  The 
micro-tip columns were loaded with diluted cell filtrate (loading = 30 mg mAb-1/mL 
adsorbent) at pH 7.1 + 0.2 and low ionic strength (no added salt).   
 
 
A 
B 
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5.4.4.3. Definition of the Final Purification Sequence  
The four optimal loading conditions shown in Figures 5.6 and 5.7 were compared by 
carrying out a staircase elution (0.25 M increments) with sodium chloride at pH 8.  A 
direct load of the clarified cell filtrate (pH 7.2, conductivity ≤ 10 ms/cm) was carried 
out in lieu of the pH 7.1 condition (no salt added), whereas for the other conditions, 
the clarified cell filtrate was exchanged into the desired solution condition by 
dialysis.  In these experiments, the columns were loaded at 20 mg mAb-1 per mL of 
adsorbent.  The elution profiles from these purifications are shown in Figure 5.10A, 
along with the yield as measured by the Octet protein-A biosensor assay.  
Interestingly, for the condition loaded at 0.9 M ammonium sulphate (pH 7.0), the 
product begins to elute with decreasing salt concentration (0.9 to 0 M) and a 
concomitant increase in the pH from 7 to 8.  In contrast, elution for the other three 
conditions does not begin until the salt concentration is increased to 0.25 M NaCl at 
pH 8.0.  This suggests that adsorption in 0.9 M ammonium sulphate is driven 
primarily by hydrophobic interactions, whereas the interaction in the other three 
loading conditions is predominantly electrostatic, or a combination of the two. 
 
While the recovery is comparable for the four loading conditions (83-88%), the 
extent of purification differs, as observed in Figure 10B.  Several protein 
contaminants as well as free antibody light chain elute at pH 8 (0 M NaCl).  As a 
result, some of the product co-elutes with these impurities for the feed loaded in 0.9 
M ammonium sulphate.  The purity of each of the products from the other three 
loading conditions is comparable, with a purity of ~90% by SDS-PAGE.  Since the 
direct loading of the clarified cell filtrate is the most convenient of the three 
conditions, with no buffer exchange required, it was chosen as the winning condition 
for verification in a dynamic laboratory-scale column chromatography experiment.  
The adsorbent capacity for mAb-1 (when loading the clarified cell filtrate) as 
determined by the micro-tip chromatography experiments is about 35 mg/mL.  At 
this loading, the product recovery was ~80%, and over a 5000-fold reduction in host 
cell protein levels was achieved (as determined by HCP ELISA).   
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Figure 5.10. Secondary evaluation of four loading conditions in the purification of 
mAb-1 from clarified cell filtrate by multimodal weak cation-exchange (Capto 
MMC) chromatography.  (A) Incremental step elution with increasing sodium 
chloride concentration (0.25 M/step), with the % yield of the mAb shown in the 
legend:  (•) direct load of cell filtrate at pH 7.2 (conductivity < 10 mS/cm); (▼) load 
at pH 7.0 in 0.9 M ammonium sulphate (AS; dialyzed); (■) load at pH 6.75 
(dialyzed, no added salt); and (♦) load at pH 5.5 in 0.25 M ammonium sulphate 
(dialyzed).   Each micro-tip column was underloaded at 20 mg/mL and eluted with 
sodium chloride at pH 8.  (B) SDS-PAGE (reducing conditions; Sypro Ruby protein 
stain) of each microscale purification.  The first lane is the clarified cell filtrate. 
Within each loading condition, lane 1 is the nonbound fraction, and lanes 2-4 are the 
eluted fractions (pH 8) at 0 M NaCl, 0.25 M NaCl, and 0.5 M NaCl, respectively.  
HC = heavy chain of the mAb; LC = light chain of the mAb.    
Load
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direct
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B 
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5.4.5. Laboratory-Scale Column Verification of the Microscale Results 
The optimised purification determined by micro-tip chromatography (direct load of 
the clarified filtrate and elution with sodium chloride at pH 8.0) was verified with a 
laboratory-scale column experiment using a 1-mL Hi-Trap Capto MMC column.  
The crude cell filtrate (pH 7.2 + 0.2; conductivity < 10 mS/cm) was loaded directly 
onto the column at a residence time of four minutes (37.5 cm/h; total load time of 
145 minutes) and a loading challenge of 36 mg of mAb-1 per mL of adsorbent.  The 
product was eluted with sodium chloride at pH 8.0 in a twenty column-volume (CV) 
linear gradient from 0 to 1 M.   
 
The UV chromatogram and purity (by HCP ELISA and gel electrophoresis) results 
from the column experiment are shown in Figure 5.11.  Most of the host-cell protein 
impurities do not bind to the column and are recovered in the column flow-through 
fractions, as was the case in the microscale purification.  The dynamic binding 
capacity at 2% breakthrough was determined from this column experiment to be 
approximately 34 mg/mL adsorbent, in line with the semi-equilibrium capacity of 35 
mg/mL observed in the micro-tip experiments.  The product elutes from the column 
at about 0.36 M NaCl, also consistent with the micro-tip chromatography (elution 
between 0.25 and 0.5 M NaCl elution steps, as shown in Figure 5.10).   For those 
host-cell proteins that do bind to the column, the majority of them appear to elute 
following the mAb-1 elution, at around 0.7 M NaCl.  It therefore may be possible to 
achieve additional HCP clearance by modifying the elution gradient.  The product 
purity is 88% by SDS-PAGE, comparable to a protein-A purified product. 
 
The laboratory-scale column results are compared to the microscale results in Table 
5.3.  The microscale purification is predictive of the column performance with 
respect to column capacity, yield, and purity.  Although the step yield is below 90%, 
it is still an acceptable step recovery given the significant clearance of host cell 
proteins (99.99%) and DNA (97.99) that is achieved.  The remaining HCP 
contaminants are about 3-fold lower in the laboratory-column product than in the 
micro-tip column.  This is presumably due to the increased resolution gained in 
carrying out column chromatography with linear gradient elution.  However, given 
the reasonable separation achieved between the mAb-1 product and the HCPs in   
    
 
 
- 186 -
 
  
B
1    2   3   4   5
A
Figure 5.11.  Verification of the microscale results for the multimodal weak cation-exchange (Capto MMC) chromatography at the laboratory 
column scale (1-mL Hi-trap column).  (A) Column chromatogram in which the clarified cell filtrate was loaded directly on the column at a 
residence time of four minutes.  The product (mAb-1) was eluted at pH 8.0 with NaCl in a 20-CV linear gradient from 0 to 1.0 M.  The dotted 
line represents host-cell protein (HCP) elution as measured by ELISA.  (B) SDS-PAGE (under denaturing and reducing conditions; Sypro 
Ruby protein stain) to examine the extent of purification: lane 1, column feed (clarified cell filtrate); lane 2, nonbound fraction; lane 3, 
column product; lane 4, microscale chromatography product; lane 5, purified product from protein A chromatography (for comparison). HC = 
heavy chain; LC = light chain. 
HC 
LC 
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Figures 5.10 and 5.11, a step gradient yielding similar results seems achievable with 
careful optimisation of the NaCl concentration.   
 
 
Table 5.3. Comparison of results between micro- and laboratory-scalesa for the 
purification of mAb-1 from cell filtrate using multimodal weak cation-exchange 
(Capto MMC) chromatography.   
 Capto MMC 
Micro-Tip Column 
(10 μL; Batch) 
Capto MMC 
Lab-Scale Column    
(1 mL; Dynamic) 
 
Step Recovery (%) 
 
 
77 
 
82 
Purity, by SDS-PAGE (%) 
 
88 88 
Purity, by HCPb ELISA (ppm) 
 
5346 1624 
HCP Clearance (%) 
 
99.98 99.99 
DNA clearance (%) 
 
not assayed 97.99 
a) Adsorbent loading at each scale was approximately 35 mg mAb/mL adsorbent. 
b) HCP = Pichia pastoris host cell proteins 
 
 
 
5.5. Experimental Throughput 
The microscale workflow demonstrated here allowed the mixed mode 
chromatographic purification to be developed in under 2-3 weeks.  This time 
accounts for not only the purification experiments but also the analytical testing and 
sample preparation.  With one Tecan robot and one trained full-time equivalent 
(FTE), the range-finding study and primary evaluation can be completed in 
approximately 5-7 days, assuming 1 day for the initial range finding experiment and 
1-1.5 days per salt condition (accounts for evaluation of both the purified and 
impurity samples).  If more parameters are examined (e.g. buffer concentration), then 
this would increase this time or require a more sophisticated DoE strategy, as 
opposed to the brute-force one applied here.  Alternatively, use of a 96-channel 
liquid handing arm would increase the throughput by a factor of 12 over the 8-
channel arm used in these experiments.  The secondary evaluation can be completed 
in about 2-5 days, depending on the experimental outcomes, but this time does not 
account for any associated analytical testing or sample preparation.  If these are taken 
into account, then the evaluation could take double this time.  The column 
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verification then requires 1-2 days.  In contrast to the throughput of the microscale 
experiments, a comparable set of conventional laboratory-scale columns experiments 
might conservatively take about 2-3 months.  Most likely though, fewer experiments 
would be done and, consequently, the parameter space would not be as thoroughly 
characterised.     
 
 
5.6. Summary 
A high-throughput, automated workflow using batch microscale chromatography has 
been designed for the rapid and comprehensive development of mixed mode 
chromatography steps.  Such a workflow allows development to be completed in 
days rather than weeks and is amenable to chromatography types beyond that of 
mixed mode.  This workflow was successfully demonstrated here in the development 
of a capture step using multimodal weak cation-exchange (Capto MMC) 
chromatography for the purification of a monoclonal antibody from crude cell 
filtrate.  One hundred and twenty solution conditions were evaluated in the primary 
screen for their effect on binding capacity, enabling a thorough exploration of the 
design space and helping to guide development of loading and elution conditions.  
Four lead conditions for loading were then further evaluated, and elution conditions 
were defined for maximum product yield and purity.  The final selected conditions 
revealed that mixed mode chromatography provides a potential alternative to protein 
A chromatography for the purification of mAb-1 from crude yeast cell filtrate.  The 
optimised microscale purification was then scaled up to the laboratory scale (1-mL 
column), with the results from the dynamic column experiment consistent with the 
batch 10-μL micro-tip experiments in terms of yield, purification, and adsorbent 
capacity.  This agreement between scales is consistent with the results of Chhatre and 
colleagues (2009), in which the data from 20-μL micro-tip screening experiments 
trended well with those from 10-mL column experiments.    
 
Having a high-throughput microscale workflow like the one outlined here is a first 
step in implementing a quality by design (QbD) process development paradigm.  
High-throughput, parallel experimentation allows the 'knowledge space' and critical 
operating boundaries of a chromatography step to be thoroughly mapped.  Although 
not all aspects of microscale chromatography will scale linearly to the laboratory or 
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process scale, fundamental knowledge about the chromatography can be learned and, 
in turn, used to define the design space.  Furthermore, the use of appropriate 
modelling techniques like those described in Chapter 4 may offer a route to scale-up 
prediction using these data.  In these ways, the use of microscale methods not only 
accelerates process development but also leads to more robust, better understood 
bioprocesses. 
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6. A MULTI-STEP CHROMATOGRAPHIC SCALE-DOWN WITH MICRO- 
    TIP CHROMATOGRAPHY 
6.1. Introduction 
The optimisation of yeast fermentation processes requires balancing expression titres 
with product quality.  Changes to cell fermentation conditions are typically evaluated 
following cell disruption, with expression levels quantified by immunoassay (Cruz et 
al., 1998; Sun et al., 2002; Maranga et al. 2003; Zhang and Lynd, 2003), HPLC 
(Amari and Mazsaroff, 1996), enzyme activity (Fisher and Woods, 2000), flow 
cytometry (Soriano et al., 2002), optical biosensors (Bracewell et al., 2004), or 
fluorescence polarization (Sun et al., 2002).  However, these titres do not always 
predict the effects that intracellular aggregation, proteolysis, post-translational 
modifications, and differences in relative impurity levels can have on purification 
yield and product purity.  Furthermore, for recombinant subunit vaccines, 
heterogeneity in the size and surface properties inherent in virus-like particles 
(VLPs) makes unit operations such as chromatography less predictable.  Experiments 
which optimise fermentation conditions should therefore consider more than mass 
expression, but also the quality of the material and its effect on the downstream 
purification.   
  
Such an example was encountered in the production of recombinant human 
papillomavirus (HPV) VLPs.  The VLPs are produced by expression of the major 
capsid L1 protein of HPV in Saccharomyces cerevisiae (Hofmann et al., 1995; 
Hofmann et al., 1996; Neeper et al., 1996; Rossi et al., 2000), which assembles into 
icosahedral particles whose structure resembles the native capsid (Baker et al., 1991).  
Here, the most informative feedback on fermentation changes was obtained by 
completing a two-step chromatographic purification and then evaluating process 
yield and product purity (Wenger et al., 2007).  This chapter addresses the 
development of a mimic of this purification using micro-tip columns.  The 
performance of the micro-tip chromatography is compared to the laboratory-scale 
column chromatography with respect to yield, purity, and experimental throughput.  
The successful miniaturisation of the chromatography subsequently necessitated a 
microscale method for yeast cell disruption in order to eliminate this resulting 
bottleneck and obtain a fully microscale purification.  The development of a 
microscale cell disruption technique for yeast is discussed in Chapter 7.    
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6.2. Chromatography of Viral Particles 
The majority of preparative chromatographic adsorbents for protein purification are 
optimised for proteins having diameters less than 5 nm.  DePhillips and Lenhoff 
(2000) investigated the mean pore diameters of 14 cation exchange resins by inverse 
size-exclusion chromatography and found that they ranged from 20-150 nm, 
consistent with the average pore sizes given by the manufacturers of these 
adsorbents.  Because viral particles can range in size from about 10 to 100 nm in 
diameter, their capture by standard chromatographic methods is inefficient due to 
low particle diffusivity and inaccessibility to much of the pore volume (Lyddiatt and 
O'Sullivan, 1998; Zhang et al., 2001; Lyddiatt, 2002).  The chromatography of viral 
particles is further complicated by aggregation and variable particle morphology, 
which have been observed for HPV VLPs produced in eukaryotic cells (McCarthy et 
al., 1998; Shi et al., 2005; Mach et al., 2006).  In particular, Mach and co-workers 
(2006) observed that the expression of HPV types 6, 11, and 16 VLPs in yeast 
yielded particles that were irregularly shaped, broadly distributed, and smaller than 
the native virus particles.  Transmission electron micrographs showing the 
distribution of VLPs expressed in yeast are provided in Figure 6.1.  VLPs that were 
disassembled and then reassembled in vitro are also shown in Figure 6.1 in 
comparison to the those that were not treated.   
 
Because aggregation and heterogeneity in the particle size and morphology of VLPs 
would be expected to impact the performance of chromatographic steps, developing 
fermentation processes which are consistent for these product attributes is important 
to obtaining downstream process consistency.  As shown in Figure 6.2, analysis of 
post-fermentation HPV VLP titres by immunoassay does not adequately predict final 
purification yields, presumably because of differences in these attributes, so that a 
laboratory-scale purification is needed to assess fermentation performance.  The 
purification involves first disrupting the yeast cells by homogenisation and removing 
the cellular debris by centrifugation.  The VLPs are then captured from the clarified 
lysate by strong cation exchange chromatography (CEX; 80-mL POROS 50HS 
column) and additionally purified by ceramic hydroxyapatite chromatography (CHT; 
30-mL column).  Each fermentation paste is then evaluated on its final product yield 
and purity through the purification.  The specific details of the laboratory-scale 
purification are given in Chapter 2.  
    
 
 
 
Figure 6.1. Transmission electron 
micrographs of HPV 6, 11, 16, and 18 
VLPs, from the publication by Mach et 
al. (2006).  Untreated VLPs, as expressed 
and purified from yeast, are compared to 
VLPs that were disassembled and then 
reassembled in vitro. 
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Figure 6.2. Correlation of the VLP titre in lysate by immunoassay to the total protein 
recovery through a multi-step chromatographic purification.  The protein recovery is 
normalised to cell weight input. 
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6.3. Miniaturisation of the VLP Chromatographic Purification 
The thorough optimisation of fermentation conditions for a multivalent vaccine 
requires that many hundreds of fermentations be carried.  Given that a purification is 
needed to best evaluate the impact of these fermentation changes on the downstream 
chromatography, this means hundreds of small-scale purifications must be 
performed.  Miniaturising and automating these development experiments allows 
them to be carried out in the numbers necessary to rigorously optimise and validate 
the fermentation process, while simultaneously decreasing the time, materials, and 
labour required.  Therefore, in the case of HPV VLPs, a chromatographic mimic of 
the laboratory-scale column purification was developed using micro-tip 
chromatography (Wenger et al., 2007), as outlined in the flow diagram in Figure 6.3.  
The micro-tip chromatography was performed using an 80-μL CEX column and a 
40-μL CHT column.  In doing so, the purification was miniaturised by about three 
orders of magnitude and automated on the Tecan workstation. 
 
Micro-tip chromatography was carried out as described in Chapter 3, with pre-wash, 
equilibration, loading, wash, and elution steps.  The chromatographic sequence was 
the same as that performed for the laboratory-scale purification (Chapter 2), with one 
primary exception.  The linear sodium-phosphate gradient elution of the laboratory-
scale CHT polishing chromatography was converted to a single step elution.  The 
specific parameters of micro-tip column operation are given in Table 6.1, along with 
the run times.  Eight micro-tip columns were picked up in each automated run, with 
the product pool of two CEX columns loaded onto one CHT column.  This allowed 
for a sufficient loading of the CHT column, while providing excess material for 
analytical testing of the CEX process intermediate.  Flow rates used throughout the 
VLP purification ranged from 5-20 μL/sec, equivalent to an average linear velocity 
of 270-1080 cm/hr for the 80-µL CEX column and 405-1620 cm/hr for the 40-μL 
CHT column.  Prior to the CEX purification, the micro-tip columns were wetted with 
50% methanol (200 μL), followed by washes with water (650 μL), elution buffer 
(160 μL), and equilibration buffer (3 X 500 μL).  For the CHT chromatography, tips 
were washed with 0.4 M sodium phosphate (pH 6.8) and the elution buffer (150-300 
μL) prior to washes with equilibration buffer (4 X 600 μL).  Pre-treatment and 
equilibration steps were carried out using a 12-column reservoir plate.   
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Figure 6.3. Purification scheme of HPV VLPs using micro-tip chromatography to 
provide feedback on fermentation performance.   
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Table 6.1.  Run parameters for the CEX and CHT micro-tip chromatography for the purification of HPV VLPs.  
  
 
 
Reagent 
Dispensing 
 
 
Pre-Washes 
 
Equilibration 
 
 
Loading 
 
Wash 
 
Elution 
#1 
 
Elution 
#2 
 
 
          
CEX Volume (μL) 
 
N/A 160-650 500 410 400 300 100  
 Aliquots/Step 
 
N/A 3 3 1 3 1 1  
 Cycles/Aliquot 
 
N/A 1 1 3 - 4 1 3 2  
 Flow rate (μL/s) 
 
N/A 5-20 10 20 10 10 10  
 Delay Time/Cycle (s) a 
 
N/A 60-90 75  90 120  80  80   
 Time/Stage (min) 
 
10 8 9 9 10 7 4 Total = 57 min 
          
CHT Volume (μL) 
 
N/A 160-300 600 533 300 120 100  
 Aliquots/Step 
 
N/A 3 4 1 2 1 1  
 Cycles/Aliquot 
 
N/A 1 1 4 1 4 2  
 Flow rate (μL/s) 
 
N/A 5-10 20 20 10 10 10  
 Delay Time/Cycle (s) a 
 
N/A 75-150  90  100  100  100  80   
 Time/Stage (min) 10 9 10 11 6 8 4 Total = 58 min 
          
a) Delays times greater than 30 s (60 s per cycle) were used to increase the contact time with the mobile phase and/or to account for higher sample viscosity.
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The clarified lysate was applied to each CEX column at a volumetric loading of 410 
μL, and 533 μL of the CEX product was loaded onto each CHT column.  The loading 
flow rate for both chromatography steps was 20 μL/s, and the delay time was 45 s 
after each aspiration and dispense step.  This delay time is longer than the 30 s 
recommended in Chapter 3 but was used to ensure a complete volumetric loading, 
particularly for the more viscous clarified lysate.  As discussed in Chapter 3, 
although the average linear velocities used in the micro-tip column format are within 
the range of typical laboratory column operation, the residence and contact times per 
aspiration-dispense cycle are much lower due to the short bed height.  The principal 
strategy for increasing total residence time is to perform multiple aspiration-dispense 
cycles.  The protein uptake of each column feed onto the CEX and CHT micro-tip 
columns was examined as a function of cycle number (Figure 6.4).  These uptake 
experiments were carried out as described in Chapter 4, with each micro-tip column 
having a different cycle number and hence a different contact and residence time.  
The loading times are also shown in Figure 6.4.   The loading of the column feed was 
monitored by absorbance at 280 nm (ABS280) and total protein concentration (BCA 
assay).  For the CHT feed, the ABS280 and BCA measurements represent the 
approximate VLP concentration since the CEX product is >75% purified.   However, 
for the CEX feed, they represent both impurity and VLP binding.  Therefore, an 
immunoassay was used to determine VLP binding to the CEX column.   
 
Four aspiration-dispense cycles were used for sample loading in both the CEX and 
CHT chromatography steps (represented by the dotted vertical lines in Fig. 6.4).  
This cycle number achieved a compromise between experimental throughput and 
completeness of binding, with the goal being to having a total run time for each 
chromatography step of less than one hour.  For the CEX chromatography (Fig. 
6.4A), VLP and total protein binding is nearly complete (>95%) after about three 
cycles (contact time, TC, of 6.6 min; residence time, TR, of 24 sec); however, four 
cycles (TC of 8.7 min; TR of 32 sec) were performed in the final method to ensure 
method robustness.  This rapid uptake is presumably because the column is 
underloaded to allow for variations in VLP titres under different fermentation 
conditions.  It is also consistent with the favourable mass transport properties of the 
POROS 50HS adsorbent.   
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Figure 6.4. Binding of the column feed sample to (A) the 80-μL CEX and (B) the 
40-μL CHT micro-tip columns as a function of cycle number and loading time 
(contact time, TC; and residence time, TR). For the CEX chromatography, 410 μL of 
clarified lysate was loaded at 20 μL/s.  For the CHT chromatography, 533 μL of the 
CEX product was loaded at 20 μL/s.  The post-aspiration and -dispense delay times 
(45 s) are included in the calculation of TC, but not TR.  The dotted vertical lines in 
each graph represent the number of cycles chosen for the final method, providing a 
compromise between throughput and completeness of adsorption.  
 
A 
B 
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In contrast to the CEX step, protein uptake is only 70-80% complete for the CHT 
chromatography after four cycles (Fig. 6.4B).  This may be because of differences in 
the mass transport properties of the adsorbents (i.e. pore size), because the column is 
loaded closer to saturation, or because the residence time is shorter (16 s vs. 32 s for 
CEX) even though the contact time is about the same (9.6 min vs. 8.7 min for CEX).   
Compared to the antibodies studied in Chapters 3-5, micro-tip residence time is 
expected to contribute more to the overall uptake rate of VLPs because much of the 
pore volume is inaccessible, as indicated by the low adsorbent capacities for VLPs.  
Yet, residence time does not fully explain the difference in uptake between the two 
chromatography steps, since binding remains incomplete (<90%) for the CHT step 
even when operated with the same residence time as the CEX step (32 s).  Therefore, 
the difference also probably has to do with the higher mass loading of the CHT 
column and differences between the mass transport properties of the two adsorbents.  
With the CHT chromatography, there is an initial phase of rapid uptake of about 70-
80% of the protein, presumably from binding onto the adsorbent particle surface.  
This is followed by a second phase of much slower uptake of the remaining protein.  
This slower uptake likely represents adsorption within the accessible pore volume.  
However, here the effective pore diffusivity would be relatively low for VLPs, and 
therefore uptake would be slower.  
 
There is almost no protein breakthrough (< 5%) observed in the laboratory-scale 
column operation (TR of 2.5 min; total load time of > 15 min).  This difference may 
be due to the longer loading time of the column, but it also reflects the operational 
differences between micro-tip (bi-directional flow; batch operation) and conventional 
column (uni-directional flow; dynamic operation) chromatography, as discussed 
throughout this thesis.  However, even though binding is incomplete for the CHT 
micro-tip chromatography after four cycles, it was selected for the final method for 
the purpose of higher experimental throughput.  As described later in the chapter, 
because the offset in recovery was consistent, it could be accounted for by using an 
empirical correction factor when predicting laboratory-scale column performance. 
 
In the final optimised method, the micro-tips columns for each chromatography step 
are washed after the loading step and then eluted as described in Table 6.1.  The 
CEX column is eluted with 1.25 M sodium chloride (buffered at pH 7), and the CHT 
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column, with a single step elution with sodium phosphate (buffered at pH 7).  The 
final selected elution volume is a balance between having a volume large enough to 
ensure robust micro-tip operation yet small enough to yield a concentration sufficient 
for analysis.  Multiple aspiration cycles are performed to ensure sufficient contact 
and residence time for reproducible and quantitative desorption.  In each 
chromatography, a second elution with a smaller aliquot of buffer is carried out to 
recover the column hold-up volume from the first elution and maximise recovery.   
 
Overall, the CEX chromatographic sequence required no significant modification at 
the microscale since the laboratory-scale chromatography is operated in an on-off 
mode.  For the CHT chromatography, although the linear gradient elution was 
converted to a single step elution, this change does not significantly affect the final 
product purity as demonstrated in the section below.  One reason for this close 
agreement is that neither chromatographic step requires resolution from closely 
eluting protein impurities due to the strong retention of VLPs.  Therefore, these steps 
can be operated in a simple step-gradient mode for miniaturisation, with load, wash, 
and elution steps.   Additional wash and elution steps would be required in cases 
where the retention properties of the product and impurities are very similar.   
 
 
6.4. Performance of the Microscale Chromatography 
VLP recovery and purity through the micro-tip chromatographic purification are 
comparable to what is obtained with the laboratory-scale columns.  The results from 
a purification carried out with multiple replicates are summarised in Table 6.2.  The 
SDS-PAGE results are shown in Figure 6.5, with the corresponding purity values 
reported in Table 6.2.   Since the feed to the CEX column is impure, the total protein 
recovery at this step is normalised to the input of cell weight.   The protein recovery 
at the CEX step is slightly lower for the microscale format, although when adjusted 
for purity, the difference in recovery is < 5%.  The step yield across the CHT column 
is also lower for the micro-tip chromatography when compared to the laboratory 
scale (~11% in this example), even when accounting for purity.  It should be noted, 
however, that the CHT step yield is very low even at the laboratory scale for this 
particular fermentation paste, providing an example of how the upstream process can 
impact the downstream chromatography.  In addition to the acceptable accuracy of 
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Figure 6.5. SDS-PAGE analysis (4-12% NuPage gel; reducing conditions; Sypro 
Ruby protein stain) of the HPV VLP multi-step chromatographic purification 
comparing the laboratory and micro-tip column scales.  Lane 1, molecular weight 
standard; Lane 2, clarified lysate (CEX column feed); Lane 3, laboratory-scale 
column CEX product; Lane 4, laboratory-scale column CHT product; Lane 5, 
micro-tip column CEX product; Lane 6, micro-tip column CHT product.  The HPV 
L1 capsid protein migrates at ~55 kDa.  The corresponding purity of the laboratory-
scale and microscale CHT products is 94 and 96%, respectively, within the error of 
the assay.    
 
 
 
 
 
 
55.4 kDa
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66.3 kDa
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Table 6.2. Comparison of the micro-tip and laboratory column purifications of HPV 
VLPs for the assessment of fermentation performance. 
 
 n Recovery   % Purity
b  
 
CEX Chromatography 
   mg total protein recovered 
per  unit cell weight inputa 
 
Micro-Tip Column (80 μL) 8 7.7 + 0.2 83 
Laboratory Column (80 mL) 2 8.7 + 0.2 77 
    
CHT Chromatography  % protein step yield           
Micro-Tip Column (40 μL) 8 24 + 1 96 
Laboratory Column (30 mL) 2 27 + 1 94 
 
a) Recovery of the CEX chromatography is expressed as the milligrams of total protein recovered per 
input of wet cell weight since column feed is a crude lysate. 
b) Purity was determined by SDS-PAGE (reducing conditions; Sypro Ruby stain) densitometry, as 
described in Chapter 2, using the product pool of replicate purifications.   Assay variability is 
estimated to be <5%.      
   
the micro-tip purification, the precision of the method is very high, an essential 
requirement for chromatographic miniaturisation.  In this example, the coefficient of 
variation (CV) was less than 5% for eight replicate purifications. 
 
The correlation of the automated microscale chromatographic purification to the 
laboratory-scale column purification was examined by comparing the VLP recovery 
under a wide range of fermentation cell induction and growth conditions for multiple 
HPV types.  Fermentation productivity is expressed here as the total protein 
recovered after each chromatographic step per input of cell weight.  This value 
generally reflects the recovery of VLPs since the chromatographic product purity is 
relatively high (>75% for the CEX product and >95% for the CHT product).   Figure 
6.6 shows the correlation between the two formats following the CEX and CHT 
steps.  In both cases, the data is fit by linear regression through the origin. 
 
A very good correlation in productivity is observed between the two scales through 
both chromatography steps, and this correlation might improve even further with 
more replicates of the laboratory-scale purifications (n=1 per condition in 
fermentation paste).  While there is more scatter observed in the CEX recovery data 
(Fig 6.6A; R2 = 0.73) than in the CHT recovery data (Fig 6.6B; R2 = 0.92), the 
agreement between scales for the CEX step is very close to one (y = 0.98x).  The 
observed scatter is not entirely unexpected for a capture step, where an impure feed 
    
 
 - 203 -
Laboratory Column, mg protein / cell weight input
4 6 8 10 12 14 16
M
ic
ro
sc
al
e,
 m
g 
pr
ot
ei
n 
/ c
el
l w
ei
gh
t i
np
ut
4
6
8
10
12
14
16
 
 
 
Laboratory Column, mg protein / cell weight input
0 1 2 3 4 5 6 7 8
M
ic
ro
sc
al
e,
 m
g 
pr
ot
ei
n 
/ c
el
l w
ei
gh
t i
np
ut
0
1
2
3
4
5
6
7
8
 
 
Figure 6.6. Correlation between the automated microscale purification and the 
laboratory-scale column purification in the assessment of fermentation productivity 
(mg protein recovered / cell weight input) across a wide range of cell growth and 
induction conditions:  (A) recovery following the CEX chromatography; (B) 
recovery following the CHT chromatography.  Only one replicate was carried out for 
each of the laboratory-scale purifications, whereas two to eight replicates were 
performed in each microscale assessment.  The variability (CV) of the laboratory-
scale purification is estimated to be < 10%. 
 
A 
B 
y = 0.76 x  
y = 0.98 x  
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is loaded (leading to more operational and assay variability).  Increasing the number 
of loading cycles might reduce the scatter of the data, but the results here 
demonstrate a reasonable compromise between throughput and binding.  In contrast, 
the overall recovery following the CHT chromatography is considerably less 
variable.  However, it is consistently lower for the microscale purification (y = 
0.76x), implying a lower step yield through the CHT microscale purification.     
 
The lower step yield of the CHT chromatography is predicted by the data shown in 
Figure 6.4, in which binding is about 70-80% complete after four cycles (TC of 9.6 
min; TR of 16 sec).  In the laboratory-scale column chromatography, the total protein 
recovered in the flow-through of the laboratory-column purification was typically 
<5%, whereas 25% + 8% of the total protein was recovered in the flow-through of 
the micro-tip columns. As discussed above, this incomplete binding was accepted as 
a trade-off for higher throughput.  Another minor contribution to the lower recovery 
of the micro-tip columns may also involve differences in desorption between it and 
conventional column chromatography.  Elution is carried out in batch mode with the 
micro-tip format, with two stages (two microwell aliquots) of elution, as opposed to 
the multistage operation of laboratory chromatography, where the buffer is 
continuously being replenished and pushing the equilibrium toward desorption.  
Despite these effects, the offset in overall yield of 24% is very consistent across all 
the purifications, allowing the correlation to be used as an empirical correction factor 
in order to obtain higher throughput.    
 
 
6.5. Throughput and Resource Benefits Using the Microscale Purification  
The microscale purification increases throughput by 8- to 16-fold over the laboratory 
column purification depending on whether or not replicate purifications are 
performed, while the materials requirement is lowered by two to three orders of 
magnitude.  In addition, the labour is reduced by 50%.  These calculations assume 
that the Tecan is operated continuously over a full 24 hours.  The other assumptions 
used in these calculations are described in Table 6.3.  The time of each micro-tip 
chromatography step conservatively incorporates an additional half hour in these 
calculations, yielding a final time of 1.5 hr per chromatography step.  Therefore, the 
total time to process eight data points through the multi-step microscale purification 
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is 4.5 hr, since two CEX purifications are carried out for every one CHT purification.  
An additional two hours is allotted per day for the set-up of each Tecan and for 
sample preparation (centrifugation of cell lysate and dilution to the target feed 
concentration).  If overnight runs are performed, then about four runs can be 
completed within a 24-hour period, for a total of 32 purifications per Tecan system.  
Overnight runs require that the pre- and post-run samples be chilled to ensure their 
stability and that the plates be covered to avoid evaporation.  The calculations in 
Table 6.3 make the assumption that two Tecans are available to be operated per day.  
This allows for a total of 64 purifications to be performed, so that 32 fermentation 
pastes can be evaluated in duplicate, or 64 with one replicate. 
 
In contrast, only four pastes can be evaluated per day at the laboratory-column scale 
by one person operating two chromatography systems.  This assumes that overnight 
operation is not possible because some manual operation between the CEX and CHT 
chromatography steps is required (which was the case for the laboratory-scale 
method compared here).  In principle, full automation is possible with a more 
sophisticated chromatography system, and hence, throughput would double. The 
laboratory-scale purification also requires more manual labour for packing and 
cleaning columns, setting up the chromatography systems, and preparing purification 
reagents, totalling to about six hours of labour per day.  Therefore, the productivity 
of the laboratory-scale purification, defined here as the number of pastes processed 
per hour of labour required, is about 0.67 pastes/hr, while the productivity of the 
microscale purification is 8 pastes/hr when duplicate purifications are performed, or 
16 pastes/hr if only a single replicate is carried out.  This translates into a 12- to 24-
fold improvement in overall productivity.  In addition to these gains, over 200 times 
less sample volume is required.   
 
 
 
6.6. Summary 
A laboratory-scale chromatographic purification of HPV VLPs was miniaturised by 
three orders of magnitude using micro-tip chromatography and automated on a 
robotic workstation.  Overall, the automated purification is concordant with the 
laboratory-scale purification in the assessment of VLP recovery and purity, while the 
productivity (pastes evaluated/hour of labour) of the purification is improved by 
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more than 10-fold, even when duplicate purifications are carried out at the 
microscale.  The miniaturisation and automation of the chromatography also 
significantly decreases the amount of sample needed to evaluate yeast fermentations, 
requiring low millilitre quantities.  Successfully eliminating the chromatographic 
purification as a bottleneck affords the possibility of scaling down the fermentation 
and cell disruption steps, thereby enabling whole microscale process development 
strategies.  The scale-down of the cell disruption step is discussed in Chapter 7. 
 
 
 
 
Table 6.3. Comparison of the experimental throughput, labour, and resources 
required for the microscale and laboratory-scale chromatographic purifications. 
   
Microscale  
 
 
Laboratory Scale 
 
    
Throughput Run time (hr) 4.5 a 4.5 
 Systems 2 2 
 Data points/run 8 1 
 Overnight runs yes no 
 Runs/day/system 4 2 
    
 Throughput / 24hr 
(single replicate) 
64 4 
    
 Throughput / 24hr 
(two replicates) 
32 2 
    
Labour Column packing/day 0b 2c 
 Manual operation/day 4 4 
    
 Total Labour (hr) 4 6 
    
Material/ Sample (mL) <1  200 
Purification CEX Adsorbent (mL) 0.16d 80 
 CHT (mL) 0.04 30 
 Buffers (mL) <100  2000-3000 
    
a)  One total microscale run includes two CEX purifications and one CHT purification. 
b) Micro-tip column preparation is outsourced to PhyNexus. 
c)  The CEX column was re-used but the CHT column was not. 
d) Two CEX columns X 0.08 mL = 0.16 mL. 
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7. A CELL DISRUPTION METHOD FOR INTEGRATED MICROSCALE  
    BIOPROCESSING 
7.1. Introduction 
Recombinant proteins that are not secreted extracellulary require a cell disruption 
method for their release and subsequent purification.  For the VLP purification 
described in Chapter 6, the cell disruption method (microfluidizer) used at the 
laboratory scale is relatively low throughput and requires tens to hundreds of 
millilitres of cell slurry.  A small-scale disruption method for Saccharomyces 
cerevisiae was therefore needed to fully realise the throughput and low-volume 
benefits of the micro scale-down process.  However, developing a microscale 
disruption method for yeast is challenging because of its mechanically rigid cell wall.   
 
In this chapter, the use of a newly developed technology known as Adaptive Focused 
Acoustics (AFA; Laugharn and Garrison, 2004) is examined to enable a reduction in 
scale into the low millilitres to hundreds of microlitres range while matching the 
contaminant profile of homogenisation, with the goal being to assess the suitability 
of the method as an element of a microscale process.  AFA operates by delivering 
highly focused, computer-controlled acoustic radiation at frequencies significantly 
higher than those used in conventional ultrasonication.   In this study, key instrument 
parameters and operating conditions were optimised for yeast cell disruption with the 
aid of design-of-experiment (DoE) methodologies.   The addition of a yeast lytic 
enzyme was also examined to decrease treatment times and further improve the 
comparability to the laboratory-scale homogenate.  The effectiveness of the AFA 
technique was evaluated by total protein release, product-specific protein release, 
optical density, and light microscopy.  In addition, the micro-tip chromatographic 
purification described in Chapter 6 was used to assess the effect that the AFA cell 
disruption has on the downstream chromatography, since the chromatography is 
known to be sensitive to upstream changes, including those from aggregation and 
changes in VLP morphology.   
 
7.2. The Yeast Cell Wall 
Saccharomyces cerevisiae is commonly used as an expression system for the 
commercial production of non-glycosylated proteins.  It can be grown to high cell 
densities in chemically defined media, yields high levels of protein expression, is 
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scalable, and has no bacterial endotoxins (Hatti-Kaul and Mattiasson, 2003; 
Gerngross, 2004).  The yeast cell wall is a highly dynamic structure which serves to 
stabilise the cell against changes in osmotic potential, protect against physical stress, 
maintain cell shape, and limit permeability, especially of macromolecules (Klis et al., 
2006).  As shown in Figure 7.1, the cell wall of Saccharomyces cerevisiae is 
comprised of an inner layer of cross-linked glucan (β1,3 linkage with some β1,6 
branches) and chitin, with a thickness of 70-100 nm, and an outer layer of heavily 
glycosylated mannoproteins (Kollar et al., 1997; Klis et al., 2002; Lesage and 
Bussey, 2006).  However, the exact composition and mechanical properties of the 
cell wall will vary with growth conditions and genetic modifications (Firon et al., 
2004; Klis et al., 2006).   The three dimensional network of β1,3-glucan comprises 
about 30-55% of the cell wall mass (Klis et al., 2006) and provides much of its 
mechanical strength, shape, and elasticity.  Young's moduli of 112 + 6 MPa and 107 
+ 6 MPa have been determined for exponential and stationary phase yeast cells, 
respectively (Smith et al., 2000).  At least 20 different glycoproteins are present in 
the external mannoprotein layer of the cell, comprising 30-50% of the wall mass.  
One potential function of this glycoprotein layer is to protect the inner glycan layer 
from enzymatic attack.   
 
 
7.3. Small-Scale Disruption of Yeast Cells 
Yeast cell lysis requires a method that can disrupt the highly rigid cell wall.  A 
summary of some commonly employed laboratory-scale methods is provided in 
Table 7.1, using either mechanical or non-mechanical mechanisms.  While 
mechanical methods such as high-pressure homogenisation or glass-bead mills are 
most often used at the laboratory and industrial scales (Follows et al., 1971; Kula and 
Schutte, 1987; Hopkins, 1991; Garcia, 1999; Hatti-Kaul and Mattiasson, 2003), these 
methods generally require tens to hundreds of millilitres at a minimum.  Volumes 
less than ten millilitres are generally not practical.  
 
Glass beads have been used for processing microlitre volumes in high throughput 
purifications, often in combination with a lysis buffer containing Triton X-100 (Holz 
et al., 2003; Prinz et al., 2004).  In these experiments, the cells are vortexed with 
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Figure 7.1.  Architecture of the yeast cell wall.  Chains of β-1,3-linked glucose 
residues are connected with β-1,6 branching to form a glucan backbone which 
provides much of the mechanical rigidity of the cell wall.  Chitin, β-1,6 glucan, and 
mannoproteins are anchored to this glucan layer.  The outer layer is comprised of 
heavily glycosylated mannoproteins, which provides protection against degradation 
of the glucan layer by enzymes.   
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Table 7.1.  Overview of laboratory-scale methods for yeast cell disruption. 
 
Method 
 
Principle 
 
Scale 
 
Advantages 
 
Disadvantages 
  μL mL L   
Mechanical       
High-pressure 
homogenisation 
Fluid shear from valve unit and cavitation 
in impingement zone 
 √ √ Efficient and effective for yeast; Scale-
able to production scale 
Requires 10's of millilitre volumes; 
Usually requires multiple passes 
       
Glass beads (batch) 
+ Vortex 
Solid-shear from glass beads 
 
√ √  Efficient and effective for yeast; Scale-
able to production scale (bead mill) 
Harsh conditions (product damage); 
Can be difficult to control and 
optimise 
       
Ultrasonication  
(> 20 kHz) 
Liquid shear from cavitation 
 
√ √  Works well at microlitre volumes; 
Independent of cell concentration 
Inefficient and often incomplete; 
Sample heating; Free radicals; May 
not be representative of 
homogenisation 
       
Non-Mechanical       
Chemical/Physical 
Treatment 
Permeabilisation by detergent (e.g. Triton 
X-100) or solvent (e.g. DMSO), often 
combined with physical method such as 
freeze/thaw or osmotic shock 
√ √  Works well at microlitre volumes; 
Solution-based lysis 
Permeabilisation or incomplete 
lysis -therefore, not representative 
of homogenisation  
       
Lytic Enzymes Enzymatic degradation of cell wall, with 
disruption of cell membrane using a 
chemical agent (e.g. Triton X-100) or 
with osmotic shock 
√ √  Works well at microlitre volumes; 
Simple; Solution-based lysis; Selective 
product recovery 
Permeabilisation or incomplete 
lysis - therefore, not representative 
of homogenisation; Proteolysis of 
product can be a concern; 
Expensive at larger scales 
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multiple on-off cycles.  Hummel and Kula (1989) used glass beads in combination 
with a mixer-mill device to disrupt bacteria and yeast cells.  Volumes as low as 100 
μL were disrupted, with eight samples treated in parallel.  A treatment time of six 
minutes was sufficient to release greater than 90% of the total protein for cell 
concentrations < 40%, therefore making it possible to disrupt about eighty samples 
per hour.  Kim et al. (2004) used glass beads within a microfluidic compact disc 
(CD) chamber, in which the yeast cells were disrupted by the forward and backward 
movement of the CD over the course of five to seven minutes.  The efficiency of this 
method was about 65% of the laboratory method.  In general, a critical disadvantage 
of glass-bead methods is that they can be difficult to control, thereby resulting in 
higher variability and potential damage to the product. 
 
Sonication has also been used for yeast cell disruption (James, et al., 1972; Ciccolini 
et al., 1997; Garcia, 1999; Agrawal and Pandit, 2003) but is often inefficient due to 
the rigidity of the yeast cell wall.  Long treatment times are typically required, which 
lead to sample heating and the accumulation of free radicals.  This, in turn, can result 
in damage to the protein product.  Furthermore, non-uniformity in the distribution of 
energy resulting from interference and scattering in small treatment vessels and from 
the complex nature of the sample can diminish the effectiveness of cell disruption 
and lead to poor reproducibility.   
 
Non-mechanical approaches to yeast cell disruption involve the use of physical 
methods, chemical agents, and/or lytic enzymes.  A chemical procedure using 0.05% 
Triton X-100 or 40% DMSO in combination with a freeze-thaw step was 
demonstrated by Miozzari and co-researchers (1978) for the permeabilisation of 
Saccharomyces cerevisiae.  However, the most effective non-mechanical methods 
typically use a lytic enzyme (Hunter and Asenjo, 1988; Asenjo and Andrews, 1990; 
Garcia, 1999; Salazar and Asenjo, 2007), either alone or in combination with 
osmotic shock or a chemical agent.  An enzyme cocktail comprised of a cell wall 
lytic protease, acting on the mannoprotein layer, and a β-1,3 glucanase, acting on the 
glucan layer, is often used for Saccharomyces cerevisiae.  Other enzymes such as a 
β-1,6 glucanase, mannanase, or chitinase may also be beneficial.  One disadvantage 
of enzymatic techniques is that proteolysis of the product can occur from 
contaminants in the enzyme reagents and/or from intracellular proteases when the 
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cell breakage is not sufficiently fast (Salazar and Asenjo, 2007).  An advantage of 
enzymatic techniques, though, is that they can provide for differential or selective 
product release with only a fraction of the contaminating proteins (Huang et al., 
1991; Asenjo et al., 1993).  Yet, this is not necessarily desirable if the goal is to have 
a feedstock for downstream chromatography that is representative of the laboratory-
scale homogenate with respect to both product and contaminant profile, as was the 
case in this thesis for the VLP purification to evaluate fermentation changes. 
   
 
7.4. Adaptive Focused Acoustics 
Adaptive Focused Acoustics (AFA; Laugharn and Garrison, 2004) offers an 
alternative to the small-scale cell disruption methods discussed above.  It is an 
acoustic process similar to ultrasonication, with the primary difference being that it is 
operated at significantly higher frequencies, ranging from about 100 kHz to 100 
MHz (Fig. 7.2).  This provides several key advantages.  First, working in this higher 
frequency range allows the delivery of highly focused acoustic radiation for more 
efficient disruption.  The AFA instrument (Covaris E210; Woburn, MA, USA) used 
in this work has a focal zone that is ellipsoidal shaped, with a diameter of 
approximately 2 mm and a length of approximately 7 mm.  This small focal zone 
allows the method to be scaled to low-millilitre-to-microlitre vessel sizes.  Second, 
the high-frequency acoustic energy is able to transverse through a liquid water bath 
and the sample vessel (glass or plastic), with no direct contact with a probe required.  
As a result, the procedure is entirely non-contact, with sealed tubes placed into a de-
gassed water bath above the acoustic transducer of the instrument.  Third, the 
interference and scattering of the acoustic energy field that is commonly associated 
with ultrasonication is minimised in AFA because the operating wavelengths are in 
the millimetre-to-micron range, similar to the pathlength through the treatment 
vessel.  This reduces sample heating and improves the overall efficiency of 
disruption.  Another advantage of AFA process is that it is computer-controlled, 
facilitating walk-away automation and improving reproducibility. 
 
The operating principle of AFA for the disruption of cells is similar to that of 
conventional sonication (Davies, 1959; Clarke and Hill, 1970; Doulah, 1977), with 
the key difference being the higher operating frequency.  Pressure waves generated 
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Figure 7.2.   Frequency range of the Adaptive Focused Acoustics (AFA) device 
from Covaris (Woburn, MA, USA).  The ranges for conventional sonicators and 
diagnostic imaging devices are shown for comparison.  The instrument is typically 
operated in the megahertz range (similar to diagnostic imaging techniques), which 
results in shorter wavelengths* and therefore enables the process to be scaled down 
to lower sample volumes. 
 
*   Relationship of wavelength and frequency:    λ = c/f, 
where λ is the wavelength (m) of the ultrasound wave, f is the frequency (Hz), and c is the velocity of the 
sound wave (~1500 m/s in distilled water at 25 °C).  The energy imparted to the fluid (intensity) is proportional 
to the pressure amplitude of the sound wave.         
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from the acoustic vibrations lead to non-linear sub-micron bubble growth.  When the 
energy dissipates, these cavitation bubbles then collapse, resulting in elastic waves 
that generate intense local shear gradients and eddying.  Because millions of 
cavitation events are created in very short intervals of time (microseconds), the 
disruption power can be quite significant and ultimately will lead to cell rupture.  In 
this way, the cells are disrupted mechanically, essentially with high velocity jets of 
solute.  Parameters affecting sonication efficiency include temperature, the amplitude 
of the sound wave vibrations, sample volume and viscosity, cell concentration, and 
vessel properties (Hopkins, 1991; Garcia, 1999; Hatti-Kaul and Mattiasson, 2003). 
 
7.4.1. Experimental Details 
Recombinant human papillomavirus (HPV) virus-like particles (VLPs) were cloned 
and expressed in Saccharomyces cerevisiae as described in Chapter 2.  Fermentation 
product was provided frozen for purification as a centrifuged cell pellet.  Twenty 
percent (wet cell weight/volume) cell suspensions buffered at pH 7.2 were lysed at 
the laboratory scale using a Microfluidizer model 110 Y from Microfluidics 
International Corporation (Newton, MA, USA), as described in Chapter 2.  
 
Cell disruption experiments by AFA were performed with a Covaris E210 instrument 
(Fig. 7.3).  A list of instrument parameters and their operating ranges is provided in 
Table 7.2.  Each experiment was performed with 1.5 mL of cell suspension (buffered 
at pH 7.2) ranging from 10 to 20% (wet cell weight/volume) in capped 16 x 100 mm 
(diameter x height) borosilicate glass tubes supplied by Covaris.  A 3 x 4 rack 
containing the sample tubes was placed into the de-gassed water bath of the 
instrument maintained at 8 + 4° C in which the acoustic transducer was also 
submerged (Fig. 7.3B).  The disruption experiments were carried out serially, with 
each tube sequentially moved over the transducer.  The ellipsoidal-shaped focal zone 
(diameter of ~2 mm and an axial length of ~7 mm) is focused to a geometric point 
approximately 70 mm from the face of the transducer.  Acoustic power delivered to 
the sample vessel is monitored by an RF power meter, which measures the electrical 
power that the RF amplifier supplies to the transducer.   The instrument can be 
operated in one of three modes to optimise the mechanical reflux and ensure the 
precise transfer of ultrasonic energy (refer to section 7.5.3 for a discussion of these 
modalities).  
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 A 
 
 
 
 
 
 
 
 
 
B 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.3. The Covaris E210 instrument (Woburn, MA, USA) for 
Adaptive Focused Acoustics: (A) Photograph of the Covaris E210; and (B) 
Schematic showing the instrument configuration.  Acoustic energy radiates 
from a dish-shaped transducer that converges on a small focal zone, 
enabling a high degree of control without directly contacting the sample.  
Figures are adapted from Covaris, Inc. (www.covarisinc.com). 
Borosilicate 
Glass Tube
1.5 mL Sample
Volume
70 mm
2 mm diameter X 
7 mm axial length
Water
Bath
Heat exchanger
(stainless steel tubing)
Transducer
(black tray)
De-gasser 
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Table 7.2.  Instrument parameters for the Covaris E210 (Adaptive Focused Acoustics) 
    
Parameter Definition Operating Range Range Evaluated 
    
 
Vessel Type/Rack 
Configuration 
 
Vessel (tube) type and rack used for 
AFA treatment 
 
 
 
 
Racksa exist for glass and plastic tubes of 
varying size, 96-well microtitre plates, 
and microcentrifuge tubes 
 
6 X 4 rack for 13 x 65 mm (d x h) 
borosilicate glass tubes 
3 X 4 rack for 16 x 100 mm (d x h) 
borosilicate glass tubes 
 
Duty cycle (dc) Percent of time that the transducer is 
generating acoustic waves (on-off 
cycle) 
 
0.1 - 20%  
(0.1, 0.5, 1, 2, 5, 10, and 20%) 
5, 10, and 20% 
Intensity Proportional to the amplitude of the 
pressure wave 
 
5 – 500 mVb 
 
25 -500 mV 
Cycles per burst 
(cpb) 
Number of waveforms created by the 
transducer in an "on" cycle 
 
50 – 1000 
(50, 100, 200, 500, and 1000) 
50 - 1000 
Dithering The controlled horizontal movement of 
the treatment vessel around a centre 
point for sample mixing 
 
Vary radius (in mm) and rate (in rpm) of 
the circular motion and dwell time (s) 
between motions 
Not evaluated 
(All settings at 0) 
Mode of Operation  Modality for delivering acoustic 
energy (frequency tuning) 
Vertical sweeping, frequency sweeping, 
power tracking 
Vertical sweeping, frequency sweeping, 
power tracking 
    
a) Number of vessels per rack depends on the specific configuration. 
b) In more recent versions of the software, intensity is expressed as a scale from 0.1 to 10.
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Cellular debris was separated from the lysate by batch microcentrifugation (1.5 
mL/microcentrifuge tube) at 10,000 x g for 5 minutes using an Eppendorf (North 
America; Westbury, NY, USA) 5417R microcentrifuge.  One millilitre of this 
supernatant was then aspirated for subsequent analysis or purification by micro-tip 
chromatography.  The micro-tip chromatographic purification was performed as 
described in Chapter 6.  Analyses of the lysate and purification samples were carried 
out by the methods described in Chapter 2.  These included the measurement of total 
protein release by the BCA assay, product release by either RP-HPLC or 
immunoassay, optical density at 660 nm, light microscopy, and SDS-PAGE. 
 
7.4.2. Characterisation of Instrument Parameters 
The overall intent of this work was to demonstrate the application of AFA as a 
suitable method for small-scale yeast cell disruption and additionally to define 
conditions that produce lysate that is representative of the laboratory-scale 
homogenate for downstream chromatographic study.   However, before optimising 
toward these goals, several key AFA instrument parameters were first characterised 
in order to understand their effect on the delivery of acoustic power and on changes 
in sample temperature.  The acoustic power delivered to the sample vessel during 
cell disruption was monitored as a function of two instrument settings, duty cycle 
(dc; percentage of time that the transducer is generating acoustic waves) and 
intensity (proportional to the amplitude of the pressure wave).  Refer to Table 7.2 for 
a detailed description of the instrument parameters.  One and a half millilitres of a 
12% (w/v) cell suspension were used in this study since this volume and 
concentration are suitable for both microscale cell disruption and subsequent 
downstream micro-tip chromatography.  Duty cycle was varied at 5, 10 or 20%, 
while the intensity was examined over a range from 25 to 500 mV.  The cycles-per-
burst (cpb) setting was held constant at 50 in these experiments, and the instrument 
was operated in the power tracking modality. The impact of duty cycle and intensity 
on acoustic power is shown in Figure 7.4A.  The effect of duty cycle is generally 
linear, whereas that of intensity is nonlinear across the range examined.  The 
maximum power input into this system approaches 120 W and is achieved at the 
maximum instrument settings of 20% dc and 500 mV.   
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Figure 7.4. Characterisation of instrument parameters in the disruption of yeast cells 
by Adaptive Focused Acoustics (Covaris E210). 1.5-mL cell suspensions at 12% 
(w/v) were used in these experiments.  (A) Acoustic power as a function of intensity 
at duty cycles of 5, 10, and 20% (power tracking modality).  (B) Change in 
temperature (ΔT = T-T0) over time at duty cycles of 5, 10, and 20% (power tracking 
modality; intensity of 500 mV; 50 cbp).  The starting temperature is 8 + 4 °C.  The 
dotted lines represent the mean temperature change of the last three timepoints (120, 
300, and 600 sec) at each duty cycle.   
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The material type (glass or plastic), thickness, and size of the sample vessel can 
affect the transfer of acoustic power.  Borosilicate glass tubes were used in these 
experiments to ensure the most efficient energy transfer.  The geometry of the 
sample vessel can also affect the cell disruption by impacting the mechanical reflux.  
In this investigation, two tube diameters were examined, 13 and 16 mm.  While both 
were equally effective for use in yeast cell disruption, the 13-mm tube was prone to 
breaking on occasion, especially at high acoustic power.  This is presumably because 
its diameter is closer to the size of the focal zone, thereby putting more stress on the 
tube.  Consequently, 16-mm tubes were used for all subsequent experiments. 
 
Sonication methods often lead to sample heating during cell disruption.  However, 
because AFA operates at significantly shorter wavelengths, there should be less 
interference and scattering of the acoustic energy field in microscale sample vessels 
(low-millilitre-to-microlitre volumes).  This reduces the potential for sample heating.    
To evaluate the thermal stability of the system, the temperature change of the 1.5-mL 
12% cell suspension was measured as a function of time (30 – 600 s) at 5, 10, and 
20% dc (intensity of 500 mV and cpb of 50).  In these experiments, the samples were 
first allowed to equilibrate in the water bath of the instrument maintained at 8 + 4 °C 
and then temperature measurements were made immediately before and after AFA 
treatment using a Fisher Scientific (Pittsburgh, PA, USA) traceable double 
thermometer.  At least two experiments were carried out for each timepoint.     
 
The change in temperature at each treatment time is shown in Figure 7.4B.  The 
increase in temperature is highest at a 20% dc, consistent with a higher input of 
acoustic power.  Most of the temperature increase occurs in the initial minute of 
lysis, with little additional change thereafter.  As observed from Figure 7.4B, the 
average temperature increase (mean of the 120, 300, and 600-sec timepoints) is 4.6 
°C at 5% dc, 6.2 °C at 10% dc, and 8.1 °C at 20% dc, all of which is below the 20-25 
°C increase observed for homogenisation.  This relatively modest increase in 
temperature minimises the risk of thermal damage to biological samples.   
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7.5. Optimisation of AFA for Yeast Cell Disruption 
Although power is an important parameter in optimising cell breakage, higher power 
is not necessarily optimal.  For example, the mechanical reflux of the sample must be 
optimised so that as much of the sample as possible remains in contact with the focal 
zone and does not move up the sides of the tube.  Furthermore, conditions for 
maximal cell breakage must be balanced with product stability.  Therefore, design-
of-experiment (DoE) approaches were used to empirically optimise the yeast cell 
disruption by AFA for the various operating conditions.  Initially, a fractional 
factorial was used to rapidly screen five operating parameters to determine which 
have the most significant effect on yeast cell disruption.  A limitation of a fractional 
factorial, however, is that parameter interactions cannot be estimated.  These were 
examined in a subsequent response-surface analysis, with product stability then 
evaluated under these optimised conditions. 
 
7.5.1. Fractional Factorial to Identify Critical Operating Parameters 
The three primary instrument parameters of duty cycle, intensity, and cycles-per-
burst were examined.  While duty cycle and intensity directly contribute to acoustic 
power and, hence, the mechanical reflux of the cell lysis, cycles-per-burst is 
optimised empirically for different sample viscosities on the basis of cavitation and 
mixing.  In this investigation, duty cycle was varied at 5 or 20%, the intensity at 250 
or 500 mV, and the cycles per burst at 50 or 500.  In addition, the cell concentration 
was varied at 10% or 20% and the time, at 60 or 300 sec.  Sample volume was held 
constant in this evaluation at a quantity that is sufficient for the downstream 
microscale purification (1.5 mL), but is another variable for consideration if larger 
volumes are required (Feliu et al., 1998).   
 
The extent of cell disruption was quantified by the total soluble protein released 
during cell disruption.  Parameters significant to cell disruption were identified by 
evaluation of a half-normal probability plot.  The % contribution of each parameter 
as shown in Table 7.3 was then calculated from the partial (Type III) sum of squares 
for each individual term divided by the total sum of squares for all terms.  The % 
contribution was used here as a measure of parameter significance since the degrees 
of freedom is the same for all terms.  Treatment time, duty cycle, and intensity each 
have a significant effect on cell disruption, consistent with an increase in acoustic 
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power and time, as described above.   An increase in the disruption of microbial cells 
and protein release kinetics with increasing acoustic power has been demonstrated 
previously for ultrasonication (James et al., 1972; Feliu et al., 1998; Kapucu et al., 
2000).  The effects of the cycles-per-burst and cell concentration factors are 
negligible.     
 
Table 7.3.  Two-level fractional factorial to screen parameters affecting cell 
disruption by Adaptive Focused Acoustics. 
Factor Duty Cycle b Intensity c Cycles/burst d Time Cell Density e 
% Contribution a 28.8 35.9 0.8 34.0 0.5 
a) The % contribution is calculated from the partial (Type III) sum of squares for each individual term divided by the        
     total sum of squares for all terms.  The degrees of freedom is the same for all terms.  
b)  Duty cycle is defined as the percentage of time that the transducer is creating acoustic waves (5, 20%). 
c)  Intensity is proportional to the amplitude of the pressure wave generated by the AFA transducer (250, 500 mV).   
d)  Cycles per burst are the number of waveforms generated by the transducer in a burst (50, 500).  
e)  Cell density was varied at 10 and 20% (wet cell weight per volume).   
 
 
7.5.2. Response Surface for the Optimisation of AFA Operating Conditions 
A central composite response surface design was subsequently carried out to define 
the empirical optimum for yeast cell disruption by adjusting duty cycle, intensity, 
and time.  In this study, the time was varied over five levels: plus and minus the axial 
points (4, 386 s), plus and minus the factorial points (60, 330 s), and the midpoint 
(195 s).  The intensity was varied at four levels instead of five because the upper 
instrument limit was exceeded for the higher axial point: plus and minus the axial 
points (100, 500 mV), plus and minus the factorial points (250, 500 s), and the 
midpoint (400 s).  The midpoint (195 s, 400 mV) was replicated five times, while all 
other points were carried out once.  In addition, the response surface design was 
repeated over two levels of duty cycle (categorical factor), 10 and 20%.   The 
amounts of total soluble protein (measured by the BCA assay) and product (HPV L1 
protein measured by RP-HPLC) released under each of these conditions were 
analysed to quantify the extent of cell disruption.  All data were normalised to 
disruption by the homogeniser.  The response surface was best fit with a two-factor 
interaction model.    
 
Under the conditions examined here, a duty cycle of 20% outperformed that of 10%.   
The response map showing the release of soluble protein and product (HPV) as a 
function of time and intensity at a duty cycle of 20% is given in Figure 7.5.  To guide 
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subsequent optimisation experiments, the results were extrapolated to identify 
treatment times where the AFA disruption method is representative of 
homogenisation.  This model predicts that a treatment time of about ten minutes is 
required at an acoustic power >100 W (maximum instrument settings of 20% dc and 
500 mV intensity) to achieve total protein and product release that are comparable to 
that of homogenisation.   
 
7.5.3.Evaluation of Instrument Operating Modality 
 In addition to the parameters evaluated in the response surface, the operating 
modality of the instrument was examined for its impact on cell breakage.  Three 
modalities are available for the purpose of maximising the efficiency of the 
ultrasonic energy transfer and, hence, the mechanical reflux.  In the first modality, 
known as vertical sweeping, the treatment vessel is mechanically moved up and 
down very slightly to vary the position of the focal zone (in this study, by 0.5 mm at 
10 cycles per minute).  In the second modality, referred to as frequency sweeping, 
the transducer electronically sweeps through a range of acoustic frequencies, thereby 
altering the position of the focal zone.  This is the default modality for many 
biological applications.  Finally, in the third modality, called power tracking, the 
instrument optimises the operating frequency using an electrical feedback loop to 
deliver peak power to the sample vessel.  The impact of these three operating 
modalities on yeast cell disruption is shown in Figure 7.6.  Here, soluble total protein 
release (measured by the BCA assay) is shown as a function of time.  Also compared 
in this figure is the VLP release (measured by immunoassay) for vertical sweeping 
and power tracking.   The choice of instrument modality has only a minor effect on 
cell disruption at these optimised instrument settings, with power tracking offering a 
slight advantage.  In general, about 8-10 minutes is required for soluble protein 
release that is equivalent to that of homogenisation, with the trend suggesting that 
additional protein release may occur beyond ten minutes.  The extent of VLP release  
appears to level off at about 80% of that obtained from homogenisation in this same 
time interval, although the product recovery through the microscale chromatographic 
purification is closer to 90%, as discussed below (Figure 7.7D). 
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Figure 7.5. Response surface contour plots of yeast cell disruption by Adaptive Focused Acoustics (central composite design, fit with a two-
factor interaction model): (A) total soluble protein (measured by the BCA assay) and (B) product release (HPV L1 protein measured by RP-
HPLC) as a function of treatment time and acoustic power at a duty cycle of 20% (1.5 mL of a 12% w/v cell suspension).  Each contour line 
represents the iso-response (z-value) of the fraction of cell disruption normalised to disruption by homogenisation.   The curvature of the lines 
indicates that there is a parameter interaction.  These data reveal that the system output power should be maximised (20% duty cycle and 500 mV 
intensity) to achieve levels of cell disruption comparable to the homogeniser in a reasonable treatment time.    
    
 
 - 224 -
  
 
 
 
Figure 7.6.  Effect of the AFA operating modality on total soluble protein release:  
vertical sweeping (○), frequency sweeping (Δ), and power tracking (□).  A 1.5-mL 
cell suspension (12% w/v) was disrupted at an intensity of 500 mV and a duty cycle 
of 20%.  Also shown is the HPV VLP release (measured by immunoassay) for 
vertical sweeping (●) and power tracking (■).  All results are normalised to cell 
disruption by homogenisation.  
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7.5.4. Addition of a Lytic Enzyme to Improve AFA Cell Disruption Efficiency 
The addition of a lytic enzyme, β1,3-glucanase (acting on the β1,3-glucan layer of 
the yeast cell wall), was examined in combination with the optimised AFA operating  
conditions for its ability to reduce exposure time and improve the comparability of 
the AFA method to homogenisation.  In these experiments, cells were treated with 
one unit of β1,3-glucanase per mg (wet cell weight) for 2 hr (with end-over-end 
rotation) at 18-22 °C prior to disruption by AFA.  Timecourse studies of varying 
AFA treatment time over a range of 30 to 600 s were then carried out with enzyme-
treated and untreated cells. 
 
The effect of the enzyme pre-treatment was assessed by measuring the release of 
soluble protein (BCA assay) and VLPs (immunoassay), monitoring the turbidity of 
the clarified lysate (OD 600nm), and determining the recovery of VLPs through the 
micro-tip chromatographic purification described in Chapter 6.  These results are 
shown in Figure 7.7 plotted against AFA exposure time.  Although pre-treatment 
with enzyme is not absolutely required given a sufficient AFA exposure time, 
enzymatic pre-treatment does significantly improve the overall efficiency.  The 
soluble protein concentration is equivalent to or exceeds that for homogenisation 
after only one minute (Fig. 7.7A), and equivalent VLP release is achieved in 2-3 
minutes (Fig. 7.7B).  The longer time required for product release is presumably 
because VLP assembly occurs in the nucleus (Rose et al., 1993; Wang et al., 2003) 
and therefore requires additional time for the disruption of the nuclear envelope.  The 
turbidity of the clarified lysate from the microscale disruption does not quite achieve 
that of homogenisation, even with enzyme present (Fig. 7.7C).  These results most 
likely derive from the differences in the lysis mechanism between the two methods, 
with more cell membrane disruption occurring in the homogeniser, which is also 
reflected in the light microscopy differences discussed below (Fig. 7.8).  
 
For the yeast strain and growth conditions used here for VLP production, no lytic 
protease was required.  The β1,3-glucanase alone was sufficient to decrease exposure 
time and improve the efficiency of cell disruption.  This may not always be the case, 
however, since the yeast cell wall architecture can vary with yeast strain and growth 
conditions (Firon et al., 2004; Klis et al., 2006).  For example, the composition of the 
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Figure 7.7. Timecourse of cell disruption 
by Adaptive Focused Acoustics with (▼) 
and without (•) β1,3-glucanase pre-
treatment.  (A) Total soluble protein 
release (BCA assay); (B) release of HPV 
VLPs (immunoassay); (C) turbidity 
(OD600 nm) of the clarified lysate; (D) 
final product recovery through the two-
step micro-tip chromatographic 
purification.  All data are normalised to 
that obtained by homogenisation.   
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outer layer may be such that it hinders the accessibility of the β1,3-glucanase to the 
inner glucan layer, thereby requiring the use of a lytic protease or mannanase.   In 
some cases, β1,6-glucanase or chitinase may also be required.  One potential 
alternative to a lytic protease is to use β-mercaptoethanol (Salazar and Asenjo, 
2007), which reduces the disulfide bridges that bind mannoproteins and thereby 
improves the accessibility of β1,3-glucanase to the glucan layer. One drawback of 
using an enzymatic pre-treatment is the risk of product degradation, such as 
proteolysis from residual protease activity in the enzyme mixture.  Consequently, 
when selecting a lytic enzyme, it is critical to establish that it causes no 
modifications to the product. 
 
7.5.5. VLP Stability During AFA Cell Disruption 
The stability of the HPV VLPs during AFA cell disruption was monitored by the 
immunoassay for VLPs (refer to Chapter 2), which is specific for a conformational 
epitope.  In this experiment, purified VLPs were spiked into a cell slurry solution and 
their recovery determined by immunoassay following AFA treatment for ten 
minutes.  This result was compared to a control in which the purified VLPs were 
spiked into the lysate after cell disruption (to determine the analytical spike recovery 
in the crude cell lysate).  As shown in Table 7.4, the spike recovery of the sample 
undergoing AFA treatment is identical to that of the control, indicating that the VLPs 
are not significantly affected under these conditions.   
 
Table 7.4. Recovery of purified VLPs spiked into the yeast cell 
suspension prior to disruption and also into the yeast lysate after 
disruption (control) to assess product stability during AFA disruption 
(exposure time of ten minutes).  The VLP concentration was measured by 
the immunoassay described in Chapter 2.  
Sample Measured Concentration 
(μg/mL) 
% Recovery 
Spike Concentration 447 ------- 
Spiked prior to disruption 383 86 
Spiked after disruption 
(control) 
385 86 
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A second measure of stability is drawn from the analysis of the chromatographically 
purified VLPs from the AFA lysate and the homogenate, as described in section 7.6 
below.  No additional protein degradation is observed by SDS-PAGE relative to 
homogenisation, even in the presence of the lytic enzyme (Figs. 7.9B and 7.9C).  
However, this enzyme addition may be less suitable for other product types, 
particularly for those containing carbohydrates.  It should also be noted that HPV 
VLPs demonstrate relatively good thermostability (Shank-Retzlaff et al., 2006). 
 
7.5.6. Evaluation of Cell Disruption by Light Microscopy 
Oil-immersion light microscopy was carried out to visually assess the nature of cell 
breakage.  Figure 7.8 shows images of the initial cell slurry and the lysates following 
homogenisation and AFA lysis.  Cell disruption is clearly evident in all three lysate 
samples, although some qualitative differences are observed.  The lysate from the 
homogeniser shows extensive fragmentation of cells, with large particles of 
aggregated cellular debris visible.  In general, fewer cell ghosts are observed in the 
homogenate than in the lysate from the AFA disruption, in which cell ghosts and 
large membrane fragments are more evident.  Of the two AFA lysates, the cell 
breakage appears to be more extensive for the enzymatically treated cells, consistent 
with the observations in Figure 7.7. 
 
 
7.6. AFA Cell Disruption as a Component of a Fully Microscale Purification 
The final developed AFA method for yeast cell disruption involves operating the 
instrument at 20% dc, 500 mV intensity and 50 cpb, and using the power tracking 
modality, although the choice of modality is less critical.  Cell concentration is also 
less critical and may be varied, at least between the range of 10 and 20% (w/v) that 
was examined here.  Treatment time will depend on whether or not the cells are pre-
treated with a lytic enzyme and may also vary with sample volume (not examined in 
this study).  Without a lytic enzyme, AFA treatment times of > 7 minutes are 
generally required.  With a lytic enzyme pre-treatment, these times are reduced to 
about 3 minutes, and the overall comparability of the AFA disruptate to the 
laboratory-scale homogenate is improved because of a greater degree of cell 
disruption. 
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Figure 7.8. Light microscopy of yeast cells before and after cell disruption: (A) 
initial cell slurry; (B) after homogenisation; (C) after AFA cell disruption (treatment 
time of 10 min); (D) after β1,3-glucanase pre-treatment and AFA cell disruption 
(treatment time of 7 min).   
  
 
 
 
 
 
 
 
 
 
 
    
 
 - 230 -
7.6.1.Performance of the AFA Lysate Through the Chromatographic Purification 
Differences in cell breakage such as the ones observed above by light microscopy 
can potentially impact the debris clarification stage, as described by Clarkson et al. 
(1993).  Hence, the AFA method developed here will be less useful as a mimic of 
homogenisation for developmental experiments focusing on solid-liquid separations.  
However, by incorporating a small-scale batch centrifugation for solid debris 
removal, the technique is useful for providing representative feed material for 
chromatography experiments since the soluble protein contaminant profile of the 
clarified lysate is very similar to that from homogenisation, as evidenced by SDS-
PAGE (Fig. 7.9A).  
 
To demonstrate this point, the micro-tip chromatographic purification described in 
Chapter 6 was performed to assess whether the AFA cell disruption method 
impacted upon the downstream multi-step chromatography.  Overall, the microscale 
disruption exerted no significant effects on the downstream chromatography relative 
to the laboratory-scale homogenisation.  Recovery of VLPs through the microscale 
purification using AFA cell disruption is equivalent (< 10% difference) to 
homogenisation after three minutes of AFA treatment in combination with enzymatic 
pre-treatment (Fig. 7.7D).  Without enzymatic pre-treatment, the recovery is 
somewhat less but is 80% of that of the homogenisation after 7 minutes and about 
90% after ten minutes.  The robustness of the AFA disruption was further evaluated 
with three different fermentation pastes (Table 7.5).  In this assessment, the 
difference in chromatographic product recovery between the AFA method and 
homogenisation ranged from 0 to 13%, even though the AFA exposure time was 
only seven minutes and there was no enzyme pre-treatment.  Comparability should 
improve even further with the inclusion of the β1,3-glucanase pre-treatment step.  In 
addition to VLP recovery, product purity after each chromatographic step is 
comparable, as shown in Figures 7.9B and 7.9C.  Furthermore, the addition of the 
lytic enzyme does result in any additional proteolytic degradation.   
 
7.6.2. Sample Requirement, Experimental Throughput, and Labour Savings  
The AFA cell disruption supports a fully microscale purification in which to 
characterise the impact of fermentation changes on the downstream VLP purification 
and ultimately enables the subsequent scale-down of yeast fermentation experiments.  
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The amount of cell weight input (milligram quantities) required for the microscale 
purification is about 100-fold less than that needed for the standard laboratory-scale 
purification.  Because of this reduced sample requirement, the microscale 
purification enables fermentation timepoints to be evaluated in order to provide 
feedback throughout the fermentation process rather than for just a single end-point 
evaluation.  Consequently, parameters such as the harvest time window can be more 
rapidly and easily defined.  An example of this is shown in Figure 7.10, with the 
product recovery through the multi-step chromatography shown as a function of 
harvest time.  In this example fermentation, an induction phase is observed, followed 
by an optimal time for cell harvest at the penultimate timepoint, prior to an observed 
decline in productivity at the final timepoint. 
 
Table 7.5. Performance of the AFA cell lysate through the micro-tip 
chromatographic purification for three different fermentation pastes. The 
AFA cell disruption (7-min treatment time; without β1,3-glucanase addition) 
is compared to homogenisation with respect to final chromatographic 
product recovery.   
 Final Chromatographic Recovery  
(mg protein / cell weight input) 
Fermentation 
Paste 
 
AFA 
 
Homogenisation
 
% difference 
1 4.3 + 0.1 4.5 + 0.1 -4% 
2 3.4 + 0.6 3.4 + 0.2 0% 
3 5.4 + 0.4 6.2 + 0.4  -13% 
 
 
In addition to needing considerably less sample input, the AFA cell disruption 
improves the throughput and reduces the labour required of the fermentation-
feedback purification.  The projected throughput and labour costs are given in Table 
7.6 relative to the laboratory-scale cell disruption with the microfluidizer.  If a lytic 
enzyme is used, the throughput is increased by over four-fold while the labour is 
reduced in half.  This translates into greater than an eight-fold improvement in 
productivity, defined here as the number of pastes processed per hour of labour.  
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Figure 7.9.  SDS-PAGE (4-12% gel; reducing conditions; Sypro Ruby protein stain) of (A) the clarified yeast lysate following cell disruption 
and of the (B) cation exchange and (C) hydroxyapatite chromatographic products following the microscale purification. (A) Lane 1, molecular 
weight standard;  Lane 2, lysate from homogenisation; Lane 3, lysate from AFA method (no β1,3-glucanase pre-treatment). (B) and (C), Lane 
1, molecular weight standard;  Lane 2, chromatographic product from homogenisation; Lane 3, chromatographic product from AFA lysis; Lane 
4, chromatographic product from AFA lysis and β1,3-glucanase pre-treatment.  The HPV L1 protein migrates at ~ 55 kDa.  
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Figure 7.10. Final chromatographic recovery through the microscale VLP 
purification as a function of fermentation harvest time.  Recovery is expressed as the 
total protein recovered following the second column (CHT) per unit cell weight 
input, and harvest time is normalised to the final harvest time (harvest time / final 
harvest time).   (These units were selected to protect Merck intellectual property 
while retaining the scientific importance of the data.)  The five harvest timepoints 
prior to the final harvest time are fit with an empirical line of best fit (3-parameter 
logarithmic function): y = y0 + a ln(x-x0).      
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Table 7.6. Experimental throughput and labour of the AFA cell disruption method (+/- 
lytic enzyme) when used as a component of the microscale HPV VLP purification (for 
evaluating yeast fermentation conditions).  These calculations are shown relative to the 
laboratory-scale homogenisation. 
  
AFA Disruption 
- Lytic Enzyme 
 
 
AFA Disruption 
+ Lytic Enzyme 
 
 
Lab-Scale 
Disruption 
 
    
System Set-up / Clean-
up Time (hr) 
 
0.5 0.5 0.5 
Batch Size (number of 
pastes/run) 
 
12a 12a 1 
Run Time (hr) 
 
2.25b 0.85c 0.5 
Number Runs / 8-hr 
Day d 
 
2 4 12 
Cell Preparation Timee 
(hr) /8-hr Day  
 
1.5 1.5 1.5 
Pre-treatment Time (hr) 
/ 8-hr Day 
0 2.5 0 
    
Throughput (pastes 
processed / 8-hr day) 
24 48 12 
    
Total Labour (hr)f 2.5 3.5 8 
    
a) 3 X 4 configuration using the 16 X 100 mm borosilicate glass tubes 
b) 10-minute run time / paste + 15 min post-run sample handling 
c) 3-minute run time / paste + 15 min post-run sample handling 
d) Accounts for system and cell preparation times as well as run time  
e) Includes dilution, transfer to treatment vessel, enzyme addition (when applicable).  Excludes cell thawing 
time. 
f) Includes system set-up/clean-up, cell preparation, and post-run sample handling (15 min/run) times.  For 
laboratory-scale disruption, also includes run time.  
 
 
 
The VLP purification is typically a two-day process, with the cell disruption carried 
out on the first day, followed by an overnight incubation and subsequent 
centrifugation and chromatographic purification on the second day.  The throughput 
projected for the downstream chromatographic purification is about 32 pastes per 
day, when the chromatography is carried out in duplicate (Table 6.3).  By using the 
AFA cell disruption technique (in combination with enzyme pre-treatment), the cell 
disruption is no longer the bottleneck and is able to keep pace with throughput of the 
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downstream purification.  In this way, 32 pastes can be evaluated every two days.  
However, this calculation does not account for the time required for analysis, and 
often it is the analysis of these large experimental sets that can become a bottleneck. 
 
 
 
7.7. Summary 
Having low volume methods for yeast cell breakage that are capable of disrupting the 
rigid cell wall is critical to the miniaturisation of bioprocesses that use these 
expression systems.  Adaptive Focused Acoustics offers a small-scale technique for 
yeast cell disruption that is comparable to high pressure homogenisation with respect 
to soluble protein release and performance through the downstream chromatography.  
The addition of a lytic enzyme significantly decreases processing time and 
consequently increases throughput.  No adverse effects on the product (HPV VLPs) 
are observed under the exposure times required for yeast cell lysis by AFA. 
 
The AFA microscale cell disruption technique (Wenger et al., 2008) facilitates 
integrated microscale process development strategies for proteins produced 
intracellularly, alongside microscale techniques for fermentation (Micheletti and 
Lye, 2006), microfiltration (Jackson et al., 2006), centrifugation (Hutchinson et al., 
2006), and chromatography (Bensch et al., 2005; Wenger et al., 2007; Bergander et 
al., 2008; Coffman et al., 2008).  Interactions between upstream and downstream 
operations can be studied, and representative feed material for the downstream 
chromatography can be produced for high-throughput experiments.  Although a 
completely automated downstream purification sequence is not demonstrated in this 
thesis, a robotic interface on a new model of the Covaris AFA instrument (model 
E210R) makes integration with a liquid-handling workstation feasible, enabling not 
only a fully microscale process, but also a fully automated one.     
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8. CONCLUSIONS AND FUTURE DIRECTIONS 
8.1. Conclusions 
The next generation of bioprocess development depends on the seamless integration 
of microscale bioprocessing techniques into its routine workflow to cope with the 
many challenges facing it.  Automated microscale techniques allow bioprocess 
information to be obtained efficiently with microlitre sample volumes, thus reducing 
manual intervention, improving product understanding, and accelerating process 
development.  Because chromatography is usually an integral part of protein 
purification processes, the capacity to deploy microscale chromatography can make 
an important contribution towards the development of robust processes.  Micro-tip 
chromatography is therefore a key element to an integrated, high-throughput process 
development strategy.  In this thesis, the technique was demonstrated as a tool for 
adsorbent characterisation, as an integral component of a high-throughput workflow, 
and as a small-scale mimic of a laboratory-scale purification that evaluates the 
interactions between fermentation processes and the downstream chromatography.  
Acquiring such knowledge will become increasingly important as industry seeks to 
understand the consequence of how upstream process changes can affect the 
performance of downstream operations. 
 
8.1.1. Micro-Tip Chromatography as a Platform for Microscale Chromatography 
Micro-tip chromatography is operated with bi-directional (up, down) flow through a 
small bed height of packed adsorbent.  An important advantage of the micro-tip 
format over other microscale chromatographic techniques is that it provides a simple 
path to full walk-away automation, without the requirement to manipulate loose 
adsorbent slurries by mixing and filtration in the way that is required for other 
approaches such as micro-batch incubation.  As with traditional packed beds, 
dynamic flow of the mobile phase is employed through the micro-tip column, but 
without the multiple plates (separation stages) seen in a conventional 
chromatography column.  Consequently, both column residence time and contact 
time (total loading time) are key operational parameters that must be considered, and 
these in turn are a function of aspiration-dispense cycle number, sample volume, 
column size, and flow rate.  For the test IgG proteins used in this thesis, uptake onto 
micro-tip columns containing preparative porous cation-exchange adsorbents was 
found to be primarily a function of total resin-sample contact time and not the 
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column residence time.  It is postulated that this occurs because intra-particle mass 
transfer is rate limiting in the case of globular proteins such as immunoglobulin 
(Helfferich, 1965; Ruthven, 2000; Dziennik et al, 2003 and 2005), whereas film mass 
transfer is presumably rate determining for much larger viral particles which are 
excluded from the adsorbent pore volume.   
 
8.1.2. Adsorbent Characterisation by Micro-Tip Chromatography 
Obtaining fundamental knowledge about the equilibrium and mass transport 
properties of an adsorbent for a particular protein can assist in the development of a 
Quality by Design (QbD)-based approach to process characterisation and the late-
stage definition of manufacturing design space.  As shown in this thesis, micro-tip 
columns can be used to obtain thermodynamic and kinetic data, employing methods 
for performing equilibrium adsorption isotherms, finite-bath batch uptake 
experiments, and shallow-bed chromatography.   Finite-bath methods for adsorption 
isotherm and uptake experiments were used primarily in this thesis, with micro-tip 
results found to agree well with those obtained from micro-batch (static-mixing) 
methods.  This agreement was expected for the adsorption isotherm data since they 
are carried out at (or close to) equilibrium conditions.  In the case of the kinetic 
experiments, although the external mass transport conditions differ significantly 
between the formats, the similarity of the results can be attributed to the fact that 
intra-particle pore diffusion is the main rate limiting factor governing the adsorption 
of comparatively small proteins inside porous adsorbents.  Shallow-bed 
chromatography also appears to be a feasible approach for micro-tip 
chromatography, providing an alternative to finite-bath methods, although there is a 
constraint on the lower range of sample concentration that may be used.  Therefore, 
this approach was not pursued further in this thesis.  
 
Although a qualitative comparison of adsorption kinetics is useful for resin 
screening, ultimately a more quantitative measurement of column dynamic binding 
capacity (DBC) is required in order to define the productivity and process economics 
of the step.  Modelling DBC from microscale data can help to conserve limited 
materials and resources, and in this thesis, two data-driven models were evaluated.  
The goal here was not to predict the full shape of the breakthrough curve or elucidate 
the underlying mechanisms of mass transfer, but simply to predict column DBC10% 
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from micro-tip data sets.  The modelling approaches used in this thesis were selected 
because they are primarily data-driven and do not require complex mass transport 
models and mathematics.  Given the finding above that micro-tip batch uptake data is 
analogous to micro-batch adsorption when pore diffusion is rate limiting, the first 
model used an approach applied by Bergander et al. (2008) to micro-batch adsorption 
data, in which shrinking-core pore-diffusion behaviour was assumed.  The approach 
showed reasonable agreement between the predicted and experimental column data, 
with errors ranging from 5 to 29% across the 10-fold flow-rate range examined.  The 
second approach employed a simple staged-reaction model, analogous to that used 
by Chase (1984), but with the model parameters obtained instead from pre-
equilibrium adsorption isotherm data.  The predicted values of this approach showed 
very good agreement with the laboratory-scale experimental data, with all errors < 
12%.  However, one limitation of this approach is that it requires a column 
calibration experiment to be performed in order to relate micro-tip contact time to 
that of the column.     
 
8.1.3. Micro-Tip Chromatography Applied to High-Throughput Process  
          Development 
Micro-tip chromatography was demonstrated in this thesis as an element of high-
throughput process development for two different applications.  In the first, a 
microscale workflow was applied to the development of a mixed mode 
chromatography step in the purification of a monoclonal antibody from cell filtrate.  
Conditions were defined in days instead of weeks and with only milligram quantities 
of feed material.  More significantly, the examination of a wide operating space 
revealed conditions where the mixed mode chromatography might be used as an 
alternative to Protein A chromatography in order to reduce cost, clean with sodium 
hydroxide, and eliminate the low-pH elution step.  The batch microscale results were 
subsequently verified in the dynamic column mode using a 1-mL laboratory-scale 
column (a 100-fold scale-up), with the results in agreement in terms of yield, 
impurity clearance, and adsorbent capacity.   
 
In the second application, a two-step chromatographic purification of VLPs was 
miniaturised by 1000-fold with micro-tip columns.  This purification was used to 
inform upstream yeast fermentation development by examining the effect that 
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fermentation changes have upon the downstream chromatography.  As in the mixed-
mode chromatography example, the microscale purification was predictive of the 
laboratory-scale purification in terms of yield and purity, although an empirical 
correction factor was applied in this case to correct for a consistent offset in 
recovery.  This offset was shown to be due to the deliberately shortened loading 
times of the second tip chromatography step, serving as an example of the trade-off 
that sometimes needs to be made between experimental throughput and predictive 
performance.  The micro-tip chromatography increased the overall productivity of 
the purification (number of fermentation pastes purified per hour of labour) by > 12-
fold.   
 
8.1.4. Adaptive Focused Acoustics for Microscale Cell Disruption 
The miniaturisation of the VLP purification necessitated the need for a small-scale 
disruption method for yeast cells, with the goal being to provide representative feed 
material for the microscale chromatography.  This was achieved using a relatively 
new technology known as Adaptive Focused Acoustics.  With this method, the total 
soluble protein release was equivalent to that of laboratory-scale homogenisation, 
and cell disruption was evident by light microscopy.  The recovery of VLPs through 
a microscale chromatographic purification following AFA cell disruption differed by 
< 10% from that obtained using homogenisation, with equivalent product purity 
observed.  The addition of a yeast lytic enzyme prior to cell disruption reduced 
processing times by nearly three-fold and further improved the comparability of the 
lysate to that of the laboratory-scale homogenate.  In addition, unlike conventional 
sonication methods, sample heating was minimised (< 8 °C increase), even when 
using the maximum power settings required for yeast cell disruption.  The small-
scale disruption method improved the overall productivity of the microscale VLP 
purification by an additional factor of six or more, while reducing the amount of cell 
input by nearly 100-fold.  Together the microscale cell disruption and micro-tip 
techniques facilitate integrated microscale strategies and enable the scale-down of 
additional process steps including the fermentation.  
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8.2. Future Directions 
8.2.1. Future Directions in Micro-Tip Chromatography 
Within process development groups, there can be debate over which microwell 
chromatographic format to implement (micro-batch adsorption, micro-tip 
chromatography, or miniature columns).  Yet, these formats are not necessarily 
mutually exclusive and often can be employed in a complementary manner.  The 
batch methods (micro-batch adsorption and micro-tip chromatography) lend 
themselves well to high-throughput screening of adsorbents and mobile phase 
conditions, especially in early development.  While these batch methods also can 
potentially be validated for the prediction of specific aspects of large-scale operation, 
the mini-column format appears to provide the best opportunity for a validated scale-
down model, although it too has some important differences from laboratory-scale 
columns with respect to bed height and wall effects.  Even between the two batch 
methods, there are clear differences.  Micro-batch adsorption provides very high 
throughput, ease of use in a manual or semi-automated manner, and the lowest cost.  
Consequently, this format can be deployed easily across a wide number of end users, 
especially when there are no automation capabilities available.  On the other hand, 
micro-tip chromatography is much simpler to automate and, therefore, is better suited 
for automated laboratories wanting to achieve full walk-away automation.  
Moreover, it enables additional capabilities such as shallow-bed chromatography and 
potentially more predictive column lifetime experiments.   
 
Although in this thesis micro-tip experiments were performed with only eight micro-
tip columns at a time, the micro-tip format should be capable of performing 96 
parallel experiments in a single run.  To do so, though, requires the availability of 96-
channel arms that can accommodate 1-mL pipette tips, in order to maintain the 
operational flexibility of the format.  Currently, most conventional 96-channel liquid-
handling arms are made for 200-μL pipette tips.  However, recently some robotic 
manufacturers such as Hamilton Robotics (Reno, NV, USA) and Tecan have 
introduced 96-channel pipetting heads that can accommodate larger pipette tips (0.5-
1.0 mL pipetting volume), and other manufacturers are sure to follow.  This increases 
the throughput over an eight-channel micro-tip experiment by a factor of 12, and 
because the micro-tip format is fully automated and requires no resin manipulation, it 
potentially offers greater throughput than 96-well micro-batch adsorption.  
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Furthermore, an additional advantage of 96-channel liquid-handling arms over the 8-
channel Tecan arm used in this thesis is that they typically operate by positive 
displacement.  This means that no system liquid is required, thereby avoiding the 
chance of water dripping into the tip.  Furthermore, the delay times after pipetting 
may be reduced.  Developing 96-channel micro-tip methods is therefore an important 
area of future work for enhancing the throughput and robustness of the technique.   
 
8.2.2. Need for High-Throughput Assays and a Comprehensive Analytical Strategy 
The mainstream implementation of high-throughput microscale methods depends on 
a well-coordinated analytical strategy; otherwise, analytical resources risk being 
overwhelmed.  This analytical strategy must be capable of handling very high sample 
numbers and low-microlitre sample volumes.  Therefore, development and 
refinement of such a strategy is an important area for future contribution.   
 
A number of assays used in this thesis were automated on a Tecan workstation, 
including the host-cell protein ELISA, the BCA total protein assay, and the 
PicoGreen DNA assay.  This automation improved throughput and reduced labour.  
Yet, even with these high-throughput methods, analytical resources were still 
sometimes overwhelmed, especially if there was not careful planning and close 
collaboration with the analytical testing groups.  One way of alleviating this problem 
is to run the automated assays on the same robotic deck as that of the purification 
experiments, thereby eliminating the logistics of sample transfer.  Moreover, in 
addition to automated assays, new assay technologies, like the ForteBio (Menlo Park, 
CA, USA) Octet, provide a path to low-volume, parallel testing.  Microfluidic 
technologies (Ohno et al., 2008) also present opportunities for rapid, low-volume 
testing, with an example being the Caliper (Hopkinton, MA, USA) Labchip for 
protein electrophoresis.  These new technologies when combined with automated 
procedures can potentially eliminate the analytical bottleneck in high-throughput 
process development.  
  
8.2.3. Experimental Design to Best Utilise Increased Experimental Throughput 
In addition to a well-planned analytical strategy, the smart experimental design of 
microscale experiments is another important means to avoiding analytical gridlock 
and improving the overall efficiency of process development.  Options for 
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experimental design may include simple brute-force approaches like the one used in 
Chapter 5, conventional DoE methodologies such as factorial and central composite 
designs, and complex iterative approaches such as simplex and genetic algorithms.  
A particularly fascinating concept known as the 'Robot Scientist' has recently 
emerged (Whelan and King, 2004; King et al., 2009) with respect to experimental 
design.  A Robot Scientist borrows from techniques in the field of artificial 
intelligence and consists of programmable hardware and intelligent software.  This 
software integrates the physical experimentation with results analysis, formation of a 
hypothesis, and subsequent experimental design.  King et al. (2009) recently 
demonstrated a Robot Scientist known as 'Adam' for the identification of genes 
encoding orphan enzymes in Saccharomyces cerevisiae.  Some have criticised this 
concept by arguing that what is discovered by the Robot Scientist is often implicit in 
the formulation of the problem.  However, for the empirical optimisation typical of 
bioprocess development, this may not necessarily be problematic.  Clearly then, the 
Robot Scientist concept offers an exciting opportunity for automated microscale 
bioprocessing, but is just emerging as an area of future work.  
 
8.2.4. A Vision for Microscale Bioprocess Development 
Microscale techniques hold the promise of transforming bioprocess development, but 
the fulfilment of this promise depends on their routine integration into the workflow 
for both early- and late-stage development.  Early-stage integration is 
straightforward, with these methods used to acquire information about likely trends 
in output variables across the operating space that can be used subsequently to 
minimise the scope of the ensuing laboratory-scale development.  However, their 
integration into late-stage development is considerably more difficult, since to be of 
most value, these techniques must be validated for their capacity to accurately predict 
the absolute values of process-scale outputs. 
 
8.2.4.1. High-Throughput Examination of the Parameter Space 
In the simplest scenario, microscale experiments are used to rapidly locate optimal 
ranges for the ensuing laboratory studies, as outlined in Figure 1.6.  This strategy was 
used for the mixed mode chromatography development described in Chapter 5 and 
also in the high-throughput approaches published by Coffman et al. (2008) and 
Chhatre et al. (2009).  The advantage of this strategy is that although the microscale 
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technique needs be predictive of trends in large-scale operation, it does not have the 
burden of needing to be a fully validated scale-down model.  The disadvantage 
though is that some laboratory-scale experiments are still required.  This strategy is 
analogous to an explorer searching for a lost city on an island out at sea.  In this 
analogy, high-throughput microscale methods are used to narrow the search, i.e. 'find 
the island in the sea'.  A few focused laboratory-scale experiments are then 
performed to verify the microscale results and locate the optimum, i.e. 'verify that 
you have landed upon the right island and then find the city on the island'.  Although 
laboratory-scale experiments are not entirely eliminated, this approach nevertheless 
builds in improved quality by increasing knowledge of the operating window, even if 
these data cannot be formally used from a regulatory perspective to support process 
validation ranges.  
 
8.2.4.2. Validated Micro Scale-Down Models  
Achieving the full potential of microscale bioprocessing techniques ultimately 
depends on having validated methods which can be used to quantitatively predict 
pilot- or manufacturing-scale performance, without the need for intermediate 
laboratory-scale verification.  To do so, these validated microscale techniques may 
have to rely on the use of predictive modelling or engineering correlations.  The 
microscale multi-step VLP purification described in this thesis is an example of one 
such opportunity.  While correlation of the micro-tip data with the laboratory scale 
results was established with respect to purity and recovery, such a correlation with 
pilot and manufacturing scales was not examined.  Another possible opportunity 
comes from the ultra scale-down work by Hutchinson et al. (2006) in which shear 
stresses on cells in the feed zone of an industrial-scale continuous centrifuge were 
examined using a small-scale shear device.  These researchers used these data in 
combination with laboratory-scale test tube centrifuge studies to successfully predict 
the performance in the large-scale centrifuge.  For a chromatography step, this same 
research group (Hutchinson et al., 2009) demonstrated an ultra scale-down approach 
in which a 1-mL laboratory-scale protein A column was used to predict the elution 
profile of an 18.3-L pilot-scale column.  This was achieved by applying empirical 
correction factors derived from changes in the conductivity profile to account for 
differences in dispersion and retention between the scales.   
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Having validated scale-down techniques for late-stage development enables their 
formal use in setting process validation ranges and supporting the definition of a 
manufacturing design space.  However, developing these methods and subsequently 
validating them is a formidable task, especially in the highly regulated environment 
of biopharmaceuticals.  Therefore, this remains an important but very challenging 
area of future work. 
 
8.2.4.3. An Integrated Strategy for Bioprocess Development 
A strategy for the full integration of microscale bioprocess techniques into routine 
process development is proposed in Figure 8.1.  This strategy includes the use of 
screening methods for early-stage development as well as validated scale-down 
methods for late-stage process definition.  Instead of following a linear sequence, as 
the one shown in Fig 1.6, this strategy is more dynamic, with information flowing 
back and forth between stages.  A typical workflow might first use high-throughput 
microscale techniques to screen a wide range of conditions in order to guide 
laboratory-scale development, with the details of the experimental design depending 
on prior experience, expert knowledge, the number of potential variables, and the 
DoE methodology employed.  The results of the microscale experiments would then 
be verified and optimised at the laboratory scale.  However, additional microscale 
experiments might sometimes be required if there were any unexpected findings at 
the laboratory scale, especially if this meant performing a large number of follow-up 
experiments.  After these additional microscale experiments, laboratory-scale 
verification would again ensue, followed by scale-up to the pilot and manufacturing 
scales.  Any unforeseen issues at the production scale, as well as initiatives for 
process improvement, might trigger additional microscale and laboratory-scale 
experiments.   
 
As an alternative to this workflow, validated microscale methods might be used, 
allowing conventional laboratory-scale development to be bypassed all together.  The 
validated methods would then be used to define optimal process ranges at the pilot or 
manufacturing scale, and later on, to troubleshoot unforeseen issues that arise at 
these scales.  High-throughput screening methods might still precede the use of these 
validated microscale methods if doing so improved the overall efficiency of process 
development.  In this way, microscale techniques become an integral element of the 
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process development workflow, with a number of paths available for achieving a 
robust final manufacturing process.  The further refinement and implementation of 
this vision for microscale process development is an important area of future work.   
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Figure 8.1. Integration of microscale bioprocess techniques into the process development workflow.  Microscale experiments can be used for 
early-stage development and late-stage range finding, troubleshooting, or process development experiments.  This integrated approach facilitates 
quality-by-design process development.   
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